Studies on the structure and function of protein kinase G, a virulence factor of "Mycobacterium tuberculosis" by Scherr, Nicole
  
 
 
 
 
Studies on the Structure and Function of Protein Kinase G, 
 
a Virulence Factor of Mycobacterium tuberculosis 
 
 
 
 
 
 
 
Inauguraldissertation 
 
 
 
 
zur 
 
 
Erlangung der Würde eines Doktors der Philosophie 
vorgelegt der 
Philosophisch-Naturwissenschaftlichen Fakultät 
der Universität Basel 
 
 
von 
 
 
 
 
Nicole Scherr 
aus Landau/Pfalz, Deutschland 
 
 
 
 
Basel, 2008 
 
 
  
 
Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von  
Prof. Jean Pieters, Prof. Peter Philippsen und Dr. Michel Steinmetz. 
 
Basel, den 24. Juni 2008 
 
                                                                                                                 Prof. Hans-Peter Hauri 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
The work described in this thesis has been performed from August 2004 to April 2008 
at the Biozentrum, Department of Biochemistry, University of Basel, Switzerland, in 
the laboratory of Prof. Jean Pieters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table of contents 
 
 
 
 
CHAPTER 1:  The Eukaryotic-like Serine/Threonine Protein Kinase Family    
                         in Mycobacteria                                                                                    1
             
1.1 Signal transduction systems………………………………………………………… .2 
1.2 Appearance of eukaryotic-like serine/threonine protein kinases in  
      mycobacteria………………………………………………………………………… .3 
1.3 Mycobacterial kinases………………………………………………………............. .5 
1.3.1 Group I Serine/Threonine Kinases: Protein Kinases A, B and L…………….7 
1.3.2 Group II Serine/Threonine Kinases: Protein Kinases D, E and H…….......... 11 
1.3.3 Group III Serine/Threonine Kinases: Protein Kinases F, I and J…………....17 
1.3.4. Group IV Serine/Threonine Kinases: Protein Kinases K and G………….... 19 
1.4 Protein kinases in the context of drug design……………………………………... 22 
1.4.1 Tuberculosis – a global threat to human health…………………………….. 22 
1.4.2 Inhibition of mycobacterial kinases……………………………………….... 22 
1.4.3 Requirements for the development of potent kinase inhibitors…………….. 23 
1.5 Synopsis and concluding remarks………………………………………………….. 25 
1.6 References…………………………………………………………………………… 26 
1.7 Aim of the thesis……………………………………………………………………... 31
          
 
 
CHAPTER 2:  Material and Methods       32 
 
2.1 Reagents………………………………………………………………………………33    
2.2 Kits…………………………………………………………………………………… 36 
2.3 Columns……………………………………………………………………………… 37 
2.4 Radiochemicals……………………………………………………………………… 37 
2.5 General buffers and solutions………………………………………………………. 38 
2.6 Bacterial media and supplements…………………………………………….......... 40 
2.7 Eukaryotic cell culture media and supplements……………………………….….. 41 
2.8 Vectors……………………………………………………………………………….. 42 
2.9 Primers………………………………………………………………………………. 44 
2.10 Antibodies and dyes……………………………………………………………….. 46  
2.11 Bacterial strains and culture conditions…………………………………….......... 47 
2.12 Eukaryotic cells and culture conditions………………………………………….. 48 
2.13 Molecular genetics methods………………………………………………………. 48 
2.13.1 Preparation of ultracompetent E. coli DH10β……………………….......... 48 
2.13.2 Preparation of electrocompetent E. coli DH5α/BL21……………….......... 48 
2.13.3 Preparation of electrocompetent M. bovis and M. tuberculosis.................... 49 
2.13.4 Preparation of electrocompetent M. smegmatis…………………………… 49 
2.13.5 Transformation of ultracompetent E. coli DH10β……………………….... 49 
2.13.6 Transformation of electrocompetent E. coli DH5α/BL21………………… 50  
2.13.7 Transformation of M. bovis BCG and M. tuberculosis…………………… 50 
2.13.8 Transformation of M. smegmatis.................................................................. 50 
  
2.13.9 Preparation of bacterial stocks…………………………………………...... 51 
2.13.10 Agarose gel electrophoresis…………………………………………...…. 51  
2.13.11 Preparation of plasmid DNA from E. coli cultures……………………… 51 
2.13.12 Digestion of plasmid DNA by restriction enzymes…………………….... 51 
2.13.13 Dephosphorylation of DNA……………………………………………… 51 
2.13.14 Purification of DNA from agarose gels………………………………….. 51 
2.13.15 Ligation of insert and vector……………………………………………... 51 
2.13.16 Precipitation of DNA……………………………………………….......... 52 
2.13.17 Sequencing………………………………………………………….......... 52 
2.13.18 Polymerase chain reaction (PCR)…………………………………........... 52  
2.13.19 Colony PCR……………………………………………………………… 53 
2.13.20 Site-directed mutagenesis…………………………………………........... 54 
2.13.21 Construction of different expression vectors………………………...…... 55  
 
2.14 Cell culture methods………………………………………………………………. 56 
2.14.1 Thawing eukaryotic cells…………………………………………….......... 56 
2.14.2 Determination of cell numbers……………………………………………. 57 
2.14.3 Splitting of J774 macrophages……………………………………….......... 57 
2.14.4 Trypsinization of adherent cells……………………………………............ 57 
2.14.5 Preparation of cell stocks………………………………………………...... 57  
2.14.6 Preparation of murine bone marrow derived macrophages……………….. 57 
2.14.7 Testing cells for mycoplasma contamination………………………........... 58 
2.14.8 Transfection of cells………………………………………………………. 58 
2.14.9 Infection of J774 and bone marrow macrophages………………………… 58 
 
2.15 Biochemical methods………………………………………………………………. 58 
2.15.1 Determination of protein concentrations…………………………….......... 58 
2.15.2 Discontinuous SDS polyacrylamide gel electrophoresis (SDS-PAGE)…... 59 
2.15.3 Western Blotting…………………………………………………………... 59 
2.15.4 Stripping of membranes for reprobing……………………………...…….. 60 
2.15.5 Expression of PknG……………………………………………………….. 60 
2.15.6 Purification of PknG………………………………………………………. 61 
2.15.7 Aging assay…………………………………………………………........... 62 
2.15.8 Analytical gel filtration……………………………………………………. 62 
2.15.9 Kinase assay………………………………………………………….......... 63 
2.15.10 Inhibitor screen (ProQinase/Freiburg)…………………………………… 63 
2.15.11 Phosphorylation and dephosphorylation of PknG………………….......... 64 
2.15.12 Limited proteolysis………………………………………………………. 64 
2.15.13 Electroblotting proteins to PVDF membranes…………………………… 64 
2.15.14 Preparation of M. bovis BCG lysates…………………………………….. 65 
2.15.15 Cell fractionation of mycobacterial lysates……………………………… 65 
2.15.16 Size-exclusion chromatography of mycobacterial lysates……………….. 65 
2.15.17 Chemical crosslinking of mycobacterial lysates…………………………. 66 
2.15.18 Preparation of lysates from eukaryotic cells……………………………... 66 
 
2.16 Biophysical methods………………………………………………………….......... 66 
2.16.1 Optimum solubility screen………………………………………………… 66  
2.16.2 Static light scattering……………………………………………………… 67  
2.16.3 Circular dichroism spectroscopy………………………………………….. 67 
2.16.4 Crystallization……………………………………………………………... 67 
2.16.5 Structure determination…………………………………………………… 68 
  
2.16.6 Crystallographic data and refinement statistics…………………………… 69  
2.16.7 Sequence analysis…………………………………………………………. 70 
 
2.17 Cellular assays……………………………………………………………………... 70 
2.17.1 Phagocytosis of mycobacteria by J774 macrophages……………………... 70 
2.17.2 Proliferation assay………………………………………………………… 70 
2.17.3 Survival assay……………………………………………………………... 71 
2.17.4 Protein translation assay…………………………………………………... 71 
2.17.5 Cell organelle electrophoresis…………………………………………..…. 72 
2.17.6 Video microscopy…………………………………………………………. 72 
2.17.7 Growth of mycobacteria…………………………………………………... 72 
 
2.18 Microscopy…………………………………………………………………………. 73 
2.18.1 Staining cells for immunofluorescence microscopy………………………. 73 
2.18.2 Measuring cell length of Ag84 expressing mycobacteria…………………. 74 
2.18.3 Localization of Ag84 within mycobacteria………………………….......... 74 
2.18.4 Lysosomal trafficking……………………………………………………... 74 
 
2.19. References…………………………………………………………………………. 75 
 
 
 
CHAPTER 3:  Structural Basis for the Specific Inhibition of PknG,  
                          a Virulence Factor of Mycobacterium tuberculosis   76 
 
3.1 Introduction…………………………………………………………………………. 77 
3.2 Results………………………………………………………………………………... 79 
3.2.1 Specificity of the PknG inhibitor AX20017………………………………... 79 
3.2.2 Purification of PknG………………………………………………………... 80 
3.2.3 Defining PknG∆N…………………………………………………………... 83 
3.2.4 The structure of PknG………………………………………………………. 85 
3.2.5 The tetratricopeptide repeat containing domain……………………………. 86 
3.2.6 The kinase domain………………………………………………………….. 88 
3.2.7 The rubredoxin motif……………………………………………………….. 90 
3.2.8 Structure of the AX20017-binding pocket……………………………......... 91 
3.3 Discussion……………………………………………………………………………. 95 
3.4 References…………………………………………………………………………… 97 
 
 
 
CHAPTER 4:  Analysis of PknG Autophosphorylation      99 
 
4.1 Introduction…………………………………………………………………………. 100 
4.2 Results………………………………………………………………………………... 102 
4.2.1 PknG autophosphorylation……………………………………………......... 102 
4.2.2 Analysis of PknG kinase activity in the absence of autophosphorylation….. 103 
4.2.3 Role of PknG autophosphorylation on intracellular trafficking and  
         survival of pathogenic mycobacteria………………………………….......... 104 
4.2.4 Analysis of intracellular survival of internalized mycobacteria……………. 105 
4.3 Discussion……………………………………………………………………………. 107 
4.4 References…………………………………………………………………………… 108 
  
CHAPTER 5:  Localization of PknG within Eukaryotic Cells            109 
 
5.1 Introduction…………………………………………………………………………. 110 
5.2 Results………………………………………………………………………………... 111 
5.2.1. Localization of PknG in eukaryotic cells…………………………………... 111 
5.2.2. Construction of a mycobacterial FLAG-PknG vector to be used for  
          infections………………………………………………………………….... 117 
5.3 Discussion……………………………………………………………………………. 118 
5.4 References…………………………………………………………………………… 119 
 
 
 
CHAPTER 6:  Antigen 84, an Effector of Pleiomorphism in    
                          Mycobacterium smegmatis              120  
 
6.1 Abstract…………………………………………………………………………….... 121 
6.2 Introduction…………………………………………………………………………. 121 
6.3 Results……………………………………………………………………………….. 124 
6.3.1 Effects of Ag84 overexpression on cell morphology………………………. 124 
6.3.2 Effects of Ag84 overexpression on cell size………………………………... 125 
6.3.3 Intracellular localization of Ag84…………………………………………... 127 
6.3.4 Oligomerization of Ag84………………………………………………….... 128 
6.4 Discussion……………………………………………………………………………. 131 
6.5 References…………………………………………………………………………… 133 
 
 
 
CHAPTER 7:  Summary and Conclusions              135 
 
 
 
APPENDIX                   138 
 
Appendix I: Abbreviations         138 
Appendix II: Acknowledgements        140 
         
 
 
 
 
 
 
 
 
_______________________________________________________________________________CHAPTER 1 
1 
 
 
- CHAPTER 1 - 
 
 
The Eukaryotic-like Serine/Threonine Protein Kinase Family  
in Mycobacteria 
 
 
 
 
 
 
 
 
Based on 
 
Book Chapter „Mycobacterium: Genomics and Molecular Biology“ 
Nicole Scherr und Jean Pieters 
 
(Caister Academic Press, January 2009) 
 
 
 
 
_______________________________________________________________________________CHAPTER 1 
2 
Mycobacteria have a complex life style comprising different environments and 
developmental stages. Signal sensing and transduction leading to cellular responses must be 
tightly regulated to allow survival under variable conditions. Prokaryotes normally regulate 
their signal transduction processes through two-component systems, however, the genome 
sequence of Mycobacterium tuberculosis revealed a large number of eukaryotic-like 
serine/threonine kinases. It is becoming clear that in M. tuberculosis, many of these kinases 
are involved in the regulation of metabolic processes, transport of metabolites, cell division 
and virulence. This chapter summarizes the current knowledge on eukaryotic-like 
serine/threonine protein kinases in mycobacteria. Investigating the biochemistry and the 
physiological role of these enzymes may lead to a better understanding of the signalling 
networks in mycobacteria. 
 
 
1.1 Signal transduction systems 
 
Cellular responses such as differentiation and adaptation are carried out by signal 
transduction systems, many of which are based on protein phosphorylation. Prokaryotes 
utilize two different principles to respond to their environment: The so-called two-component 
systems with kinases phosphorylating asparagine residues upon autophosphorylation of 
histidine residues, and, less frequently, eukaryotic-like kinases phosphorylating serine or 
threonine residues (Parkinson, 1993; Stock et al., 2000). 
 
Two-component systems consist of a membrane-bound sensor histidine kinase and a 
cytosolic response regulator (figure 1.1). The histidine kinase contains an extracellular 
domain responsible for binding of small molecular weight ligands. Binding of ligands leads 
to activation of the kinase domain resulting in autophosphorylation of a specific histidine 
residue. The activated phosphate group is then transferred to a conserved aspartate residue in 
the receiver domain of the response regulator, thereby activating the output domain. The 
activated output domain finally initiates the adequate cellular response (Dutta et al., 1999; 
Stock et al., 2000). 
 
Eukaryotic-like serine/threonine protein kinases employ the γ-phosphate of adenosine 
triphosphate (ATP) to form phosphate monoesters using the hydroxyl groups of serine or 
threonine as phosphate acceptors (figure 1.1). These enzymes share several conserved motifs 
within the two-lobed catalytic domain which consists of 250-300 amino acid residues. The 
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kinase domain contains 11 conserved subdomains (I-XI) folding into a complex catalytic 
core structure which carries out the following functions (Hanks and Hunter, 1995): 
 
a) binding and orientation of ATP complexed with a divalent cation such as  
            Mg2+ or Mn2+ 
b) binding and orientation of the protein substrate 
c) transfer of the γ-phosphate from ATP to the acceptor hydroxyl group of serine or 
            threonine 
 
Serine/threonine kinases can be either membrane-bound acting as signal receptors, or be 
located as a soluble molecule in the cytosol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2 Appearance of Eukaryotic-like Serine/Threonine Kinases in Bacteria 
 
Two-component systems have long been considered as the only signal transduction systems 
existing in prokaryotes. The expression of serine/threonine protein kinases was believed to be 
restricted to eukaryotes. However, due to the recent availability of hundreds of microbial 
genome sequences it is becoming apparent that serine/threonine protein kinases may also be 
widely expressed in the prokaryotic kingdom (CMR/TIGR database). While some species, 
Figure 1.1. Schemes showing a two-
component signal transduction 
system and a receptor-type 
serine/threonine kinase.  
Left side: Two-component system. 
The input domain of the histidine 
kinase detects a signal resulting in 
autophosphorylation of a conserved 
histidine residue. The phosphate is 
transferred to an aspartate residue in 
the receiver domain of the response 
regulator leading to activation of the 
output domain which then carries out 
the cellular response. Right side: 
Serine/threonine kinase: The receptor 
domain at the C-terminus of the 
protein senses the signal leading to a 
conformational change/activation of 
the kinase. The kinase domain located 
at the N-terminus binds ATP, whose γ-
phosphate is transferred to the acceptor 
serine or threonine residue of the 
bound substrate. 
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such as E. coli, possess only very few genes encoding serine/threonine kinases, other 
bacterial genomes, such as the ones from Anabaena and Myxococcus, display a high 
prevalence of these genes.  
 
The first serine/threonine protein kinase described in a prokaryote was protein kinase N1 
(Pkn1), expressed in Myxococcus xanthus. This soil bacterium is characterized by a complex 
social behavior; it grows vegetatively in the presence of nutrients but forms fruiting bodies 
upon starvation. Pkn1 was shown to play an important role in this differentiation process 
(Munoz-Dorado et al., 1991; Zhang et al., 1992). Another kinase also expressed by M. 
xanthus, protein kinase N2 (Pkn2), was the first receptor-type serine/threonine protein kinase 
identified in prokaryotes and found to function as a negative regulator of fruiting body 
formation (Udo et al., 1996; Udo et al., 1997). 
 
Regarding the origin of eukaryotic-like serine/threonine kinases in bacteria, two hypotheses 
have evolved: the first hypothesis states that genes encoding serine/threonine kinases were 
already present in the common ancestor of the phyla bacteria, archea and eukaryotes. 
Consequently, the kinase genes evolved and adapted to their genetic background or even 
disappeared in some prokaryotes (Han and Zhang, 2001; Ogawara et al., 1999; Ponting et al., 
1999). The second hypothesis postulates that genes encoding serine/threonine protein kinases 
were acquired by prokaryotes through horizontal gene transfer from eukaryotic organisms 
(Leonard et al., 1998; Ochman et al., 2000). In order to clarify the origin of prokaryotic genes 
encoding serine/threonine kinases, the G+C-content and codon usage of open reading frames 
has been analyzed. In Synechocystis sp. PCC 6803 and several other prokaryotic species 
including Mycobacterium tuberculosis (Han and Zhang, 2001; Ogawara et al., 1999) it was 
shown that G+C content and codon usage of individual open reading frames of 
serine/threonine kinases are similar to the average of all genes from this particular genome. 
These findings therefore suggest that the so-called eukaryotic-like kinases were already 
present before eukaryotes and prokaryotes diverged. Phylogenetic analysis of kinases within 
a certain species showed that they are only distantly related, supporting the theory that they 
have diverged early in evolution and evolved independently of each other (Han and Zhang, 
2001; Ogawara et al., 1999; Ponting et al., 1999). 
 
On the other hand, the horizontal transfer hypothesis is supported by the presence of certain 
eukaryotic domains (such as β-propeller domains) in prokaryotic serine/threonine kinases, 
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which implies that these domains were acquired from eukaryotic donors, possibly due to a 
parasitic life-style. Domains with universal distribution such as tetratricopeptide repeats and 
PDZ domains are likely to have been present already in the common ancestor of eukaryota, 
archea and bacteria (Ponting et al., 1999). 
 
 
1.3 Mycobacterial Kinases 
 
In mycobacteria, signal transduction processes occur through both two-component systems 
as well as serine/threonine protein kinases. Sequence analysis of the M. tuberculosis genome 
revealed the presence of genes encoding 11 two-component systems as well as 11 
eukaryotic-like serine/threonine protein kinases (Av-Gay and Everett, 2000; Cole et al., 1998; 
Ponting et al., 1999). Thus, as opposed to other bacterial species having comparable genome 
sizes, mycobacterial genomes contain a relatively low number of two-component systems 
and an unusual high number of serine/threonine protein kinases. However, it should be noted 
that the number of serine/threonine kinases varies from four in Mycobacterium leprae to 24 
in Mycobacterium marinum (Wehenkel et al., 2008). Interestingly, M. leprae is characterized 
by a lower G+C content and a 26% reduced genome size compared to M. tuberculosis (Cole 
et al., 2001). In addition, only about half of the genome codes for proteins, while the 
remaining sequences are regulatory or cover pseudogenes, which is in marked contrast to M. 
tuberculosis possessing over 90% protein coding genes. The extensive gene decay in M. 
leprae suggests that this mycobacterial species retained a minimal set of genes required for 
pathogenicity. Consequently, the four genes encoding serine/threonine kinases still present in 
its genome are regarded as essential and probably carry out crucial physiological functions 
(Cole et al., 2001) (figure 1.2). 
 
 
 
 
 
 
 
 
 
Figure 1.2. Members of the 
serine/threonine protein kinase 
family of M. tuberculosis. Based 
on their amino acid sequence, the 
receptor-like kinases can be 
clustered in three distinct groups: 
group I: PknA, PknB, PknL, 
group II: PknD, PknE, PknH and 
group III: PknF, PknI, PknJ. 
PknG and PknK, the soluble 
kinases, are only distantly related 
to the other kinases. In red boxes 
are the four kinases present in M. 
leprae. The phylogenetic tree was 
created using ClustalW and 
Phylodendron software. 
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Of the 11 kinases identified in the genome of M. tuberculosis, nine are typical receptor-like 
kinases containing a transmembrane domain, whereas two of these kinases are predicted to 
be cytosolic, namely protein kinase G (PknG) and protein kinase K (PknK) (Cole et al., 
1998). Based on their amino acid sequence similarity, the receptor kinases can be clustered in 
the following three distinct groups: PknA/PknB/PknL, PknD/PknE/PknH, and 
PknF/PknI/PknJ (Av-Gay and Everett, 2000; Gopalaswamy et al., 2004; Narayan et al., 2007) 
(Figure 1.2 and 1.3). All mycobacterial serine/threonine kinases possess eleven conserved 
motifs characteristic of Hanks-type kinases (Wehenkel et al., 2008) and are thus members of 
the Protein Kinase N2 family which is most closely related to eukaryotic serine/threonine 
kinases (Boitel et al., 2003, Cole et al., 1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Overview of the eleven eukaryotic-like serine/threonine protein kinases of M. tuberculosis 
grouped according to their sequence similarity. The N-terminally located kinase domains are labelled in light 
blue, characteristic features are indicated (CXXC: Thioredoxin motif, TPR: Tetratricopeptide repeat domain, PDZ 
domain: Post synaptic density protein (PSD95), Drosophila disc large tumor suppressor A (DlgA), and Zonula 
occludens-1 protein (zo-1), PASTA: Penicillin A binding and Ser/Thr kinase attached, NHL-β-propeller: Ncl-1, 
HT2A and Lin-41 proteins, Pro-rich: Prolin-rich region). 
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1.3.1 Group I Serine/Threonine Kinases: Protein Kinases A, B and L  
 
Protein kinase A (PknA) 
 
In M. tuberculosis, the genes coding for protein kinase A and protein kinase B (pknA and 
pknB) are located within a gene cluster encompassing two genes implicated in the synthesis 
of cell wall components (phpA and rodA) as well as mstP, which encodes the single 
mycobacterial serine/threonine phosphatase belonging to the protein phosphatase 2A (PP2A) 
family of protein phosphatases (Cole et al., 1998). MstP, a manganese-dependant 
phosphatase with a transmembrane domain, was shown to efficiently dephosphorylate PknA 
and PknB suggesting that MstP regulates the activity of these kinases (Chopra et al., 2003). 
The genes forming this operon are present across pathogenic and non-pathogenic 
mycobacterial species supporting the idea that their function is essential for survival of the 
bacteria (Narayan et al., 2007; Sassetti et al., 2003). Indeed, mycobacteria with PknA and 
PknB null mutations are not viable (Kang et al., 2005). 
 
Initial experiments involving PknA overexpression both in E. coli as well as in mycobacteria 
demonstrated that the cells became elongated, pointing to a possible role in DNA replication 
and segregation or, alternatively, in septum formation (Chaba et al., 2002; Kang et al., 2005). 
Interestingly, PknA overexpression resulted in mono-and bi-nucleoidal cells suggesting that 
PknA interacts with proteins implicated in septum formation (Chaba et al., 2002). The 
mutant cells displayed an irregular shape which included broad, long and branched 
mycobacteria. Protein kinase A was found to phosphorylate a conserved hypothetical protein 
of unknown function (Rv1422), and the Rv2145c gene product Wag31, also known as Ag84 
or DivIVA. Wag31, which contains a sequence motif identified by a peptide library screen, is 
an essential protein in M. tuberculosis involved in regulation of the cell shape and septum 
formation (Kang et al., 2005). Overexpression of Wag31 causes a phenotype which includes 
aberrant cell shapes and unbalanced septum formation (Nguyen et al., 2007). The specific 
interaction between PknA and Wag31 was confirmed in vitro by kinase assays and in vivo by 
Western Blot analysis including Wag31 overexpressing strains. It was shown that the 
phosphorylation state of Wag31 is crucial for its capacity to control cell shape formation 
(Kang et al., 2005).  
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Another substrate for PknA is bacterial FtsZ, a GTPase representing the homologue of 
eukaryotic tubulin which acts in septum formation. Phosphorylation on threonines abolishes 
the capability of mFtsZ to hydrolyze GTP as well as its property to polymerize (Dubnau et al., 
2000; Thakur and Chakraborti, 2006).  
 
Additional substrates for PknA have been reported recently. PknA is able to phosphorylate 
enzymes involved in the biosynthesis of mycolic acids which are considered as major 
virulence factors of mycobacteria (Dubnau et al., 2000). These substrates, KasA and KasB, 
are part of a fatty acid elongation system, the so-called FAS-II cycle, in which they control 
the synthesis of α-branched β-hydroxy fatty acids by catalyzing condensation steps. Another 
component of this pathway, mtFabD, which is encoded by the same operon, carries out the 
first condensation step and was also shown to be efficiently phosphorylated by PknA. It 
should be mentioned that these substrates which actually do not possess a FHA-domain, are 
phosphorylated by PknB, PknE, PknF, and PknH as well (Molle et al., 2006). 
 
Overall, these findings strongly support a role for PknA in the regulation of mycobacterial 
cell division and cell shape control. 
 
Protein kinase B (PknB) 
 
M. tuberculosis protein kinase B, whose genomic locus is conserved throughout 
Mycobacterium spp, was found to be essential in M. tuberculosis and M. smegmatis. Gene 
disruption was only possible by performing allelic gene replacements using a merodiploid M. 
tuberculosis strain; bacteria depleted of pknB were not viable (Wehenkel et al., 2006). Full 
length PknB as well as the catalytic domain alone display autophosphorylation activity (Av-
Gay et al., 1999) suggesting that regions external to the kinase domain are not required to 
stabilize an active conformation (Boitel et al., 2003). The extracellular domain of PknB 
contains four sequence repeats of 66-68 amino acids classified as so-called “Penicillin A 
binding and Ser/Thr kinase attached” (PASTA) domains (Yeats et al., 2002), which often 
occur in prokaryotic penicillin binding proteins and play a role in cell wall synthesis (Young 
et al., 2003). 
 
PknB, like PknA, is dephosphorylated by MstP, the only known serine/threonine phosphatase 
present in M. tuberculosis. Since the corresponding genes are located within the same operon, 
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a functional relationship is suggested (Boitel et al., 2003; Chopra et al., 2003). 
Dephosphorylation of PknB at Thr171 and Thr173 results in decreased kinase activity, 
demonstrating that the phosphorylation state of the activation loop regulates PknB activity 
(Boitel et al., 2003). 
 
PknB expression increases about 10-fold when the cells enter the stationary phase. Studies 
involving PknB overexpression and partial depletion of pknB resulted in severe 
morphological defects and reduced viability of the cells pointing to a role of PknB in 
controlling cell shape (Kang et al., 2005). 
 
A search for PknB substrates resulted in the identification of GarA (Rv1827), a 17.3 kDa 
protein, as the only soluble mycobacterial substrate (Villarino et al., 2005). At its C-terminus, 
GarA contains a forkhead-associated (FHA) domain (Durocher and Jackson, 2002). These 
domains are phosphoprotein recognition units (Durocher and Jackson, 2002; Pallen et al., 
2002) which form 11-stranded β-sandwiches mediating phosphorylation-dependent protein-
protein interactions. Notably, in GarA, the FHA-domain spans one third of the full protein 
length. Potential phospho-acceptor sites are located in the N-terminal region of GarA. Kinase 
assays with a truncated version of GarA as well as mass spectrometry analysis allowed the 
identification of a single phosphorylated residue in the GarA molecule. PstP treatment of 
PknB or mutating both autophosphorylation sites of the PknB catalytic loop led to a 
significant decrease of GarA phosphorylation implicating that recruitment of GarA is 
dependent on autophosphorylated and thus activated PknB. Interestingly, the interaction 
between PknB-GarA is not dependent on GarA phosphorylation, suggesting that the PknB 
catalytic domain is not involved in the interaction (Villarino et al., 2005). It should also be 
realized that various FHA-containing proteins can be phosphorylated by other mycobacterial 
kinases, including PknA, PknB, PknD, PknE, PknF, PknG and PknH (Grundner et al., 2005; 
Molle et al., 2003; Molle et al., 2004; Sharma et al., 2006). Therefore, GarA might be a 
generic substrate for this class of serine/threonine kinases, rather than a physiological 
substrate within living bacteria (Sharma et al., 2006). 
Besides GarA, Penicillin binding protein A (PBPA), which belongs to a group of serine acyl 
transferases involved in peptidoglycan synthesis (Popham and Young, 2003), has been 
shown to localize to the septa and to be phosphorylated by PknB (Dasgupta et al., 2006). 
Mutagenesis of Thr437, a potential phosphorylation site of PBPA, results in a reduced 
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growth rate and mis-localization suggesting that PknB phosphorylates PBPA, thereby 
targeting it to the septum (Dasgupta et al., 2006). 
 
Elucidation of the atomic structure of PknB revealed that the intracellular kinase domain of 
268 amino acids is connected through a short linker region to the transmembrane helix and 
the extracellular domain (Young et al., 2003). The overall fold of the kinase domain 
displayed the characteristic two-lobed structure consisting of an N-terminal subdomain with 
a curled β-sheet and a long αC-helix and a C-terminal lobe containing α-helices (Ortiz-
Lombardia et al., 2003). The closest structural relative of PknB was found to be the cAMP-
dependent protein kinase (cAPK) in its activated state (Young et al., 2003). Most 
conformational signatures within the catalytic domain pointed to an universally active state 
(meaning closed conformation) when compared to eukaryotic kinases; however, the disorder 
of the activation loop and the position of αC-helix were considered as striking, but could be 
explained by the fact that hyperphosphorylation of the activation loop might be responsible 
for the observed disorders. A high degree of conservation was found in the area of the ATP 
binding pocket as well as on the “backside” of the N-terminal lobe (Young et al., 2003). 
 
Recently, the catalytic domain of PknB was crystallized in complex with mitoxantrone, an 
ATP competitive drug used in cancer treatments (Shenkenberg and Von Hoff, 1986; 
Wehenkel et al., 2006). The inhibitor is bound in a hydrophobic cleft that is usually occupied 
by ATP. Mitoxantrone does not fully exploit the shape of the ATP binding pocket suggesting 
a potential to optimize the drug. Based on the fact that the PknB-mitoxantrone complex 
crystallized as a back-to-back homodimer consisting of similar monomers having a different 
space group as observed previously, it was assumed that this conformation has physiological 
relevance. Comparisons with dimerized PKR, the human RNA-dependent antiviral protein 
kinase (Dar et al., 2005), as well as with the PknB-like protein kinase PrkC from B. subtilis 
(Madec et al., 2002) led to the assumption that the extracellular domain of PknB could 
trigger back-to-back homodimerization. Oligomerization in turn allows regulation of PknB 
activity, presumably by autophosphorylation of threonine residues within the activation loop. 
 
The fact that PknB, like PknA, is an essential kinase has made these molecules potential 
targets for the development of anti-tuberculosis compounds. Together with results discussed 
later in this chapter, such a strategy may ultimately result in the successful targeting of PknA 
and B in order to block growth of M. tuberculosis. 
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Protein kinase L (PknL) 
 
PknL is composed of 399 amino acids corresponding to a calculated molecular weight of 
42.8 kDa. PknL differs from the other receptor-like kinases in that its transmembrane domain 
is located at the extreme C-terminus. Together with PknA, PknB and PknG, PknL belongs to 
those mycobacterial kinases with homologues in the pathogen M. leprae and is therefore 
considered as essential for virulence. Bioinformatic analysis has revealed that PknL 
homologues in other species of actinobacteria possess a PASTA domain (Yeats et al., 2002), 
an extracellular sensor domain, which in mycobacteria is also found in PknB, pointing to the 
possibility that these two kinases might have a common origin (Narayan et al., 2007). This 
assumption is further supported by the analysis of the pknL gene locus in M. tuberculosis. As 
observed for pknB, the pknL gene is part of a 30 kb cluster which encompasses several genes 
involved in cell wall synthesis and cell division, suggesting that the two kinases might act in 
the same signal transduction cascade controlling cell division (Narayan et al., 2007). Recent 
work identified Rv2175c, whose genomic locus is adjacent to pknL, as a substrate of PknL 
(Canova et al., 2008). The protein shares similarity with transcriptional regulatory proteins 
by containing a helix-turn-helix motif characteristic of DNA-binding proteins. 
Phosphorylation of Rv2175 was found to be dependent on a specific phosphorylated 
threonine residue, located within the activation loop of PknL (Canova et al., 2008). 
 
 
1.3.2 Group II Serine/Threonine Kinases: Protein Kinases D, E and H 
 
Protein kinase D (PknD) 
 
M. tuberculosis protein kinase D is a 69.5 kDa transmembrane protein which has an C-
terminal extracellular domain containing six tandem repeats of a module size of 40 amino 
acids. The gene encoding PknD is located between pstS-2 and pstA-1, two genes encoding a 
phosphate-binding protein and a membrane-bound phosphate permease protein subunit. Due 
to this chromosomal arrangement, a role for PknD in regulating phosphate transport has been 
proposed, although no experimental evidence exists at present (Peirs et al., 2005). PknD from 
M. tuberculosis localizes to the cell envelope, whereas PknD from M. bovis BCG is a 
truncated protein of 31 kDa, lacking the transmembrane and the C-terminal regulatory 
domain, and is therefore likely to act as a cytoplasmic kinase (Peirs et al., 2000). 
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As with many other serine/threonine kinases, PknD possesses autophosphorylation activity 
and shows a rather complex phosphorylation pattern. The phosphorylation sites are located 
within the kinase domain including the activation loop (Thr169, Thr171, Thr173) as well as 
in a segment close to the kinase domain (Duran et al., 2005; Virginie Molle, 2006). Purified 
PknD is able to phosphorylate the forkhead-associated domain A (FHA-A) of Rv1747, which 
provides evidence that an interacting partner does not always originate from the same operon 
(Grundner et al., 2005). A multiply phosphorylated potential substrate of 83 kDa was found 
by 2D-gel analysis and subsequently identified as MmpL7, a membrane protein with 12 
transmembrane regions (Perez et al., 2006). In total, 13 MmpL genes exist in M. tuberculosis; 
many of these are located close to genes coding for proteins involved in fatty acid or 
polyketide synthesis. MmpL7 is believed to be involved in virulence, since it is responsible 
for the transport of phtiocerol dimycoceroserate (PDIM) and sulfolipid-N that are important 
mycobacterial cell wall components. However, a direct interaction between PknD and 
MmpL7 is unlikely, since the MmpL7 phospho-acceptor sites are extracellular whereas the 
kinase domain of PknD is located within the cytosol (Perez et al., 2006). 
 
To elucidate the role of PknD in signalling, PknD was expressed under control of an 
acetamide-inducible promoter (Greenstein et al., 2007). A gene homologous to anti-anti-
sigma factors, Rv0516c, was observed to be significantly induced upon PknD overexpression. 
It was found that PknD specifically phosphorylates Rv0516c on one single threonine residue; 
the reaction was inhibited by SP600125, a c-Jun N-terminal kinase inhibitor, in a dose-
dependent manner (Greenstein et al., 2007). The fact that an anti-anti-sigma factor is 
regulated by an eukaryotic-like serine/threonine kinase is an unexpected finding, since these 
proteins are usually regulated by anti-sigma factors.  
 
Not much is known about the sensor domains of the mycobacterial kinases that react to 
external signals. Based on structure predictions, the PknD sensor domain has been proposed 
to contain a ß-propeller, a motif found in diverse eukaryotic proteins. The structure of the 
261 amino acid PknD sensor domain (figure 1.4) has been solved at a resolution of 1.8 Å, 
revealing that the sensor domain forms a ß-propeller consisting of six blades which are 
arranged in a circle around a central pore (Good et al., 2004). The blades are characterized by 
high internal sequence conservation, as opposed to the loops, which show considerable 
variability. Loops connecting the blades form a cup-like structure which often comprises the 
active site or a functional binding surface. Due to the remarkable sequence identity of the 
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blades, it has been speculated that PknD might in fact bind six homologous ligands (figure 
1.4). Alternatively, PknD may interact via its variable residues with a single asymmetric 
ligand (Good et al., 2004). 
 
 
 
 
 
 
 
 
 
 
Dimerization of PknD leads to allosteric activation of the kinase (Greenstein et al., 2007), a 
mechanism that has also been proposed for PknB, PknE, PknG, and PknK, since these 
kinases contain N-terminally located potential interaction domains. It is unlikely to occur in 
PknA, PknF, PknH, PknI and PknJ because of the different predicted N-terminal structures of 
these kinases (Greenstein et al., 2007). 
 
Protein kinase E (PknE) 
 
Biochemical characterization of PknE revealed that this kinase becomes autophosphorylated 
on multiple serine and threonine residues within the catalytic domain and especially in the 
activation loop (Duran et al., 2005; Molle et al., 2003a; Virginie Molle, 2006). Interestingly, 
phosphorylation of the juxtamembrane region was not only shown for PknE, but also for 
PknB, PknD and PknF, indicating that these sites could be relevant for stability, activity or 
alternatively, for binding of interacting partners (Duran et al., 2005). PknE was found to 
phosphorylate Rv1747, a putative ABC transporter which is also a substrate for PknB, PknD 
and PknF (Grundner et al., 2005). Moreover, PknE phosphorylates GarA in vitro, which, as 
mentioned, is also phosphorylated by several other protein kinases (Villarino et al., 2005).  
 
The PknE kinase domain is a homodimer in analogy to PknB with which it shares 37% 
sequence similarity (Gay et al., 2006). However, some interactions across the dimer interface 
clearly differ in PknE as compared to PknB. The PknE subunits adopt an open conformation 
characteristic of inactive serine/threonine kinases although the soluble protein was 
 
Figure 1.4. Sensor domain of PknD. Structure of the β-
propeller of PknD consisting of 6 identical blades 
(numbered 1-6) arranged around a central pore. Each blade 
is composed of four antiparallel β-strands. Loops connecting 
the blades form a cup-like structure which often comprises 
the active site or a functional binding surface. Indicated by a 
box is the topological overlap which holds the structure 
together (taken from Good et al., JMB, 2004) 
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phosphorylated and active (but as well monomeric). The conformation of critical catalytic 
residues within the kinase domain indicates that PknE is unable to bind ATP (Gay et al., 
2006). 
 
The promoter of pknE responds to nitric stress. Exposure to nitric oxide donors such as 
sodium nitroprusside (SNP) or S-nitrosoglutathione (GSNO) leads to up-regulation of 
promoter activity. In contrast, transcription is downregulated by hydrogen peroxide thus 
supporting the idea that pknE expression is not required during oxidative stress (Jayakumar et 
al., 2007). 
 
To elucidate a role for PknE, the pknE gene was deleted by specialized transduction. 
Mycobacteria lacking PknE showed no growth defect or differential sensitivity towards nitric 
stress (Jayakumar et al., 2007). However, the mutant strain was more sensitive to reducing 
agents, such as dithiotreitol (DTT) and reduced glutathione (Otter et al., 1992), and to certain 
metal ions, such as Zn and Cd. Based on these findings, a role for PknE in scavenging nitric-
oxide free radicals is proposed, which would increase the resistance to this innate defence 
mechanism during macrophage infection. 
 
The observed sensitivity to reducing agents can be explained by the presence of a protein 
disulfide isomerase DSBA-like thioredoxin domain at the C-terminus of PknE. Proteins 
harbouring such CXXC-motifs are thought to be involved in redox signalling or -homeostasis. 
Pathogenic species, such as Neisseria meningitides, express disulfide oxidoreductases, 
members of the thioredoxin family which contain CXXC motifs at their active site. These 
enzymes act as chaperones and reduce their substrates, mostly membrane-bound or exported 
proteins, to ensure stability or proper folding (Tinsley et al., 2004). Mycobacteria encounter 
different redox environments, ranging from aerobic conditions of free-living bacteria to an 
oxygen-depleted situation in granulomas; a lifestyle which requires a tight adaptation and 
regulation of protein function, and the presence of CXXC motifs in mycobacterial 
serine/threonine kinases may help to regulate protein function appropriately. 
  
Since the presence of nitric oxide can be linked to host cell apoptosis, the M. tuberculosis 
∆pknE mutant was used in a macrophage infection model and the possible contribution of 
PknE to apoptosis was studied. Apoptosis was found to be significantly increased in the case 
of the mutant strain and the apoptotic effect was even more pronounced upon treatment of 
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macrophages with a nitric oxide donor indicating that PknE plays a cytoprotective role. In 
addition, proliferation of ∆pknE mycobacteria inside macrophages as well as the cytokine 
response of TNF-α and IL-6 were considerably reduced (Jayakumar et al., 2007).  
 
Protein kinase H (PknH)  
 
Adjacent to the C-terminus of its kinase domain, PknH features a proline-rich region with 38 
proline residues distributed over a stretch of 107 amino acids. This region was proposed to 
function as a linker region or to mediate substrate binding. Like other mycobacterial 
serine/threonine kinases, PknH was shown to undergo autophosphorylation in the presence of 
divalent ions and to phosphorylate histones as exogenous substrate (Molle et al., 2003; 
Sharma et al., 2004). 
 
Low pH values and heat shock (42°C) decrease PknH expression significantly, but oxidative 
stress, hypoxia or nutrient deprivation have no influence on transcription levels. The fact that 
pknH is not present in non-pathogenic species, such as M. smegmatis, and the observation 
that its expression is induced under certain stress conditions suggests that PknH could play a 
role in sensing stress factors occurring in a hostile environment (Sharma et al., 2004). 
 
The pknH gene is located downstream of the embR gene, that encodes a putative 
transcriptional activator assigned to the OmpR-like family. EmbR was proposed to control 
the transcription of the emb operon, which in M. tuberculosis consists of the embA, embB 
and embC genes (Sharma et al., 2006). The corresponding proteins are arabinosyltransferases 
involved in the synthesis of arabinan, which is a complex homopolymer integrated in the cell 
wall components arabinogalactan or lipoarabinomannan (LAM), the latter one being an 
important virulence factor (Molle et al., 2003). The structure of EmbR revealed the existence 
of a N-terminal helix-turn-helix DNA binding domain, a central bacterial transcription 
activation domain and a C-terminal forkhead-associated domain containing the 
phosphothreonine recognition motif (Alderwick et al., 2006). Autophosphorylation of the 
activation loop of PknH has a regulatory role and is required for activation of the kinase. 
Furthermore, EmbR phosphorylation by PknH is mediated by the FHA domain of EmbR, as 
proved in assays with mutated EmbR versions (Molle et al., 2003). 
 
Phosphorylation dependent DNA binding activity of EmbR is necessary for positive 
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regulation of the embCAB operon. High levels of arabinosyltransferases result in a high 
LAM:lipomannan (LM) ratio which is directly correlated with an increase in mycobacterial 
virulence (Sharma et al., 2006). A high LAM:LM ratio allows the bacteria to suppress the 
immune response of the host, since the arabinan domain of LAM inhibits the 
proinflammatory activity of LM on macrophages (Sharma et al., 2006). In addition, 
expression levels during the transition phase from extracellular to intracellular lifestyle were 
studied. Interestingly, it was found that PknH expression is significantly upregulated within 
host cells (Sharma et al., 2006).  
 
Recently, a genomic region was identified in M. tuberculosis CDC1551, which encoded a 
gene highly homologous to EmbR (Molle et al., 2007). This gene, termed embR2, is not 
present in M. tuberculosis H37Rv. Although the domain organization and crucial amino acid 
residues within the FHA domain are similar, EmbR2 is not a substrate of PknH in vitro. 
However, other serine/threonine kinases tested were partially able to phosphorylate EmbR2, 
indicating a different substrate specificity. Since an interaction between PknH and EmbR2 as 
well as potential docking sites within PknH were found, it was assumed that EmbR2 acts as 
an inhibitor of PknH. By performing kinase assays, dose-dependent inhibition of PknH 
autophosphorylation, as well as inhibition of EmbR substrate phosphorylation was confirmed. 
These findings suggest that EmbR2 might act as a key regulator of PknH activity which in 
turn mediates phosphorylation of EmbR. Furthermore, an ATP-competitive CDK inhibitor 
named O6-cyclohexylmethylguanine was found to efficiently inhibit PknH activity. PknD 
and PknE, which, based on their amino acid sequence, are closely related to PknH, were 
inhibited as well, but no inhibition was observed for the kinases PknA, PknB, PknF, PknK 
and PknL (Molle et al., 2008). 
 
To identify a possible role of PknH in free-growing bacteria or during infection, a strain with 
a pknH deletion was constructed and tested. Since the phosphorylation state of PknH is likely 
to be regulated by intracellular signals, such as reactive oxygen species and nitric oxide 
produced by the host, the bacteria were assayed for survival under these conditions. The 
∆pknH strain displayed a higher tolerance to acidified sodium nitrite, but was more sensitive 
to peroxide and superoxide, and showed decreased viability compared to the control strains. 
However, infection of mice with M. tuberculosis lacking pknH resulted in a higher bacterial 
load compared to the load obtained in mice infected with wildtype M. tuberculosis; this 
effect of increased in vivo growth and survival was even more pronounced at late time points 
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of infection. These results suggest that PknH plays an important role in mycobacterial growth 
in the chronic phase of infection (Papavinasasundaram et al., 2005).  
 
To identify potential substrates, 40 candidate proteins were selected by a bioinformatics 
approach. DacB1 and Rv0681, both proteins which do not possess a FHA domain, were 
analyzed in detail (Zheng et al., 2007). DacB1 is a membrane-bound protein, a penicillin-
binding protein/carboxypeptidase, which is implicated in cell wall biosynthesis in B. subtilis 
(Buchanan et al., 1992). Rv0681 is a transcriptional regulatory protein possessing a TetR-
type helix-turn-helix motif (Zheng et al., 2007). Direct phosphorylation of DacB1 and 
Rv0681 was confirmed by performing in vitro kinase assays (Zheng et al., 2007). 
 
 
1.3.3 Group III Serine/Threonine Kinases: Protein Kinases F, I and J 
 
Protein kinase F (PknF) 
 
PknF, a protein of 476 amino acids, has been found to localize to the cell envelope (Koul et 
al., 2001). The operon to which pknF belongs, contains another gene, Rv1747, encoding a 
putative ATP binding cassette transporter. These transporters are translocators responsible 
for the uptake and export of various molecules across the cell membrane, in a process 
coupled to ATP hydrolysis. Since phosphorylation is known to regulate stability and activity 
of ABC transporters, a functional relationship between PknF and Rv1747 was investigated. 
Interestingly, Rv1747 is the only protein in the M. tuberculosis genome possessing two 
forkhead-associated domains, suggesting that its function may be extensively regulated 
through phosphorylation. PknF phosphorylates Rv1747 in vitro, and mutation of each of the 
two N-terminally located FHA domains on Rv1747 results in a significant decrease in 
phosphorylation (Molle et al., 2004). 
 
A physiological role for PknF was analyzed by an antisense approach in M. tuberculosis, as 
well as by expressing PknF in M. smegmatis, which normally does not express PknF. M. 
tuberculosis expressing antisense RNA against PknF had a shorter generation time and the 
cells had bulbous ends and abnormal septa (Deol et al., 2005). Conversely, expression of 
PknF in M. smegmatis resulted in reduced growth and in drastic morphological changes. 
These observations suggest that PknF is involved in the regulation of cell division at different 
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stages eg. septum formation and elongation (Deol et al., 2005). Interestingly, the M. 
tuberculosis antisense strain showed an increased  uptake  of 14C glucose compared to 
wildtype, suggesting an additional role of PknF in the negative regulation of glucose uptake 
mediated through the ABC transporter Rv1747 located within the same operon (Deol et al., 
2005). While the growth of a Rv1747 deletion mutant is normal in vitro, mice infected with 
the mutant strain displayed significantly less colony forming units in lungs and spleen (Curry 
et al., 2005), suggesting the ABC transporter function is important for normal growth in vivo. 
 
Protein kinase I (PknI) 
 
Few studies have been carried out on PknI, a 585 amino acid protein encoded in an operon 
containing genes involved in cell division (dacB and ftsY) as extrapolated from other 
bacterial species like B. subtilis and E. coli (Av-Gay and Everett, 2000; Popham et al., 1995; 
Popham and Young, 2003). PknI is the only mycobacterial kinase whose active site contains 
an asparagine instead of the usual lysine in the catalytic loop (Av-Gay and Everett, 2000). 
Cellular fractionation revealed that PknI distributes to the cytosolic fraction despite the 
presence of a transmembrane domain (Singh et al., 2006). Apart from this rather striking 
finding, PknI showed typical kinase properties such as autophosphorylation, phosphorylation 
of myelin basic protein as well as activity dependence on Mn2+ (Gopalaswamy et al., 2004). 
Analysis of PknI expression levels during the course of infection of human THP-1 
macrophage-like cells with M. tuberculosis suggests that PknI expression is initially low and 
decreases even more at later times (Singh et al., 2006) although the significance of this 
expression pattern remains unknown. 
 
Protein kinase J (PknJ) 
 
PknJ is a 61.6 kDa protein with a predicted transmembrane region. Its genomic localization is 
defined by several nearby transposon genes (Av-Gay and Everett, 2000). PknJ is only present 
in species of the M. tuberculosis complex and does not seem to harbor any specific features. 
Nevertheless, ongoing studies on PknJ may clarify functions and properties of the kinase. 
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Figure 1.5. The domain architecture of PknG. The kinase domain (blue) 
covering one third of the protein is flanked by an N-terminal domain 
characterized by two CXXC motifs and by a C-terminal region containing a 
tetratricopeptide repeat.  
1.3.4 Group IV Serine/Threonine Kinases: Protein Kinases K and G  
 
Protein kinase K (PknK) 
 
With a molecular weight of 119.4 kDa, PknK is the largest serine/threonine kinase identified 
in M. tuberculosis. PknK, together with PknG, does not possess a transmembrane domain 
and is therefore predicted to be localized in the cytosol of the bacilli. Thus far, the kinase 
itself has not been biochemically characterized, hence the only conclusions regarding PknK 
function can be drawn from its genomic localization and domain architecture. PknK contains 
an additional ATP binding pocket within the kinase domain as well as an ATP binding motif 
(Av-Gay and Everett, 2000). This particular AAA domain comprises a so-called PDZ domain, 
which has been shown to be required for targeting signalling molecules to sub-membranous  
sites (Ponting et al., 1997). PknK is further characterized by a C-terminal region which 
displays homology to regulatory regions found in transcriptional regulators of the LuxR 
family (Av-Gay and Everett, 2000). This regulatory region further encompasses a helix-turn-
helix motif as well as a tetratricopeptide domain which often mediates protein-protein 
interactions. The genomic localization of pknK upstream of a gene homologous to members 
of the LuxA family (involved in flavin monucleotide metabolism) supports the hypothesis 
that PknK might play a role in the regulation of secondary metabolism. However, pknK is 
also closely localized to the transcriptional regulator virS, implicated in virulence (Av-Gay 
and Everett, 2000; Narayan et al., 2007). The elucidation of a physiological function of PknK 
will require more extensive analysis. 
 
Protein kinase G (PknG) 
 
PknG, a 82 kDa protein displaying autophosphorylation activity, is different from the other 
mycobacterial kinases in that it has an extended N-terminal region which precedes the kinase 
domain. Moreover, it does not contain a transmembrane domain, suggesting that this protein, 
like PknK, is located in the 
cytoplasm. Within the N-
terminal domain of PknG 
are two CXXC motifs 
whereas at the C-terminus, 
a tetratricopeptide (TPR)-like region is present (figure 1.5). CXXC motifs are essential for 
the catalysis of redox reactions since the cysteines can reversibly form disulfide bonds 
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(Laboissiëre et al., 1995; Walker et al., 1996). The ubiquitously distributed CXXC motifs 
enable proteins to carry out several functions which are based on protection against stress, 
such as the control of correct folding or removal of peroxides (Tinsley et al., 2004).  
TPR-like regions are motifs of 34 amino acids that are usually three-16 times repeated. These 
motifs are predominantly found in eukaryotic proteins where they mediate protein-protein 
interactions. 
 
The pknG gene locus has been shown to be present and conserved throughout the 
mycobacterial genus (Narayan et al., 2007). Interestingly, PknG is not expressed in non-
pathogenic mycobacteria such as M. smegmatis (Walburger et al., 2004). When pknG is 
deleted in pathogenic mycobacteria, no apparent phenotype is observed in mutant strains 
grown in vitro compared to wildtype mycobacteria (Nguyen et al., 2005). However, upon 
infection of macrophages, bacilli lacking PknG are rapidly transferred to lysosomes and 
killed, whereas wildtype mycobacteria can survive within non-lysosomal phagosomes 
(Walburger et al., 2004). At this point it should be noted that preventing or delaying 
phagosome-lysosome fusion is an important strategy utilized by pathogenic mycobacteria to 
ensure their survival (Hart, 1975; Nguyen and Pieters, 2005; Pieters, 2001). To analyze 
whether this capacity of PknG to prevent lysosomal delivery is related to its kinase activity, a 
kinase-dead molecule was overexpressed in wildtype M. bovis BCG. Overexpression of this 
mutant, PknG-K/M, resulted in rapid transfer to lysosomes and intracellular killing of these 
bacteria, suggesting that the kinase activity of protein kinase G is essential for its ability to 
modulate phagosome-lysosome transfer and to confer mycobacterial survival inside 
macrophages (figure 1.6). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. Trafficking of 
mycobacteria expressing 
PknG.  
Upon phagocytosis of 
pathogenic mycobacteria, 
PknG is secreted into the 
cytosol and prevents the 
fusion of the mycobacterial 
phagosome with lysosomes 
resulting in survival of the 
bacilli (left panel).  
However, mycobacteria 
expressing a kinase-dead 
version of PknG or  bacteria 
treated with the inhibitor 
AX20017 are incapable of 
blocking phagosome 
maturation, finally leading 
to degradation of the 
mycobacteria (right panel). 
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PknG is actively secreted into the macrophage cytosol upon infection (Walburger et al., 
2004), presumably phosphorylating substrates present in the macrophage cytosol. 
Importantly, PknG does not possess a classical signal sequence that would allow secretion in 
a sec-dependent manner through the mycobacterial membrane. Therefore, it is likely that 
PknG is secreted by a thus far undefined specialized secretion system. In addition, it needs to 
be established, how PknG is translocated from phagosomes into the cytosol. 
 
The relocation of PknG-deficient pathogenic mycobacteria from phagosomes to lysosomes, 
resulting in mycobacterial killing, makes this kinase a promising drug target. A screen for 
small molecular weight compounds identified a tetrahydrobenzothiophene, termed AX20017, 
that efficiently blocks PknG kinase activity in vitro (Walburger et al., 2004). AX20017 is 
highly effective in re-directing mycobacteria to lysosomes and inducing killing of M. 
tuberculosis in macrophages (figures 1.6 and 1.7). 
 
 
 
 
 
 
 
 
 
In Corynebacterium glutamicum, an actinobacterium related to M. tuberculosis, a mutant 
depleted of a PknG homologue was found to be impaired in glutamine utilization. Proteome 
analysis of wildtype and mutant strains led to the identification of Odh1 as putative substrate 
of corynebacterial PknG. This 15 kDa FHA domain-containing protein represents the 
homolog of mycobacterial GarA and is a key enzyme of the tricarboxylic acid cycle in 
Corynebacteria. It has been shown that phosphorylation of Odh1 on amino acid residue T14 
is essential for proper glutamine utilization and efficient glutamate production (Niebisch et 
al., 2006; Schultz et al., 2007).  
In the genome of M. bovis BCG, pknG is located in a putative operon containing glnH, 
encoding a protein potentially playing a role in glutamine uptake. However, deletion of pknG 
did neither affect glutamine uptake nor intracellular glutamine concentrations suggesting that 
glutamine metabolism is not controlled by PknG in M. bovis BCG (Nguyen et al., 2005). 
Figure 1.7. Intracellular trafficking of 
mycobacteria upon treatment with the PknG 
inhibitor AX20017. Macrophages (J774) were 
infected for 1 h with wildtype M. bovis BCG 
expressing GFP in the presence or absence of 
the inhibitor (20 µM). After a 2 h chase, the 
cells were fixed, permeabilized and stained with 
antibodies against the lysosomal marker LAMP 
1 (red). When macrophages are treated with the 
PknG specific inhibitor AX20017, 
mycobacteria predominantly localize within 
lysosomes (Walburger et al., 2004) 
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In conclusion, PknG has been shown to promote survival of mycobacteria within 
macrophages by preventing phagosome-lysosome fusion and is therefore considered as an 
important virulence factor. Identification of PknG substrates and secretion machinery as well 
as elucidation of the structure of PknG may help to substantiate the mode of function of 
PknG. 
 
 
1.4 Protein kinases in the context of drug design 
 
1.4.1 Tuberculosis-a global threat to human health 
 
With 2.2 billion infected individuals and over 2 million TB-related deaths per year, 
tuberculosis remains to be the world’s most infectious bacterial disease (www.who.int/tb). It 
has been prognosticated that 200 million people will become newly infected within the next 
20 years if current trends continue (Global alliance for TB drug development). M. 
tuberculosis, the causative agent of tuberculosis, possesses an almost impermeable cell wall 
and specialized defense systems providing intrinsic tolerance towards antibiotics (Nguyen 
and Pieters, 2008). The recent emergence of extensively drug-resistant (XDR) M. 
tuberculosis strains raises concerns of a future TB epidemic. These highly virulent strains are 
characterized by being resistant to at least isoniazid and rifampicin (i. e. multidrug-resistant 
or MDR-TB), plus resistance to any fluroquinolones and anyone of the injectable second-line 
anti-TB drugs like amikacin, kanamycin or capreomycin. To date, the existence of XDR 
strains has been confirmed in 41 countries (www.who.int/tb). In order to restrict TB 
dissemination, the development of novel drugs and efficient vaccines is of utmost importance. 
 
1.4.2 Inhibition of mycobacterial kinases  
 
In addition to proteins involved in control of cell wall synthesis or cell division, kinases 
implicated in signalling are intensively studied as potential anti-mycobacterial targets (Janin, 
2007). Currently, mycobacterial kinases having important physiological functions or those 
involved in virulence are being evaluated as potential drug targets. 
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Effective inhibition can be achieved by either blocking ATP binding or by preventing 
protein-protein interactions as well as by RNA-based approaches leading to downregulation 
of kinase expression levels (Melnikova, 2004). 
 
The existing knowledge about structure and function of several mycobacterial kinases 
combined with the fact that prokaryotic and eukaryotic serine/threonine kinases share with < 
30% only low sequence identities, provide a good basis for the development of anti-
mycobacterial drugs (Cohen, 2002; Wehenkel et al., 2008).  
 
1.4.3 Requirements for the development of potent kinase inhibitors 
 
Structure-based design of inhibitors might result in the development of potent drugs, whereas 
“potency” is defined by the degree of specificity and selectivity of a certain inhibitor towards 
the kinase. 
  
In general, targeting a kinase in its inactive conformation seems attractive since unique 
conformations of the kinase domain can be blocked. However, targeting the active 
conformation might be beneficial as well, since an active conformation requires conservation 
of the 3D structure and is therefore less tolerant of potential resistant mutations. The potency 
of the inhibitor increases by targeting different conformations of a particular kinase but at the 
expense of selectivity (Noble et al., 2004). Selectivity of mycobacterial kinase inhibitors is a 
crucial aspect due to the presence of 518 putative human protein kinases (Manning et al., 
2002) implicated in various important signal pathways which must not be affected. High 
selectivity can be achieved when a combination of residues at the ligand-binding forming a 
uniquely shaped binding pocket is targeted. For the development of inhibitors, targeting a 
less conserved additional pocket or non-catalytic domains as well as single residues has 
major advantages regarding selectivity (Noble et al., 2004). 
Apart from being efficient and selective, potential tuberculosis drugs must fulfil several 
requirements to be considered for clinical studies. The Global Drug Alliance proposed the 
following criteria (www.stoptb.org): 
- high efficiency to reduce the treatment duration which usually lasts for 6 months 
- potency against resistant strains 
- inhibition of dormant mycobacteria 
- compatibility with existing TB drugs 
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- action on new targets 
- no interference with other drugs 
 
Many of the eleven kinases expressed by M. tuberculosis have been reported to regulate 
redundant physiological processes. However, kinases essential for survival of mycobacteria 
such as PknA and PknB, as well as those implicated in virulence such as PknH and PknG are 
attractive drug targets. For PknB and PknG, efficient inhibitors with minimal inhibitory 
concentrations in the micromolar range have already been identified (Scherr et al., 2007; 
Wehenkel et al., 2006). Efforts are ongoing which aim at the identification and optimization 
of potent PknB inhibitors (Drews et al., 2001). A multi-targeted approach by combining two 
inhibitors targeting different kinases might be beneficial in terms of efficacy and prevention 
of resistance.  
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1.5 Synopsis and concluding remarks 
 
Due to their complex life style, mycobacteria are likely to possess elaborate signalling 
networks in which the serine/threonine kinases perform important tasks. Recent work has 
revealed the involvement of several of these kinases in controlling cell shape, cell division, 
transport, metabolism as well as virulence (figure 1.8). 
 Operon Conser./ 
Essent. 
Features Substrate Phys. role Viru-
lence 
Regulation Inhibitor Structure 
PknA pknB, 
phpA, 
rodA, 
mstP 
Yes/Yes - DivIVA 
Rv1422 
mFtsZ 
EmbR 
KasA/B 
mtFabD 
cell division ? Mstp - - 
PknB pknA, 
phpA, 
rodA, 
mstP 
Yes/Yes PASTA GarA 
PBPA 
Rv1422 
EmbR 
Rv0020c 
Rv 1747 
KasA/B 
cell division ? Mstp Mito-
xantrone 
KD, 
KD+Inh 
PknL cell 
division 
genes 
Yes/?  Rv2175c regulation of 
cell division? 
? ? - - 
PknD pstS, pstA No/?  NHL- 
 ß-prop. 
Rv0516c 
MmpL7 
GarA 
transcription, 
transport 
? Mstp, 
dimeriza-
tion 
SP600125, 
O6-cyclo- 
hexyl- 
methyl 
guanine 
SD 
PknE  No/No CXXC GarA 
Rv 1747 
KasA/B 
stress  
response 
apoptosis 
? Mstp 
 
O6-cyclo- 
hexyl- 
methyl 
guanine 
KD 
PknH embR No/No Pro-rich 
region 
EmbR 
Dac1B 
Rv0681 
KasA/B 
stress resp., 
infection, 
arabinan 
metabolism 
yes Mstp, 
Embr2 
O6-cyclo- 
hexyl- 
methyl 
guanine 
- 
PknF Rv1747 No/? - Rv 1747 
GarA 
KasA/B 
cell division, 
glucose-
uptake, 
transport 
? Mstp 
 
 
- - 
PknI dacB, ftsY No/? catalytic 
Asp    
Not 
EmbR 
cell division? ? ? - - 
PknJ transposon 
genes 
No/? - ? ? ? ? - - 
PknK luxA like No/? PDZ, 
TPR 
? secondary 
metabolism 
? ? - - 
PknG glnH, 
Rv0412c 
Yes/No CXXC, 
TPR 
GarA? 
not 
EmbR 
pathogenicity yes CXXC AX20017 wt-∆N 
+Inh 
 
 
 
Future work focussing on the identification of interacting molecules, as well as substrates, 
may help to specify the role of individual kinases and lead to a better understanding of 
signalling processes in mycobacteria. In the long-term, these results may provide a basis for 
the development of novel and potent drugs which are urgently needed in the fight against 
disease. 
Figure 1.8. The eleven serine/threonine kinases of M. tuberculosis and their characteristics. The table shows 
the eleven serine/threonine kinases of M. tuberculosis listed according to their relationship and provides an 
overview of the individual properties of each kinase. The forkhead-associated domain containing substrates are 
underlined. Abbreviations: Conser.: conserved; Essent.: essential; Phys. Role: physiological role, KD: kinase 
domain, SD: sensor domain, Inh: inhibitor, wt-∆N: part of the N-terminus missing). 
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1.7 Aim of the thesis 
 
Mycobacterium tuberculosis, causing 2 millions deaths per year, is a highly successful 
bacterial pathogen having evolved several tactics to persist within the hostile environment of 
its host. One of the strategies relies on the activity of a eukaryotic-like serine/threonine 
kinase, protein kinase G (PknG), which is released within host macrophages where it actively 
blocks the fusion of phagosomes with lysosomes, thereby allowing intracellular survival of 
the bacteria. PknG, one of eleven eukaryotic-like serine/threonine kinases of M. tuberculosis, 
displays a unique domain architecture by containing a N-terminal rubredoxin motif and a C-
terminal tetratricopeptide repeat both flanking the kinase domain. A first aim was to further 
understand the mode of action and the molecular structure of PknG. Therefore, the protein 
was crystallized and analyzed by x-ray crystallography. 
  
Autophosphorylation is a common characteristic attributing different properties to a kinase. 
In most other mycobacterial kinases, autophosphorylation is a self-regulatory mechanism 
leading to activation of the kinase. Not much is known about the role of PknG 
autophosphorylation in vitro and its implications in vivo. A second aim of this work was to 
analyze autophosphorylation of PknG and the role of autophosphorylation in kinase activity. 
 
PknG has been shown to be secreted into the cytosol of macrophages; however, the exact 
function of the kinase has not been determined. Therefore, a third aim of the work presented 
was the localization of PknG within eukaryotic cells. Preliminary data are presented which 
suggest that PknG contains signals that allow specific localization within mammalian cells. 
 
The fourth aim was the functional characterization of a M. smegmatis protein named Ag84, a 
homologue of eubacterial DivIVA-like proteins. Bacillus subtilis DivIVA was found to be 
involved in cell division by interacting with the MinCD system and directing septum 
formation. Due to the absence of a corresponding MinCD system in mycobacteria, a different 
function for Ag84 was proposed. Studies were carried out in order to elucidate the role of 
Ag84 in mycobacteria.  
 
Taken together, the aim of this thesis was to contribute to a better understanding of the 
complex network of signal transduction pathways in mycobacteria - on the one hand by 
investigating the structure and function of PknG, and in addition, by characterizing the role 
of Ag84. 
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2.1 Reagents 
 
 
Acetic acid        Merck 
Acetone        Merck 
Acrylamide        Bio-Rad 
Agarose        Eurobio 
Adenosine-5’-triphosphate (ATP)     Boehringer Mannheim 
Albumine, bovine, 96% pure      Sigma 
Alkaline phosphatase (calf intestine)     Boehringer Mannheim 
Ammonium persulfate (APS)     Bio-Rad 
Amikacin (20mg/ml)       Sigma 
Ampicillin        Sigma 
Antipain        Sigma 
Aprotinin        Merck 
Bacto-Agar        Difco 
Bacto-Tryptone       Difco 
Bacto-Yeast Extract       Difco  
Bicinchonic acid (BCA)      Pierce 
Bisacrylamide (N,N’-methylen bisacrylamide)   Bio-Rad 
Bovine serum albumine (BSA)     Equitech-Bio 
Bromophenole blue       Merck 
Calcium chloride (CaCl2x4H2O)     Sigma 
Chloroform        Merck 
Chymostatin        Merck 
α-Chymotrypsin TLCK (10 mg/ml in 1mM HCl, 2 mM CaCl2) Sigma 
Colloidal blue        Invitrogen 
Coomassie brilliant blue G-250     Bio-Rad 
Coomassie brilliant blue R-250     Bio-Rad 
Cycloheximide       Calbiochem 
Desoxynucleotides (dNTPs)      Roche Diagnostics 
Diethyl ether        Merck 
N, N’-dimethyl formamide      Merck 
Dimethylsulfoxide (DMSO)      Fluka 
Dithiotreitol (DTT)       Sigma 
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T4 DNA Ligase       NEB 
DNA standard markers      Roche Diagnostics 
Ethanol, absolute, p.a.      Merck 
Ethidium bromide       Sigma 
Ethylene diamine tetraacetate (EDTA)    Fluka 
FluoroGuard antifade reagent     Bio-Rad 
Formaldehyde (37%)       Fluka 
Gel filtration standard (1.35 kDa-670 kDa)    Bio-Rad 
G418         Calbiochem 
D(+)glucose-monohydrate      Merck 
Glutaraldehyde       Sigma  
Glycine        Fluka 
Glycerol (100%)       Fluka 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) AppliChem 
Horseradish peroxidase      Sigma 
Hydrochloric acid (HCl)      Merck 
Hygromycin B       Roche Diagnostics 
Imidazole        Fluka 
Isobutanol        Merck 
Isopropanol        Merck 
Isopropyl-thiogalactoside (IPTG)     AppliChem 
Kanamycin        Sigma 
Leupeptin        Fluka 
Manganese chloride (MnCl2)      Sigma 
Magnesium chloride (MgCl2)     Sigma 
β-mercaptoethanol       Fluka 
Methanol        Merck 
Milk powder (low fat)      Coop   
Mineral oil        Sigma 
Restriction enzymes       NEB/Roche diagnostics 
Paraformaldeyhde, 95% pure      Sigma 
Pepsin (from pig, stock 10 mg/ml H2O)    Sigma    
Pepstatin        Fluka 
Phenylmethylsulfonylfluoride (PMSF)    Sigma 
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Phosphoserine       Sigma 
Phosphothreonine       Sigma 
Phosphotyrosine       Sigma 
Ponceau S        Sigma 
Potassium chloride (KCl)      Sigma 
Potassium hydroxide (KOH)      Sigma 
Potassium dihydrogen phosphate (KH2PO4)    Merck 
Proteinase K        Roche 
Saponin (from Quillaja bark)      Sigma 
SDS-PAGE molecular weight standards    Bio-Rad 
SDS-PAGE molecular weight prestained standards   Bio-Rad 
SDS-PAGE molecular weight rainbow standards   Bio-Rad 
Shrimp alkaline phosphatase (SAP)     Roche Diagnostics 
Sodium acetate       Merck 
Sodium acide        Fluka 
Sodium carbonate (Na2SO3)      Fluka 
Sodium citrate       Fluka 
Sodium chloride       Fluka 
Sodium dihydrogen phosphate (NaH2PO4)    Fluka 
Sodium hydroxide       Merck 
Subtilisin A (stock 10 mg/ml H2O)     Sigma 
N,N,N’,N’tetramethylenethylenediamine (TEMED)  Bio-Rad 
Thermolysin (stock 10 mg/ml H2O)     Sigma 
Thrombin (1U/µl)       Sigma 
Tricloric acid (TCA)       Merck 
Tris(hydroxymethyl)aminomethane (Tris)    Sigma 
Triton X-100        Boehringer Mannheim 
Trypan blue (0.4 %)       Sigma 
Trypsin (bovine pancreas, stock 10 mg/ml H2O)   Roche 
Trypsin inhibitor       Boehringer Mannheim 
Tween 20        Fluka 
Tween 80        Fluka 
Xylene Cyanol       Sigma 
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2.2 Kits 
 
BCA protein detection Kit      Pierce 
Big Dye1.1® Terminator v1.1 Cycle sequencing Kit  Perkin Elmer 
Bradford protein detection Kit     Bio-Rad 
Crystallization Kits: 
 Basic Crystallography Kit      Sigma 
 Extension Kit       Sigma 
 Low Ionic Strength Kit      Sigma 
 Protein Crystallization Cryo Kit     Sigma 
 Additive Screen I, II and III     Hampton 
 Detergent Screen I, II and III     Hampton 
 PEG Screen       Hampton 
 Membrane Kit       Hampton 
 Wizard I+II       Emerald BioSystems  
Enhanced Chemoluminescence (ECL) Kit    Amersham Biosciences 
Expand High Fidelity PCR System     Roche 
Expand Long Template PCR System    Roche 
GenElute Plasmid Miniprep Kit     Sigma 
HiSpeed Plasmid Midi Kit      Qiagen 
HiSpeed Plasmid Maxi Kit      Qiagen 
jetPEITM DNA transfection agent     Polyplus 
jetPEITM-Macrophage DNA transfection agent   Polyplus 
MycoAlert mycoplasma detection Kit    Cambrex 
pGEM®-T-Easy Vector Kit      Promega 
QIAprep Spin Miniprep Kit      Qiagen 
QIAquick gel extraction Kit      Qiagen 
QIAquick PCR purification Kit     Qiagen 
QuikChange® Site-Directed Mutagenesis Kit   Stratagene 
Taq polymerase and PCR buffer Kit     Pharmacia 
 
 
 
 
_______________________________________________________________________________CHAPTER 2 
37 
2.3 Columns 
 
HiLoad 16/60TM Superdex 200 prep grade    GE Healthcare 
HiLoad 26/60TM Superdex 200 prep grade    GE Healthcare 
Hi-TrapTM Protein A HP 1ml      GE Healthcare 
His-TrapTM HP 1 ml / 5 ml      GE Healthcare 
His-TrapTM FF 1 ml / 5ml      GE Healthcare 
His-TrapTM FF crude 1 ml      GE Healthcare 
PD-10 columns       GE Healthcare 
Superdex 200 PC 3.2/30      GE Healthcare 
 
 
2.4 Radiochemicals 
 
EasyTagTMEXPRESS 35S Protein Labeling Mix   Perkin Elmer 
RainbowTM[14C]-methylated protein marker standard  GE Healthcare 
Redivue adenosine 5’-[γ-32P] triphosphate    GE Healthcare 
[methyl-3H] Thymidine      GE Healthcare 
[5,6-3H] Uracil       GE Healthcare 
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2.5 General buffers and solutions 
 
 
Acrylamide      30% acrylamide 
       0.8% N’-methylene-bis-acrylamide 
 
Coomassie staining solution (0.25%)  2.5 g Coomasie Brilliant Blue R-250 
       dissolved in 1L fix-destain solution 
 
CLAAP (100x)     25 mg/ml antipain in H2O 
       25 mg/ml aprotinin in PBS 
       10 mg/ml chymostatin in DMSO 
       25 mg/ml leupeptin in H2O 
       20 mg/ml pepstatin in DMSO 
      
DNA loading buffer (6x)    0.25% bromphenol blue 
       0.25% xylene cyanol FF 
       1 mM EDTA pH 8.0 
       30% glycerol anhydrous 
 
Fix-destain solution     45% ddH2O  
       45% Methanol 
       10% Acetic acid 
             
PBS (pH 7.2)      137 mM NaCl 
       2.7 mM KCl 
       8 mM Na2HPO4 
       1.5 mM KH2PO4 
        
 
PBS-T (pH 7.2)     PBS + 0.2% (v/v) Tween 20 
 
Paraformaldehyde (3%)    90 ml ddH2O and 30 µl 1 M NaOH added  
       to 3.0 g PFA, stirring on hot plate until 
       PFA is dissolved, 10 ml 10x PBS were  
       added, mixed, cooled to 37°C and pH  
       adjusted to 7.2 
 
PMSF (100x)      100 mM PMSF in  isopropanol (100%)
       (17.4 mg PMSF/ml isopropanol) 
     
 
SDS-PAGE running buffer (10x)   250 mM Trizma base 
       1.9 M glycine 
       0.1% SDS  
 
SDS-PAGE transfer buffer (10x)   480 mM Trizma base 
       390 mM glycine 
       0.375% SDS 
       20% methanol 
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SDS-SB (5x)      300 mM Tris/HCl pH 6.8 
500 mM DTT 
10% SDS 
       20% glycerol 
       0.015% bromophenol blue 
 
Stripping buffer     62.5 mM Tris pH 6.7 
100 mM β-mercaptoethanol 
       2% SDS 
        
TBE (10x)       108 g Tris 
       55 g boric acid 
      40 ml of 0.5 M Na2EDTA (pH 8.0) 
      ad 1 L with dH2O 
 
TB       10 mM PIPES 
       15 mM CaCl2 
       250 mM KCl 
       dissolve in H2O 
       adjust pH to 6.7 with KOH/HCl 
       add 55 mM MnCl2 
       ad 1 L with dH2O 
 
TE       10 mM Tris/HCl pH 8.0 
       1 mM EDTA 
 
TEN buffer      75 mM Tris pH 8.8 
       4 mM EDTA 
       100 mM NaCl 
 
Tris solution      30.3 g (for pH 6.8) or  
       121.1 g (for pH 8.8) ad 0.5L 
 
TX-100 buffer     50 mM Tris-HCl (pH 7.5) 
       137 mM NaCl 
       2 mM EDTA 
       10% glycerol 
       1% Triton X-100 
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2.6 Bacterial media and supplements 
 
 
 
LB agar      10 g tryptone (Difco) 
       5 g yeast extract (Difco) 
       10 g NaCl  
       15 g Bacto agar (Difco) 
       dissolve in 1 L H2O, autoclave 
       if required: add antibiotics and/or 
sterile 0.1% glucose, 
pour plates and store at 4°C 
 
LB broth      LB medium as described, without agar 
 
Middlebrook 7H11 agar with glycerol  21 g 7H11 (Difco) 
       900 ml H2O 
       5 ml glycerol 
       dissolve at 120°C (stirring on a hot plate  
       until solution becomes clear (1.5 h) 
       after autoclaving let cool to 55-60°C 
       add 100 ml OADC (Difco) 
       if required: add antibiotics,  
pour plates and store at 4°C 
 
Middlebrook 7H9 agar with glycerol  Difco 
 
OADC Middlebrook supplement   home-made 
 
SOC       2% trypton (w/v) 
       0.5% yeast extract (w/v) 
       10 mM NaCl 
       10 mM MgCl2 
       10 mM MgSO4 
       2.5 mM KCl 
       dissolve in 1 L H2O and autoclave 
       add 20 mM sterile glucose 
 
Tween 80      Fluka 
 
Ampicillin      Sigma, stock 100 mg/ml (1000x) 
 
Kanamycin      Sigma, stock 50 mg/ml (1000 or 2000x) 
 
Hygromycin B     Calbiochem, stock 50 mg/ml (1000x)
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2.7 Eukaryotic cell culture media and supplements 
 
 
DMEM      Sigma 
 
DMEM Glutamax     Gibco BRL 
 
Fetal bovine serum (FBS)    Gibco BRL     
 
L929 supernatant     home-made 
 
L-glutamin (200 mM)    Gibco BRL 
 
ß-mercaptoethanol (50 mM)    Sigma 
 
Sodium pyruvate (100 mM)    Sigma 
 
Trypsin/EDTA (0.05%) in HBBS   Gibco BRL 
 
Ciproxin (0.2%)      Bayer      
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2.8 Vectors 
      
Name (kb) Vector Insert Reference Application 
pGEM vector 
(3.0 kb) 
pGEM®-T Easy (Promega) 
AmpR - Promega subcloning 
pGEM-PknG pGEM
®-T Easy (Promega) 
AmpR 
pknG  
 Anne Walburger subcloning 
pGEM-NS1 pGEM
®-T Easy (Promega) 
AmpR 
pknG  
(N-term)  Nicole Scherr subcloning 
pGEM-NS2 pGEM
®-T Easy (Promega) 
AmpR 
pknG  
(kin domain) Nicole Scherr subcloning 
pGEM-NS3 pGEM
®-T Easy (Promega) 
AmpR 
pknG  
(C-term)  Nicole Scherr subcloning 
pGEM-NS4 pGEM
®-T Easy (Promega) 
AmpR 
pknG  
(kin+C-term) Nicole Scherr subcloning 
pGEM-∆N pGEM
®-T Easy (Promega) 
AmpR 
pknG                    
(N-terminal deletion) Nicole Scherr subcloning 
pGEM-inh pGEM
®-T Easy (Promega) 
AmpR 
pknG  
(I87S/A92S) Nicole Scherr mutagenesis and subcloning
pGEM-P-mut pGEM
®-T Easy (Promega) 
AmpR 
pknG  
T21/23/26/32/63/64A Nicole Scherr subcloning 
pET15b vector 
(5.7 kb) 
pET-15b (Novagen) 
AmpR - Novagen 
expression in E. coli BL21 
and purification  
pET15b-PknG pET-15b (Novagen) AmpR 
pknG  
 Anne Walburger 
expression in E. coli BL21 
and purification  
pET15b-NS1 pET-15b (Novagen) AmpR 
pknG  
(N-term)  Nicole Scherr 
expression in E. coli BL21 
and purification 
pET15b-NS2 pET-15b (Novagen) AmpR 
pknG  
(kin domain) Nicole Scherr 
expression in E. coli BL21 
and purification 
pET15b-NS3 pET-15b (Novagen) AmpR 
pknG  
(C-term)  Nicole Scherr 
expression in E. coli BL21 
and purification 
pET15b-NS4 pET-15b (Novagen) AmpR 
pknG  
(kin+C-term) Nicole Scherr 
expression in E. coli BL21 
and purification 
pET15b-∆N pET-15b (Novagen) AmpR 
pknG                            
(N-terminal deletion) Nicole Scherr 
expression in E. coli BL21 
and purification  
pET15b-K181M pET-15b (Novagen) AmpR 
pknG    
(K181M kinase dead) Philipp Müller 
expression in E. coli BL21 
and purification  
pET15b-inh pET-15b (Novagen) AmpR 
pknG  
(I87 and A92 to S) Nicole Scherr 
expression in E. coli BL21 
and purification  
pET15b-P-mut pET-15b (Novagen) AmpR 
pknG  
T21/23/26/32/63/64A Nicole Scherr 
expression in E. coli BL21 
and purification  
pET15b-C1/2 pET-15b (Novagen) AmpR 
pknG 
(C106/109/128/131S) Philipp Müller 
expression in E. coli BL21 
and purification  
pMV361 
(4.4 kb) 
pMV361 
KanR - 
Stover et al. 
(1991) subcloning, control 
pMV361-PknG pMV361 KanR pknG   Anne Walburger expression in mycobacteria 
pMV361-∆N pMV361 KanR 
pknG                    
(N-terminal deletion) 
Martin Bratschi/ 
Edith Houben expression in mycobacteria 
pMV361-P-mut pMV361 KanR 
pknG  
T21/23/26/32/63/64A Damir Perisa expression in mycobacteria 
pMV361-C1/2 pMV361 KanR 
pknG: 
(C106/109/128/131S) Philipp Müller expression in mycobacteria 
pGEM-∆N2 pGEM
®-T Easy (Promega) 
AmpR 
pknG                      
(N-terminal deletion) Nicole Scherr subcloning 
pGEM-kin pGEM
®-T Easy (Promega) 
AmpR 
pknG                
(kinase domain)   Nicole Scherr subcloning 
pGEM-∆C1 pGEM
®-T Easy (Promega) 
AmpR 
pknG                      
(C-terminal deletion) Nicole Scherr subcloning 
pGEM-∆C2 pGEM
®-T Easy (Promega) 
AmpR 
pknG                       
(C-terminal deletion) Nicole Scherr subcloning 
pGEM-∆C3 pGEM
®-T Easy (Promega) 
AmpR 
pknG                       
(C-terminal deletion) Nicole Scherr subcloning 
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pIRES vector 
(5.1 kb) 
pIRESpuro3 (Clontech) 
AmpR/PuroR - Clontech control, subcloning 
pIRES-PknG pIRESpuro3 (Clontech) AmpR/PuroR pknG  Nicole Scherr 
expression in 
mammalian cells 
pIRES-K181M pIRESpuro3 (Clontech) AmpR/PuroR 
pknG    
(K181M kinase dead) Nicole Scherr 
expression in  
mammalian cells 
pIRES-∆N1 pIRESpuro3 (Clontech) AmpR/PuroR 
pknG                      
(N-terminal deletion) Nicole Scherr 
expression in  
mammalian cells 
pIRES-∆N2 pIRESpuro3 (Clontech) AmpR/PuroR 
pknG                     
(N-terminal deletion) Nicole Scherr 
expression in  
mammalian cells 
pIRES-kin pIRESpuro3 (Clontech) AmpR/PuroR 
pknG               
(kinase domain)   Nicole Scherr 
expression in  
mammalian cells 
pIRES-∆C1 pIRESpuro3 (Clontech) AmpR/PuroR 
pknG                       
(C-terminal deletion) Nicole Scherr 
expression in  
mammalian cells 
pIRES-∆C2 pIRESpuro3 (Clontech) AmpR/PuroR 
pknG                       
(C-terminal deletion) Nicole Scherr 
expression in  
mammalian cells 
pIRES-∆C3 pIRESpuro3 (Clontech) AmpR/PuroR 
pknG                       
(C-terminal deletion) Nicole Scherr 
expression in  
mammalian cells 
pIRES-P-mut pIRESpuro3 (Clontech) AmpR/PuroR 
pknG  
T21/23/26/32/63/64A Nicole Scherr 
expression in  
mammalian cells 
pIRES-C1/2 pIRESpuro3 (Clontech) AmpR/PuroR 
pknG: 
(C106/109/128/131S) Nicole Scherr 
expression in  
mammalian cells 
pGEX-PknG pGEX-5x-3 AmpR pknG Koul A. (2001) subcloning 
pGEX-PknG-K181M pGEX-5x-3 AmpR 
pknG    
(K181M kinase dead) Koul A. (2001) subcloning 
pGEM-PknG pGEM
®-T Easy (Promega) 
AmpR pknG Nicole Scherr subcloning 
FLAG vector 
(6.3 kb) 
p3XFLAG-CMV-10 (Sigma)
AmpR/NeoR  - Sigma 
expression in  
mammalian cells 
pGEM-FLAG-PknG pGEM
®-T Easy (Promega) 
AmpR 3xFLAG::pknG Nicole Scherr subcloning 
pSD5-PknG pSD5 KanR pknG Jain S. (1991) subcloning 
pSD5-FLAG-PknG pSD5 KanR 3xFLAG::pknG Nicole Scherr expression in mycobacteria
FLAG-PknG-wt p3XFLAG-CMV-10 (Sigma)AmpR/NeoR  pknG Nicole Scherr 
subcloning, expression in 
mammalian cells 
FLAG-K181M p3XFLAG-CMV-10 (Sigma)AmpR/NeoR 
pknG    
(K181M kinase dead) Nicole Scherr 
expression in  
mammalian cells 
FLAG-∆N1 p3XFLAG-CMV-10 (Sigma)AmpR/NeoR 
pknG                      
(N-terminal deletion)  Nicole Scherr 
expression in  
mammalian cells 
FLAG-∆N2 p3XFLAG-CMV-10 (Sigma)AmpR/NeoR 
pknG                     
(N-terminal deletion) Nicole Scherr 
expression in  
mammalian cells 
FLAG-kin p3XFLAG-CMV-10 (Sigma)AmpR/NeoR 
pknG                
(kinase domain)  Nicole Scherr 
expression in  
mammalian cells 
FLAG-∆C1 p3XFLAG-CMV-10 (Sigma)AmpR/NeoR 
pknG                       
(C-terminal deletion) Nicole Scherr 
expression in  
mammalian cells 
FLAG-∆C2 p3XFLAG-CMV-10 (Sigma)AmpR/NeoR 
pknG                      
(C-terminal deletion) Nicole Scherr 
expression in  
mammalian cells 
FLAG-∆C3 p3XFLAG-CMV-10 (Sigma)AmpR/NeoR 
pknG                       
(C-terminal deletion) Nicole Scherr 
expression in  
mammalian cells 
FLAG-P-mut pIRESpuro3 (Clontech) AmpR/PuroR 
pknG  
T21/23/26/32/63/64A Nicole Scherr 
expression in  
mammalian cells 
FLAG-C1/2 pIRESpuro3 (Clontech) AmpR/PuroR 
pknG: 
(C106/109/128/131S) Nicole Scherr 
expression in  
mammalian cells 
pCB6-TACO-CHA pCB6 AmpR coronin 1::HA  John Gatfield 
expression in  
mammalian cells 
pNDL1 pMV361 KanR wag31MS::gfp          Liem Nguyen expression in mycobacteria
pNDL2 pMV361 KanR 
wag31MS::gfp         
(for integration) Liem Nguyen expression in mycobacteria 
pNDL4 pMV361 KanR wag31MS Liem Nguyen expression in mycobacteria
pNDL8 pMV361 KanR wag31TB Liem Nguyen expression in mycobacteria
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2.9 Primers 
 
 
Primers used for cloning 
 
Name  Sequence (5’-3’) Source  Application 
NS-PknG-N-term-f CAT ATG GCC AAA GCG TCA GAG ACC GAA CG pknG cloning PknG-N-terminus 
NS-PknG-N-term-r CTC GAG TTA GAC GAT GTC CCC GGG ATT TAG pknG cloning PknG-N-terminus 
NS-PknG-Kin-f CAT ATG CTA AAT CCC GGG GAC ATC GTC GC pknG cloning PknG-kin-domain 
NS-PknG-Kin-r CTC GAG TTA CTC CCG CAA CAC GCC pknG cloning PknG-kin-domain 
NS-PknG-C-term-f CAT ATG CTG CAG GCC ACG GTG CTC TCC pknG cloning PknG-C-terminus 
NS-PknG-C-term-r CTC GAG TTA GAA CGT GCT GGT GGG CCG pknG cloning PknG-C-terminus 
NS-PknG–C-term-neu-r CAT ATG CTG GGC GGC GGC CTG GTG pknG cloning PknG-∆N 
NS-inh-Ser-2 CAG TAG TCC CTG AGT TCG CCT AGC CTT AGC  CCG CGG pknG 
site-directed mut.  
PknG-inhibitor 
NS-inh-Ser-1 GTC ATC AGG GAC TCA AGC GGA TCG GAA  TCG GGC GCC pknG 
site-directed mut.  
PknG-inhibitor 
NS-PknG-dC1-NotI-r GCG GCC GCT TAC TGT TCC TCG GTG ACT TC pknG cloning PknG-∆C1 
NS-PknG-dC2-NotI-r GCG GCC GCT TAC AGC GCG CGG ACT TCC C pknG cloning PknG-∆C2 
NS-PknG-dC3-NotI-r GCG GCC GCT TAC ACG ATC TCG TTG GCG GTC pknG cloning PknG-∆C3 
NS-PknG-dN2-EcoRI-f GAA TTC ATG CCG TAT TCG TTC CTG CCG CAG pknG cloning PknG-∆N2 
NS-PknG-EcoRI-fw GAA TTC ATG GCC AAA GCG TCA GAG ACC GAA  CG pknG 
cloning 
PknG-FL 
NS-PknG- NotI-r GCG GCC GCT TAG AAC GTG CTG GTG GGC CG pknG cloning PknG-FL 
NS-PknG-HindIII-fw AAG CTT ATG GCC AAA GCG TCA GAG ACC GAA  CG pknG 
cloning 
3xFLAG-PknG 
NS-PknG-EcoRI-rev GAA TTC TTA GAA CGT GCT GGT GGG CCG pknG cloning 3xFLAG-PknG 
3-FLAG-NdeI-fw CAT ATG ACC ATG GAC TAC AAA GAC CAT GAC pknG cloning 3xFLAG-PknG 
3-FLAG-EcoRI-fw GAA TCC ACC ATG GAC TAC AAA GAC CAT GAC pknG cloning 3xFLAG-PknG 
PknG-ScaI-rev AGT ACT TTA GAA CGT GCT GGT GGG CCG pknG cloning 3xFLAG-PknG 
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Primers used for Sequencing and Colony-PCR 
 
 
Name  Sequence (5’-3’) Source  Application 
T7 promotor seq TAA TAC GAC TCA CTA TAG GG pGEM-T-easy Promega sequencing primer pGEM 
M13-forward CGC CAG GGT TTT CCC AGT CAC GAC pGEM-T-easy Promega sequencing primer pGEM 
M13-reverse TCA CAC AGG AAA CAG CTA TGA C pGEM-T-easy Promega sequencing primer pGEM 
pknG Seq1 5’ GAC TCG GAG ACC AAG GGA GCT TC pknG (bp349-bp371) sequencing primer pknG 
pknG Seq1 3’  CCC TTG GTC TCC GAG pknG (bp365-bp351) sequencing primer pknG 
pknG Seq2 5’ CCC GTC GCG GAG GCC ATC G pknG (bp745-bp771) sequencing primer pknG 
pknG Seq2 3’ GCT CAG CGC CGG CAG pknG (bp795-bp781) sequencing primer pknG 
pknG Seq3 5’ CCG CGG CAA CGG TTC ACC AC pknG (bp1132-bp1151) sequencing primer pknG  
pknG Seq3 3’ CGG ACA TCT CTT CGG pknG (bp1168-bp1154) sequencing primer pknG 
pknG Seq4 5’ GGA CGC CGA CGG CGT CGA C pknG (bp1473-bp1491) sequencing primer pknG 
pknG Seq4 3’ CGG GTG GCC TTG GCC pknG (bp1568-bp1554) sequencing primer pknG 
pknG Seq5 5’ GGC ACG GCT GAC CAG CGC G pknG (bp1914-bp1932) sequencing primer pknG 
pknG Seq5 3’ CGG TGA CTT CAC TCG pknG (bp1972-bp1958) sequencing primer pknG 
pknG Seq6 5’ CCG CGC CCT GGT GCT GGG pknG (bp2043-bp2060) sequencing primer pknG 
pknG EN 5’ GGA ATT CCA TAT GGC CAA AGC GTC AGA GACCGA AC pknG 
colony PCR for presence 
of pknG 
pknG XNH 3’ CTC GAG CAT ATG AAG CTT TTA GAA CGT GCT    GGT GGG CCG GAC pknG 
colony PCR for presence 
of pknG 
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2.10 Antibodies and dyes  
 
 
Primary antibodies 
Name  Isotype Antigen/Target Source Culture conditions
antiserum 17 rabbit PknG Anne Walburger Immunoblotting (1:1000) 
antiserum 18 rabbit PknG Anne Walburger Immunoblotting (1:1000) 
ProteinA purified 
antiserum 18 rabbit PknG Edith Houben 
Immunoblotting 
(1:1000) 
Immunofluorescence 
(1:500) 
Affinity purified 
antiserum 18 rabbit PknG Jean Pieters 
Immunofluorescence 
(1:500) 
antiserum 45 rabbit PknG-C-terminus Eurogentec Immunoblotting (1:20.000) 
anti-FLAG-M2® mouse FLAG-tagged proteins  (PknG mutants) Sigma 
Immunoblotting 
Immunofluorescence 
(1:500)  
anti-Coronin 1 rat Coronin1 Rajesh Jayachandran  Immunofluorescence (1:200) 
anti-phospho- HistoneH3 
(Ser10) rabbit 
Chromatin 
(mitosis marker) upstate 
 Immunofluorescence 
(1:100) 
F126-2 mouse Ag84 obtained from A. Kolk, KIT, Amsterdam/NE 
 Immunoblotting 
 (1:10.000) 
AI-75320 mouse GroEL MRL, Fort Collins, Colorado/USA 
 Immunoblotting 
 (1:500) 
F29-47 mouse Lipoprotein obtained from A. Kolk, KIT, Amsterdam/NE 
 Immunoblotting 
 (1:5000) 
anti-GFP mouse GFP-tagged proteins  Roche Immunoblotting (1:2000)  
anti-His mouse His-tagged proteins  Amersham Biosciences Immunoblotting (1:2000) 
 
Secondary antibodies 
anti-rabbit-HRP (1mg/ml) goat Rabbit IgG (H+L) Southern Biotech  Immunoblotting  (1:20.000) 
anti-mouse-HRP (1mg/ml) goat Mouse IgG (H+L) Southern Biotech   Immunoblotting  (1:20.000) 
anti-mouse- 
Alexa FluorTM-488 
(2mg/ml) 
goat Mouse IgG (H+L) Molecular Probes Immunofluorescence (1:200) 
anti-rat- 
Alexa FluorTM-488 
(2mg/ml) 
goat Rat IgG (H+L) Molecular Probes Immunofluorescence (1:200) 
anti-rabbit- 
Alexa FluorTM-488 
(2mg/ml) 
goat Rabbit IgG (H+L) Molecular Probes Immunofluorescence (1:200) 
Alexa FluorTM-568 
goat-anti-rabbit IgG 
(H+L), (2mg/ml) 
goat Rabbit IgG (H+L) Molecular Probes Immunofluorescence (1:200) 
 
Dyes 
DRAQ5 - DNA (nucleus) Biostatus limited Immunofluorescence (1:2500)  
Alexa Fluor®-Phalloidin 
-488 - F-Actin Molecular Probes 
Immunofluorescence 
(1:100)  
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2.11 Bacterial strains and culture conditions 
 
 
Name  Source Culture medium Culture condition Application 
E. coli DH10β Silvia Arber LB medium 37°C, 180 rpm cloning 
E. coli DH5α Invitrogen LB medium 37°C, 180 rpm cloning 
E. coli BL21(DE) Jean Pieters LB medium 37°C, 180 rpm protein expression 
M. bovis BCG-phsp60::gfp 
„Montreal“ 
V. Deretic, 
Michigan, USA 7H9 + 10% OADC 37°C, 90 rpm, dark biochemistry 
M. bovis BCG-∆pknG-phsp60
„Montreal“ Liem Nguyen 7H9 + 10% OADC 37°C, 90 rpm, dark biochemistry 
M. bovis BCG 
„Pasteur-1173P2“ 
Roland Brosch 
Pasteur/Paris 7H9 + 10% OADC 37°C, 90 rpm, dark 
expression 
growth  
survival assay 
M. bovis BCG∆pknG 
„Pasteur-1173P2“ Edith Houben 7H9 + 10% OADC 37°C, 90 rpm, dark 
expression 
growth 
survival assay 
M. bovis BCG∆pknG 
pMV361::pknG-∆N 
Martin Bratschi, 
Nicole Scherr, 
7H9 + 10% OADC 
(25 µg/µl Kanamycin) 37°C, 90 rpm, dark 
expression 
growth  
survival assay 
M. bovis BCG∆pknG 
pMV361::pknG-P-mut Damir Perisa 
7H9 + 10% OADC 
(25 µg/µl Kanamycin) 37°C, 90 rpm, dark 
expression 
growth  
survival assay 
M. bovis BCG∆pknG 
pMV361::pknG-CXXC-mut Nicole Scherr 
7H9 + 10% OADC 
(25 µg/µl Kanamycin) 37°C, 90 rpm, dark 
expression 
growth 
survival assay 
M. bovis BCG∆pknG 
pSD5::3xFLAG::pknG Nicole Scherr 
7H9 + 10% OADC 
(25 µg/µl Kanamycin) 37°C, 90 rpm, dark 
expression  
microscopy 
M. smegmatis mc2155 ATCC 7H9 + 10% OADC 37°C, 90 rpm, dark 
expression 
biochemistry 
microscopy 
M. smegmatis BCG∆pknG 
pSD5-3xFLAG::pknG Nicole Scherr 
7H9 + 10% OADC 
(25 µg/µl Kanamycin) 37°C, 90 rpm, dark 
expression  
microscopy 
M. smegmatis mc2155 
NDL1 
pMV361::wag31MS::gfp 
Liem Nguyen 7H9 + 10% OADC 37°C, 90 rpm, dark 
expression 
biochemistry 
microscopy 
M. smegmatis mc2155 
NDL4 
pMV361::wag31MS 
Liem Nguyen 7H9 + 10% OADC 37°C, 90 rpm, dark 
expression 
biochemistry 
microscopy 
M. smegmatis mc2155 
NDL8 
pMV361::wag31TB 
Liem Nguyen 7H9 + 10% OADC 37°C, 90 rpm, dark 
expression 
biochemistry 
microscopy 
M. tuberculosis H37Rv Roland Brosch Pasteur/Paris 7H9 + 10% OADC 
37°C, 90 rpm, dark 
(Med. Microbiology) 
culture maintenance
expression 
M. tuberculosis H37Rv 
∆pknG 
clones 2,7,8 
Liem Nguyen 7H9 + 10% OADC 37°C, 90 rpm, dark (Med. Microbiology) 
culture maintenance
expression 
complementation 
M. tuberculosis H37Rv 
∆pknG, pMV361::pknG 
clones B2a(2), B3a,b,d(7) 
B4-I/III(8) 
Liem Nguyen/ 
Nicole Scherr 
7H9 + 10% OADC 
(50 µg/µl Kanamycin) 
37°C, 90 rpm, dark 
(Med. Microbiology) 
culture maintenance
expression 
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2.12 Eukaryotic cells and culture conditions 
 
 
Name  Cell type Source Culture medium Culture  conditions Application 
BMM bone marrow derived macrophages C57/BL6 mice
DMEM 
10% FBS 
2 mM L-glutamine 
1 mM Na-pyruvate 
50 µM β-Mercaptoethanol 
30% L929 cond. medium 
37°C 
5% CO2 
for 5-7 days 
on Teflon 
dishes 
Survival assay 
 
J774A.1 mouse macrophage-like  cell line  ATCC 
DMEM 
10% FBS 
2 mM L-glutamine 
37°C 
5% CO2 
 
Survival assay 
Translation 
Proliferation 
Transfections and 
Immunofluorescence
HEK293 human embryonic kidney cell line ATCC 
Glutamax 
10% FBS 
1 mM Na-pyruvate 
0.002% Ciproxin 
37°C 
5% CO2 
 
Transfections and 
Immunofluorescence
Microscopy 
HeLa human cervical cancer  cell line  ATCC 
Glutamax 
10% FBS 
1 mM Na-pyruvate 
0.002% Ciproxin 
37°C 
5% CO2 
 
Transfections and 
Immunofluorescence
Microscopy 
Mel JuSo human melanoma  cell line 
Johnson et al. 
(1981), Pieters 
et al. (1991) 
Glutamax 
10% FBS 
1 mM Na-pyruvate 
0.002% Ciproxin 
37°C 
5% CO2 
 
Transfections and 
Immunofluorescence
Microscopy 
 
 
 
 
 
2.13 MOLECULAR GENETICS METHODS 
 
2.13.1 Preparation of ultracompetent E. coli DH10β 
Ultracompetent cells were prepared according to Inoue et al., 1990. A 5 ml pre-culture 
derived from a single colony and grown for 16 h (at 37°C, 180 rpm) was used to inoculate 
250 ml SOC medium. The culture was grown under vigorous shaking to an OD600 = 0.5 and 
placed on ice for 10 min. The following steps were performed at 4°C with pre-cooled 
materials. Bacteria were spun at 7280xg (10 min, 4°C) and the pellet was gently resuspended 
in 80 ml ice-cold TB solution and put on ice for 10 min. After a further centrifugation step 20 
ml ice-cold TB and 1.4 ml ice-cold DMSO were added and the cells gently resuspended. 
Aliquots (50µl) were frozen in liquid nitrogen and stored at -80°C. 
 
2.13.2 Preparation of electrocompetent E. coli DH5α/BL21  
A 5 ml pre-culture derived from a single colony and grown o/n (at 37°C, 180 rpm) was used 
to inoculate 1L LB medium. The culture was grown until an OD600 of 0.5-0.8 was reached. 
The flask was placed on ice for 15-30 min. All subsequent steps were carried out at 4°C with 
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pre-cooled materials. The bacteria were washed three times, first with 1L ice-cold dH2O, then 
with 0.5 L dH2O, followed by washing with 20 ml ice-cold 10% glycerol. In between, the 
bacteria were pelleted by spinning at 7280xg (15 min, 4°C). After the last washing step, the 
bacteria were resuspended in a final volume of 2 ml ice-cold 10% glycerol, aliquoted, frozen 
in liquid nitrogen and stored at -80°C. 
 
2.13.3 Preparation of electrocompetent M. bovis and M. tuberculosis (Parish and Stoker, 
1998) 
Hundred ml 7H9 medium containing 10% OADC were inoculated with 1 ml of a saturated 
culture (OD600>1.0) and incubated shaking at 160 rpm (37°C) until an OD600 of 0.5 was 
reached (1-2 weeks). Bacteria were pelleted by centrifugation at 1500xg for 10 min and 
gently resuspended in 10% glycerol. This washing step was repeated 3 times before the pellet 
was resuspended in 4.5 ml 10% glycerol. Aliquots of 200 µl were frozen in liquid nitrogen 
and stored at -80°C.  
Remark: Electrocompetent M. tuberculosis cells were prepared in a biosafety level 2+ 
laboratory according to the special safety rules.   
 
2.13.4 Preparation of electrocompetent M. smegmatis (Parish et al., 1998) 
Two ml 7H9 medium containing 10% OADC and 0.05% Tween 80 were inoculated from a 
glycerol stock and bacteria were grown o/n at 37°C (150 rpm) up to saturation (OD600=4.5). 
A main culture was prepared by using 1 ml of the saturated culture as inoculum for 100 ml 
7H9 medium containing 10% OADC and 0.5% Tween 80. The cultures were grown o/n at 
37°C (70 rpm). At OD600 of 0.8-1.0, the bacteria were placed on ice for 20 min and handled 
at 4°C for the whole procedure. Cells were pelleted at 1500xg (10 min, 4°C) and gently 
resuspended in 100 ml 10% glycerol, which was added drop-wise to the pellet by using two 
pipetboys at once. This step was repeated three times and the pellet was finally resuspended 
in 2 ml 10% glycerol. Aliquots of 100 µl were quickly frozen in liquid nitrogen and stored at 
-80°C. 
 
2.13.5 Transformation of ultracompetent E. coli DH10β 
Ultracompetent cells were thawed on ice, then plasmid DNA or an aliquot of the ligation mix 
was added to the cells and incubated on ice for 5 min. Then, the mixture was plated out on 
pre-warmed agar plates containing the appropriate antibiotic and incubated o/n at 37°C. 
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2.13.6 Transformation of electrocompetent E. coli DH5α/BL21  
Electrocompetent cells were thawed while electroporation cuvettes (0.2 µm, Bio-Rad or 
Eppendorf) were pre-cooled on ice. Plasmid DNA or an aliquot of the ligation mix was added 
to the cells, the mixture was transferred to the cuvette and electorporated at 1800 mV. 
Immediately, 500 µl pre-warmed LB medium were added and the cell suspension was 
transferred to an Eppendorf tube. After a recovery time of 1h (180 rpm, 37°C), the cells were 
plated on pre-warmed LB plates with the required antibiotic and incubated o/n at 37°C. 
 
2.13.7 Transformation of M. bovis BCG and M. tuberculosis 
M. bovis BCG or M. tuberculosis competent cells (200 µl) were thawed and electroporation 
cuvettes (0.2 µm, Bio-Rad) were pre-cooled on ice. A 15 ml Falcon tube with 1 ml 7H9 
(10% OACD) was prepared for recovery of the cells after transformation. Around 500 ng of 
DNA was added to the cells and the mixture was transferred to the pre-cooled electroporation 
cuvette. Electroporation (Bio-Rad Gene PulserTM) was performed at 2.5 V, 1000 Ω and 25 
µF (time constant ideally 18-22 ms). Quickly, 1 ml ice-cold 7H9 (10% OADC) was added to 
the cells and the suspension transferred to the prepared 15 ml Falcon tube. For recovery, the 
cells were incubated 16-24 h at 130 rpm and 37°C. The next day, different volumes were 
spread onto selective 7H10 (10% OADC) agar plates and incubated for 2-4 weeks at 37°C. 
Remark: Transformation of M. tuberculosis cells was performed under supervision in a 
biosafety level 2+ laboratory according to the special safety rules.   
 
2.13.8 Transformation of M. smegmatis 
M. smegmatis electrocompetent cells (100 µl) were thawed and electroporation cuvettes (0.2 
µm, Bio-Rad) were pre-cooled on ice.  For recovery, a 15 ml Falcon tube with 1 ml 7H9 
(10% OADC) was prepared. 200 ng of DNA was added to the cells and the mixture was 
transferred to the pre-cooled electroporation cuvette. Electroporation (Bio-Rad Gene 
PulserTM) was performed at 2.5 V, 1000 Ω and 25 µF (time constant ideally 18-22 ms). 
Immediately, 1 ml ice-cold 7H9 (10% OADC) was added to the cells and the suspension 
transferred to the prepared 15 ml Falcon tube. The cells were incubated for 3 h at 130 rpm 
and 37°C for recovery. Then, different volumes were plated out onto selective 7H10 (10% 
OADC) agar plates and incubated for 1-2 days at 37°C. 
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2.13.9 Preparation of bacterial stocks 
Exponentially growing bacteria were diluted to a final concentration of 15% (E. coli) or 20% 
(Mycobacteria) glycerol and aliquots of 1 ml were prepared. The stocks were snap-frozen in 
liquid nitrogen and stored at -80°C. 
 
2.13.10 Agarose gel electrophoresis  
Agarose gel electrophoresis was performed for either analytical or preparative purposes by 
preparing 0.8-2.0 % agarose gels in 0.5x TBE containing ethidium bromide (final conc. 1.0 
µg/ml). The gels were run in 0.5x TBE at 50 or 100 V using the Mupid® electrophoresis 
system (Eurogentec) and analyzed using a BioDoc-ItTM Imaging System (UVP). 
 
2.13.11 Preparation of plasmid DNA from E. coli cultures 
Plasmid DNA was prepared by using commercially available kits from QIAGEN (Maxi, 
Midi) and Sigma (Mini) according to the manufacturer’s protocols. 
 
2.13.12 Digestion of plasmid DNA by restriction enzymes 
Restriction digests were performed to analyze plasmids or to prepare DNA for ligation. 
Usually, 0.5-5 µg DNA were digested in the appropriate buffer using 1-5 U enzyme/µg DNA 
for 1-3 h at 37°C. 
 
2.13.13 Dephosphorylation of DNA 
Re-ligation of digested plasmid DNA was prevented by incubating the DNA with 5 U shrimp 
alkaline phosphatase (SAP) in 1x SAP buffer for 1 h at 37°C. SAP was inactivated by 
heating the reaction mixture for 10 min at 65°C. Dephosphorylated linearized vectors were 
applied to preparative agarose gels and purified. 
 
2.13.14 Purification of DNA from agarose gels 
Under UV illumination (312 nm, TFX 20M UV transilluminator), the bands of interest were 
quickly excised from the gel and purified from agarose gels using the Qiaquick gel extraction 
kit (QIAGEN) according to the manufacturer’s protocol. 
 
2.13.15 Ligation of insert and vector 
Ligation of DNA fragments with sticky ends was performed in a reaction volume of 15 µl 
using 1U T4 DNA ligase and buffer from New England Biolabs (NEB). The molar vector-
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insert ratio varied from 1:2 to 1:8. The ligation reaction mixture was incubated o/n at 16°C 
(cold room) to obtain a maximal number of transformants. 
 
2.13.16 Precipitation of DNA 
Plasmid DNA was precipitated by adding 0.1 volume of 3 M sodium acetate pH 5.2 and 3 
volumes of 100 % ethanol. The mixture was incubated for at least 15 min at -20°C. The 
precipitated DNA was spun (20,800xg, 15 min, 4°C) and the DNA pellet was washed once 
with 100% ethanol, air-dried and dissolved in H2O DW-trigB (Albatros).  
 
2.13.17 Sequencing 
Sequencing reactions were set up in a 0.5 ml tube by mixing 4 µl of the BigDye (Perkin 
Elmer) Terminator Ready reaction buffer with 0.5 µl primer (10 pmol/µl) and 200-400 ng 
template DNA, completed to a total volume of 10 µl. For the amplification of DNA, the 
following protocol was used: 
A. preheating:  96°C   1 min 
B. denaturation: 96°C   10 sec 
C. annealing:  50°C   5 sec 
D. elongation:  60°C   4 min, 25 cycles 
E. cooling:  4°C     
 
The extension products were purified by ethanol precipitation as follows: 90 µl H2O DW-
trigB (Albatros), 10 µl 125 mM EDTA pH 8.0, 10 µl 3 M Na-acetate pH 4.6 and 250 µl 95% 
EtOH were added to each reaction, mixed and placed in the dark for 10 min at RT. DNA was 
pelleted by centrifugation at 20,800xg and RT for 20 min. The supernatant was carefully 
removed and the pellet was washed with 350 µl 70% ethanol and centrifuged again for 5 min 
at maximum speed. This washing step was repeated once. The pellet was air-dried and stored 
at 4°C. 
Sequencing was performed by the in house sequencing facility and the obtained sequences 
were analyzed using the Mac VectorTM software (version 7.2.2). 
 
2.13.18 Polymerase chain reaction (PCR)  
In general, a PCR designated to amplify DNA for the construction of new vectors was set up 
as follows:  
-  100 ng template 
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-  1.5 µl forward primer (10 µM) 
-  1.5 µl reverse primer (10 µM) 
-  1.0 µl 25 mM dNTP 
-   5.0 µl 10x Expand buffer 1 or 10x Easy-A® buffer 
-   0.75 µl Expand Long Template Enzyme (Roche) or Easy-A® polymerase (Promega) 
-   0.75 µl DMSO (1-2%) 
-   x µl ddH2O (ad 50 µl final volume) 
 
Following standard program was used: 
A. Initial denaturation: 95°C  2 min 
B. Denaturation:  95°C  15 sec 
C. Annealing:   x °C  30 sec (Tmelting -10%) 
D. Elongation:   68°C (*) x min (1kb = 1min),  25-30 cycles 
E. Final elongation:  68°C (*) 7 min 
F. Cooling:   4°C  until usage  
(*) for Easy-A®-Polymerase, an elongation temperature of 72°C was required.  
 
2.13.19 Colony PCR 
Colony PCRs were performed as a first assay to test colonies of transformed M. bovis for the 
presence of pknG and mutant constructs. The PCR was set up by mixing: 
-  1.25 µl forward primer (12.5 µM), pknG EN 5’ 
-  1.25 µl reverse primer (12.5 µM), pknG XNH 3’ 
-   0.4 µl 25 mM dNTP 
-   2.5 µl 10x PCR reaction buffer 3 
-   0.25 µl Expand Long Template Enzyme mix 
-  18.35 µl ddH2O 
-   colony material 
The standard program was as follows: 
A. Initial denaturation: 95°C 3 min 
B. Denaturation:  95°C 40 sec 
C. Annealing:   66°C 30 sec 
D. Elongation:   68°C 2 min 20 sec   30 cycles 
E. Final elongation:  68°C 7 min 
F. Cooling:   4°C until usage  
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2.13.20 Site-directed mutagenesis 
Site-directed mutagenesis was performed using components of the QuikChange II site-
directed mutagenesis kit (Stratagene). The basic procedure utilizes a supercoiled double-
stranded DNA vector with an insert of interest and two synthetic oligonucleotide primers 
(Microsynth), both containing the desired mutation. The primers, each complementary to 
opposite strands of the vector, are extendend during temperature cycling by PfuUltra HF 
(high fidelity) DNA polymerase withouth primer displacement. Extension of the primers 
generates a mutated plasmid containing staggered nicks. Following temperature cycling, the 
product is treated with DpnI. The DpnI endonuclease is specific for methylated and 
hemimethylated DNA that exclusively occurs in DNA isolated from E. coli, but not in in 
vitro amplified DNA, and is used to digest the parental DNA template and to select for 
mutation-containing synthesized DNA. 
 
The reaction was set up in thin-walled tubes as follows: 
- 1 µl DNA (50 ng) 
- 1 µl (10 µM) Primer 1 (HPLC purified NS-inh-Ser-1) 
- 1 µl (10 µM) Primer 2 (HPLC purified NS-inh-Ser-2) 
- 1 µl 25 mM dNTPs  
- 5 µl 10x Pfu reaction buffer 
- 1 µl Pfu-Ultra HP-Polymerase (2.5 U) 
- x µl ddH2O (ad 50 µl final volume) 
 
The following program was run: 
A. Preheating lid:  100°C 
B. Initial denaturation: 95°C    30 sec 
C. Denaturation:  95°C    30 sec 
D. Annealing:   55°C    60 sec     20 cycles 
E. Elongation:   68°C     8 min 
F. Cooling:   25°C     3 min 
 
Then, the reaction was digested with 10 U DpnI (NEB) for 2 h at 37°C. Ultracompetent 
DH5α cells were transformed with 5 µl of the PCR mixture and plated on LB-Amp agar. The 
_______________________________________________________________________________CHAPTER 2 
55 
colonies were picked, the plasmid DNA isolated and the sequence analyzed for correctly 
introduced point mutations.  
 
2.13.21 Construction of different expression vectors  
 
a) Construction of vectors for expression of truncated PknG versions in E. coli 
Different PknG domains were cloned into vector pET-15b for subsequent expression and 
purification from E. coli: PknG-N-term, PknG-kin-domain, PknG-c-term, PknG-kin-c-term 
and PknG-∆N.  
By introducing NdeI and XhoI restriction sites, pknG was amplified from genomic DNA (M. 
bovis BCG) using Easy-A® polymerase (Promega). The PCR product was T/A cloned into 
pGEM®-T Easy vector (Promega), and the sequence was verified. The DNA fragments were 
then cut out by NdeI/XhoI and ligated into the expression vector pET-15b (Novagen). 
In addition, pknG was mutated by site-directed mutagenesis (to obtain PknG-I87S/A92S with 
mutated inhibitor binding sites), subcloned into pGEM®-T Easy and sequenced. Using NdeI 
and XhoI restriction sites PknG was transferred into pET-15b. 
 
b) Construction of vectors for expression of PknG mutants in mammalian cells - I 
For expression in HEK, HeLa and Mel JuSo cells, several PknG truncated sequences were 
cloned into pIRESpuro3 (Clontech) to express the following mutant proteins: 
PknG-wt, PknG-K181M: pknG inserts were excised from pGEX vectors using EcoRI and 
NotI restriction sites and ligated into pIRESpuro3. 
PknG-∆N: pknG-∆N fragment was cut out from pGEM::∆N by EcoRI and inserted into 
pIRESpuro3. The orientation was checked by BamH1 digestion. 
PknG-C/S and PknG-P-mut: pknG was amplified from pMV361::pknG-C/S and 
pMV361::pknG-P-mut using Easy-A polymerase by introducing EcoRI and NotI restriction 
sites, cloned into pGEM®-T Easy and sequenced. The inserts were excised by EcoRI and 
NotI and put into pIRESpuro3. 
PknG-∆C1, ∆C2, ∆C3, ∆N2 and kin: pknG was amplified from pET-15b::pknG adding 
EcoRI and NotI restrictions sites. The truncated pknG sequences were cloned into pGEM®-T 
Easy, excised by EcoRI and NotI and ligated into pIRESpuro3.  
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c) Construction of vectors for expression of PknG mutants in mammalian cells - II 
PknG-wt and mutants were cloned into a vector allowing the expression of following FLAG-
tagged proteins in eukaryotic cells. PknG-wt: pknG was amplified from pGEX::pknG by 
adding HindIII/NotI sites, cloned into pGEM®-T Easy and transferred to 3xFLAG® vector.  
PknG-K181M: The pknG insert carrying the point mutation was cut out from eGFP::pknG-
K181M by HindIII/NotI and ligated into the 3xFLAG® vector (Sigma).  
PknG-∆N: The pknG-∆N insert was excised from pGEM::pknG-∆N by NotI and ligated into 
3xFLAG® vector. The orientation was tested by digestion with BamH1. 
PknG-Pmut, PknG-CXXC: pknG was amplified by Expand Long Template polymerase from 
pMV361::pknG-Pmut and pMV361::pknG-C/S and HindIII/NotI restriction sites were added. 
The amplified DNA was directly digested by HindIII/NotI and inserted into the 3xFLAG® 
vector. 
PknG-∆C1, ∆C2, ∆C3, ∆N2 and kin: The pknG fragments were excised from pGEM®-T 
Easy by NotI restriction and cloned into the 3xFLAG® vector. The orientation was verified 
by restriction digests with either EcoRV or BamH1.  
 
d) Construction of a vector for PknG expression in mycobacteria 
A construct was designed which allowed the expression of 3xFLAG-tagged PknG by 
mycobacteria. 
3xFLAG-PknG: DNA was amplified using the FLAG vector containing pknG as template; 
NdeI and ScaI restriction sites were added and the 3xFLAG::pknG-fragment was T/A-cloned 
into pGEM®-T Easy. To verify the presence of the 3xFLAG-tag, different clones were 
analyzed by sequencing the N-terminal region. One positive clone was selected for 
sequencing of full length pknG. The 3xFLAG::pknG fragment was excised by NdeI and ScaI 
and cloned in the mycobacterial vector pSD5. 
 
2.14. CELL CULTURE METHODS 
 
2.14.1 Thawing eukaryotic cells 
To recover cells from liquid nitrogen, the stocks were thawed at 37°C (water bath). The cells 
were immediately diluted in 9 ml of pre-warmed medium and centrifuged (200xg, 5 min). 
The pellet was gently resuspended in medium, transferred to a culture dish and incubated at 
37°C (5% CO2) for 24 h. Then the cells were microscopically checked, the medium 
exchanged or the cells splitted into new cultures. 
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2.14.2 Determination of cell numbers 
The number of viable cells was determined using a Neubauer counting chamber (0.1 mm 
depth). An aliquot of cell suspension was diluted 1:2 with trypan blue solution (0.4 %, Sigma) 
and the non-stained cells in 4 big squares (each containing 16 small fields) were counted. The 
density in cells/ml was calculated by multiplying the mean number of cells per big square by 
2 x 104.  
 
2.14.3 Splitting of J774 macrophages 
The cells were washed with PBS, removed from the dishes using a cell scraper or a bend 
glass pipette, and the cell suspensions were transferred to Falcon tubes. After centrifugation 
(5 min, 200xg), pellets were resuspended in fresh medium and the cells were distributed onto 
new culture dishes. 
 
2.14.4 Trypsinization of adherent cells 
Adherent cells (Mel JuSo, HeLa, HEK) were washed once with PBS or medium and 
trypsin/EDTA was added. The culture dish was incubated for 3-5 min at 37°C. The digestion 
was quenched by adding medium before spinning the cell suspension for 5 min at 200xg. The 
cell pellet was resuspended in medium and splitted into new cultures. 
 
2.14.5 Preparation of cell stocks  
A cell suspension from several dishes was prepared, centrifuged (200xg, 5 min) and the pellet 
was resuspended in freezing medium (FBS with 10% DMSO) at a cell density of 5-10x 106 
cells/ml. The cell suspension was aliquoted (1 ml) into cryotubes which were placed into a 
pre-cooled (4°C) freezing box containing isopropanol, and stored at -80°C for 1-2 days 
before the tubes were transferred to the liquid nitrogen tank for long-term storage. 
 
2.14.6 Preparation of murine bone marrow derived macrophages 
The femur bones of a mouse killed by CO2 asphyxiation were isolated, cleaned and cut open 
on one side and placed inside a yellow tip. The tip was transferred into a 5 ml tube containing 
500 µl bone marrow macrophage medium. Pluripotent bone marrow cells were obtained by 
spinning at 200xg for 10 min. The bone marrow of one bone was added to Teflon dishes 
(Rowatec) containing bone marrow medium. After an incubation period of 5-7 days (at 37°C, 
5 % CO2) the differentiated cells (ca. 5-10x106 cells/bone) were used for further analysis. 
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2.14.7 Testing cells for mycoplasma contamination 
Possible mycoplasma contamination in cell cultures was tested using the Mycoalert kit 
(Cambrex) according to the manufacturer’s protocol. A luminometer (Biotek) was used to 
read out the bioluminescence which is generated in case of a contamination. 
 
2.14.8 Transfection of cells 
Mel JuSo, HeLa and HEK cells were transfected using jetPEITM (Polyplus), a polymer 
forming stable aggregates with DNA. Accordingly, macrophages were transfected by 
jetPEITM macrophages. Transfections were performed according to the Polyplus transfection 
protocol. In general, 400,000-600,000 cells were seeded in 6 cm dishes and grown to 60 % 
confluency (up to 24 h). Then, 5 µg plasmid DNA complexed to jetPEITM was added to the 
cells and the transfected cultures were further cultivated for 24-48 h. The cells were seeded 
on disinfected Teflon-coated 10 well-microscopy slides (4000-6000 cells / 50 µl) and 
incubated for 12-16 h (2 h for macrophages) to allow adherence.  
Alternatively, 5 µl of the transfection mixture (containing 50 ng DNA) were added directly to 
the cells seeded on slides and incubated for 24-48 h. 
 
2.14.9 Infection of J774 and bone marrow macrophages 
Mycobacterial cultures (OD600=0.5-1.0) were washed twice in PBS before washing and 
resuspension in macrophage medium. Suspensions were left for 20-30 min to obtain a 
supernatant devoid of mycobacterial aggregates. 
Macrophages were seeded on Teflon-coated 10-well microscopy slides > 2 h prior to 
infection. The medium was removed and replaced by 50 µl of the bacterial suspension 
(OD600 of infection variable). Slides were incubated for 4 or 24 h at 37°C (5 % CO2).  
 
 
2.15. BIOCHEMICAL METHODS 
 
2.15.1 Determination of protein concentrations 
The concentration of proteins was determined by either the Bradford (Bradford, 1976) or the 
BCA (Smith et al., 1985) method. In general, a calibration curve was prepared by pipetting 
different volumes (1, 2, 4, 6, 8 and 10 µl) of a protein standard (bovine gamma globulin, 1 
mg/ml, Bio-Rad) in duplicates into 96-well flat bottom plates (BD Falcon). For the unknown 
sample, aliquots of 1-5 µl in duplicates or triplicates were analyzed. To start the reaction, 200 
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µl Bradford reagent (Bio-Rad) or BCA reagent (Pierce) were added to the wells and the plate 
was incubated for 10 min at RT (Bradford) or for 30 min at 37°C (BCA). The protein 
concentration was measured at A595 (Bradford) or A562 (BCA) using a microplate reader 
(bucher biotec) with SoftMax®Pro software (version 4.0). Finally, the protein amount was 
calculated based on the standard curve. 
 
2.15.2 Discontinuous SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE (Laemmli, 1970) was carried out using the Bio-Rad Protean II system. Usually, 
minigels (7cm x 10cm x 0.75mm) were prepared. After assembling the glass plates, the 
components for the separating gel were mixed, poured into the assembly and overlaid with 
water-saturated butanol. The concentration of acrylamide was selected dependent on the 
molecular weight of the protein to be analyzed (quantities for 7.5-15% gels are given in the 
table below). After polymerization of the lower gel, butanol was removed and the stacking 
gel mixture was poured on top of the lower gel, followed by immediate insertion of the comb 
with 10 slots.  
Samples for SDS-PAGE were treated with 5x SDS-containing sample buffer, boiled for 
either 7 min (purified proteins) or 10-15 min (lysates), cooled to RT, centrifuged and loaded 
using a Hamilton pipet (50 µl/100 µl). The samples were run at 80V until the samples 
entered the separating gel, then the voltage was set to 120V. 
 
 
 
2.15.3 Western Blotting  
Following gel electrophoresis, proteins were transferred onto a positively charged 
nitrocellulose membrane using the semi-dry transfer technique (Bio-Rad Trans-Blot® SD 
Cell). The blot was assembled on the lower electrode (anode) as follows: thick filter paper 
component 7.5 % 10% 12.5 % 15 % stacking gel 
30% acrylamide, 0.8% bisacrylamide 2.5 ml 3.3 ml 4.2 ml 5 ml 0.65 ml 
2 M Tris/HCl, pH 8.8 2 ml 2 ml 2 ml 2 ml - 
0.5  M Tris/HCl, pH 6.8 - - - - 1.25 ml 
20 % SDS 50 µl 50 µl 50 µl 50 µl 25 µl 
dH2O 5.4 ml 4.6 ml 3.7 ml 2.9 ml 3.05 ml 
10% APS 50 µl 50 µl 50 µl 50 µl 25 µl 
TEMED 10 µl 10 µl 10 µl 10 µl 5 µl 
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(MN440, Macherey&Nagel), thin filter paper (3MM, Whatman®), nitrocellulose membrane 
(HybondTM-C super, Amersham Biosciences), gel, thin filter paper, thick filter paper and the 
upper electrode (cathode). Upon removal of air bubbles the transfer was run at 0.6 h at 2.5 
mA/cm2 = 0.17 A/minigel. Afterwards the proteins on the membrane were stained shaking in 
Ponceau S (Sigma) for 2 min and destained in dH2O until bands were visible. The molecular 
weight standard bands were marked with a pen and the membrane was scanned for 
documentation. 
The membrane was blocked under agitation in PBS-T containing 5% milk (low fat milk 
powder) for 2 h or o/n. The membrane was incubated with primary antibody diluted in PBS-
T milk for 30 min or 1 h at RT, followed by 6x 5 min washing steps in PBS-T milk. The 
incubation with HRP-coupled-secondary antibody (diluted in PBS-T milk) was performed 
for 30 min at RT. The membrane was washed 4x 5 min with PBS-T milk and 2x 5 min with 
PBS-T, then rinsed in PBS. For immunodetection, the membrane was covered for 1-2 min 
with reagents enhancing chemiluminescence (ECL, Amersham). The membrane was dried 
with tissue paper, placed in a plastic bag and exposed to ECL films for different times. 
 
2.15.4 Stripping of membranes for reprobing 
In order to remove primary and secondary antibodies, the membrane was first washed twice 
in PBS-T and then incubated under agitation in stripping buffer (20% SDS, 100 mM β-
mercaptoethanol, 67 mM Tris/HCl pH 6.7) for 30 min at 50°C. After 3x 10 min washing 
steps in PBS-T, the membrane was blocked in PBS-T with 5 % milk before the incubation 
with primary antibodies was continued as described above.  
 
2.15.5 Expression of PknG 
For expression of His-tagged PknG wt, PknG∆N, PknG-N-term, PknG-I87S/A92S and 
PknG-C/S, 50 µl competent E. coli BL21(DE3) cells were transformed with 200 ng/µl 
pET15b::his::pknG. After 1 h recovery in LB medium, the cells were spread on two LB-Amp 
plates and incubated o/n at 37°C. 
The colony material was scratched from the agar plates by adding LB medium, the cell 
suspension was pooled and distributed equally among four 2 L-Erlenmeyer flasks (with 1L  
LB-Amp medium). The cultures were incubated while shaking at 37°C and 180 rpm until 
OD600=0.5-0.6 was reached. Then, PknG expression was induced with IPTG (final conc. 0.1 
mM) and incubated for 16 h at 22°C. The cultures were incubated shaking at 180 rpm for 15-
16 h at 22°C using an aqua shaker (coldroom).  
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2.15.6 Purification of PknG 
Cells were harvested (7280xg for 25 min at 4°C), resuspended in 50 ml 20 mM Tris pH 7.5, 
500 mM NaCl, 40 mM imidazole including protease inhibitors (50x Roche protease inhibitor 
cocktail, 1 mM PMSF) and homogenized by four passages at 1000 psi (cell type 40 K) 
through a French® pressure cell press (Thermo, Electron corporation). The lysate was cleared 
by subsequent centrifugation steps at 20,000 rpm (SS34 Sorvall rotor, 20 min at 4°C) and at 
41,000 rpm (TST 41.14 Kontron rotor, 30 min, 4°C). The supernatant was filtered and 
applied to a 5 ml HisTrapTM HP column (GE Healthcare) attached to a FPLC system 
(Pharmacia). The column was washed with ca. 150 ml of 20 mM Tris pH 7.5, 500 mM NaCl, 
40 mM imidazole and His-PknG was eluted from the column by switching to 200 mM 
imidazole in 20 mM Tris pH 7.5, 500 mM NaCl. The collected 1 ml fractions were tested by 
loading 1 µl on a 10% SDS-PAGE (Laemmli, 1970). Fractions containing high PknG 
amounts were pooled and gel filtrated using the ÄKTA FPLC system (GE Healthcare) with 
attached Superdex 200 HiLoad 16/60 column (GE Healthcare) equilibrated in 20 mM Tris 
pH 7.5, 500 mM NaCl to remove imidazole and to obtain pure protein. Fractions containing 
pure PknG were tested by 10% SDS-PAGE (1-2 µl of the PknG fraction) and concentrated at 
2500xg and 4°C to 8-18 µg/µl in Vivaspin 20 tubes (30,000 MWCO PES, Vivascience AG). 
Protein concentration was determined by BCATM Protein Assay (Pierce). The overall yield of 
PknG was 15 mg/L E. coli culture. The purity of the samples was checked by 10% SDS-
PAGE; kinase activity was confirmed by performing in vitro autophosphorylation assays. 
Aliquots of purified PknG were either kept on ice for further usage or frozen in liquid 
nitrogen and stored at -80°C. 
 
When cleavage of the N-terminal His-Tag was required, the protein concentration of the gel 
filtration-purified PknG pool was determined and PknG was cleaved with 2U thrombin/mg 
protein and in sample buffer containing 4 mM CaCl2. The protein sample was incubated for 
16 hours at room temperature, centrifuged (20,800xg, 5 min, 4°C) and applied to a 1 ml 
HisTrapTM HP column to remove the His-tag. Fractions were collected, loaded on a 10% 
SDS-PAGE and analyzed by western blotting to confirm His-Tag cleavage by using an α-His 
antibody. Thrombin present in the PknG containing fractions was removed by a subsequent 
size exclusion chromatography step on a Superdex 200 HiLoad 16/60 column equilibrated in 
20 mM Tris pH 7.5, 500 mM NaCl. Fractions containing cleaved protein were pooled and 
concentrated at 4°C to 8-18 mg/ml.  
See flow-chart on the next page for overview and timing! 
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2.15.7 Aging assay 
Aging assays were performed on a regular basis to check the quality of PknG. Protein 
samples were centrifuged at 20,800xg for 15 min (4°C). The supernatant was transferred to a 
new tube. An aliquot of the supernatant and the starting sample as well as the complete pellet 
fraction were analyzed by 7.5% SDS-PAGE.  
 
2.15.8 Analytical gel filtration  
To test the quality of purified PknG, PknG was analyzed by small-scale size exclusion 
chromatography. Fifty µg protein (in 20 mM Tris pH 7.5, 500 mM NaCl) were injected onto 
a Superdex 200 PC 3.2/30 gel filtration column attached to the SMARTTM System 
(Pharmacia) and the sample was run and eluted in 20 mM Tris pH 7.5, 500 mM NaCl at a 
flow rate of 50 µl/min. 
To separate PknG monomers and dimers for further analysis, 500 µg PknG full length were 
loaded on the column. PknG was eluted in 75 µl fractions collected on ice. The concentration 
of monomer- and dimer peak fractions was determined by BCATM Protein Assay (Pierce).  
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2.15.9 Kinase assay  
In vitro autophosphorylation of PknG and mutants was performed by incubating 0.3-0.5 µg 
kinase in 25 mM Tris pH 7.5, 2 mM MnCl2, 1 mM DTT and 0.5 µCi [γ32P]ATP (GE 
Healthcare) for 30 min at 37°C. To monitor kinase activity of PknG∆N, the protein was 
combined with 0.5-2 µg PknG-K181M, the kinase-dead version of PknG (Walburger et al., 
2004). 
Alternatively, PknG mutants (PknG-I87S/A92S and PknG-C/S) were incubated in buffer 
containing the N-terminal domain of PknG used as an artificial substrate. Sample buffer was 
added and the phosphorylated proteins were boiled for 7 min at 95°C. The samples were 
separated on 7.5%, 10% or 12.5 % SDS-PAGE, analyzed by autoradiography (Hyperfilm MP, 
Amersham) and, if required, quantitated by Phospho-Imaging using a STORM 840 Optical 
Scanner System and ImageQuant software (Molecular Dynamics, version 5.2).  
 
2.15.10 Inhibitor screen (ProQinase/Freiburg) 
To test the selectivity of AX20017, the IC50 profile of the inhibitor was determined using 
different concentrations of PknG and 28 selected mammalian protein kinases representing the 
six major kinase families (Manning et al., 2002). IC50 values were determined performing a 
radiometric ATP consumptive assay (33PanQinase® Activity Assay, ProQinase) in which 12 
concentrations of AX20017 in the range from 5 x 10-5 M to 1.5 x 10-10 M were tested. For 
sample preparation, PknG was dissolved in the same storage buffer (50 mM HEPES pH 7.5, 
100 mM NaCl, 5 mM DTT and 20% v/v glycerol as the other kinases. All kinase assays were 
performed in 96-well FlashPlatesTM (Perkin Elmer) in 50 µl reaction volume. The reaction 
cocktails were pipetted by the BeckmanCoulter Biomek 2000/SL robotic system as follows:  
? 20 µl assay buffer 
?15 µl ATP solution (in H2O) 
?  5 µl test sample in 10% DMSO 
? 10 µl enzyme/substrate mixture (in H2O) 
The mixtures were incubated at 30°C for 80 min. Then the reaction was stopped with 50 µl 
of 2% (v/v) H3PO4 and the plates were aspirated and washed two times with 200 µl 0.9% 
(w/v) NaCl. The incorporation of 33Pi (in cpm) was determined with a microplate scintillation 
counter.  
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2.15.11 Phosphorylation and dephosphorylation of PknG 
Phosphorylation and dephosphorylation of PknG was visualized by performing band shift 
assays. PknG was phosphorylated by incubating 2 µg sample for 3 h at 37°C in 20 mM Tris, 
500 mM NaCl containing 50 µM ATP, 1mM DTT and 2mM MnCl2. PknG was 
dephosphorylated by using either bovine alkaline phosphatase (AP) or shrimp alkaline 
phosphase (SAP). PknG was incubated for 3 h at 37°C in 1x phosphatase buffer containing 
0.5 U phosphatase/µg PknG and protease inhibitors (CLAAP, PMSF). As controls, PknG 
was incubated in buffers lacking ATP, AP or SAP. The reactions were stopped by adding 
sample buffer, boiled for 7 min and analyzed by 7.5% SDS-PAGE. 
 
2.15.12 Limited proteolysis 
PknG (10 mg/ml, in 20 mM Tris pH 7.5, 75 mM NaCl, 10% glycerol) was stored at 4°C. To 
analyze proteolysis, aliquots were taken at different time points (days) and separated by 7.5% 
SDS-PAGE. In addition to “natural” degradation, PknG was treated with enzymes. For 
digestion of PknG (4 mg/ml, in 100 mM Tris pH 7.5, 200 mM NaCl) different enzymes 
(Trypsin, Proteinase K, Chymotrypsin, Subtilisin, Thermolysin and Pepsin) in varying 
enzyme-substrate ratios at different temperatures (4°C and 30°C) were tested. The enzyme-
substrate mixtures were incubated at 37°C and 2 µl aliquots (3 µg PknG) were removed at 
different time points (usually 2, 5, 10, 20, 30, 60, 120, 210 min), treated with sample buffer 
and boiled for 7 min at 95°C to stop the reaction. The samples were analyzed by 10% SDS-
PAGE, followed by staining with Coomassie. If required, PknG degradation was further 
analyzed by performing Western blotting with antibodies directed against the N- and C-
terminal part of PknG. In order to identify the degraded products, the samples separated by 
SDS-PAGE were electroblotted to an Immobilon-P transfer (PVDF) membrane (Millipore).  
 
2.15.13 Electroblotting proteins to PVDF membranes 
Before setting up the blot, the PVDF membrane was briefly (2-3 s) immersed in 100% 
methanol, rinsed with H2O, and equilibrated in transfer buffer (10 mM CAPS, 10% MeOH, 
pH 11.0) for at least 15 min. After electrophoresis, the gel was rinsed in transfer buffer for 5 
min. Gel and PVDF membrane were sandwiched between Whatman 3MM paper and 
assembled into the blotting cassette (Bio-Rad Trans-Blot® SD Cell). A backing sheet of 
PVDF was included to ensure that all proteins were trapped on the membrane. The amperage 
was doubled by selecting 0.34 A/minigel. After completion of the transfer, the membrane 
was rinsed several times for each 5 min in H2O DW-trigB (Albatros) to reduce the level of 
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contaminants. Proteins on the membrane were stained for 5 min in freshly prepared 
Coomassie blue R-250 solution (0.1% in 50% methanol) and destained with several changes 
of the destaining solution (50% MeOH, 10% acetic acid). The membrane was rinsed several 
times in H2O DW-trigB (Albatros), air-dried on Whatman paper and the bands of interest 
were excised using fresh razor blades for each sample. The bands were transferred to 
Eppendorf tubes and subjected to sequence analysis by Edman degradation (Urs Kämpfer, 
University of Bern). 
 
2.15.14 Preparation of M. bovis BCG lysates 
For obtaining M. bovis BCG lysates, the cultures were harvested at OD600 0.7-0.9. Cells were 
washed three times in phosphate buffered saline (PBS), resuspended in PBS or TEN buffer 
and disrupted in the presence of glass beads and protease inhibitors (1 mM PMSF and 50x 
complete EDTA-free protease inhibitor cocktail from Roche) by using the Mixer Mill (type 
MM 300, Retsch, Germany) at frequency 30/s for 20 min with chilling intervals. Cell debris 
and non-lysed cells were removed by low speed centrifugation (10 min, 10,600xg).  
Alternatively, bacteria were washed twice in PBS, followed by a final washing step and 
resuspended in TEN buffer (75 mM Tris pH 8.8, 4 mM EDTA, 100 mM NaCl). Cells were 
lysed in the presence of protease inhibitors by three passages of FRENCH® press (Thermo, 
Waltham, USA) treatment. Cell lysate was cleared by centrifugation (10 min, 10,600xg).  
 
2.15.15 Cell fractionation of mycobacterial lysates 
To analyze subcellular localization of Ag84, total mycobacterial lysate was subjected to a 
high-speed spin (100,000xg, 30-45 min, 4°C) to obtain membrane and soluble fractions. 
After determination of the protein concentration, equal amounts were loaded on 10 % SDS-
PAGE gels and analyzed by Western blotting as described above using Ag84 specific 
antibody. As controls, monoclonal antibodies GroEL AI-75320 and lipoprotein F29-47 were 
included. 
 
2.15.16 Size-exclusion chromatography of mycobacterial lysates (SMART system) 
Fifty µg M. bovis BCG lysate (soluble fraction, prepared as described above) was applied to 
a gel filtration column pre-equilibrated in PBS.  The presence of Ag84 in the collected 
fractions was detected by immunoblotting. Standard marker proteins allowing the 
determination of the molecular weight of Ag84 were bovine thyroglobulin (670 kDa), bovine 
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y-globulin (158 kDa), chicken ovalbumin (44 kDa), horse myoglobin (17 kDa) and vitamin 
B12 (1.35 kDa). 
 
2.15.17 Chemical crosslinking of mycobacterial lysates 
To analyze oligomerization of Ag84, purified protein (0.2 mg/ml) or M. bovis BCG lysate (1 
mg/ml) was added with different concentrations of formaldehyde and incubated for 15 
minutes at 37°C. Sample buffer including SDS was added and the samples were loaded 
(without boiling) on a 10% SDS-PAGE gel followed by Western blotting with Ag84 
antibody.  
 
2.15.18 Preparation of lysates from eukaryotic cells 
Cells lysates were prepared from 1-2 ml of the undiluted cell culture after centrifugation. The 
cells were washed twice with ice-cold PBS (5 min, 20,800xg, 4°C). 50 µl Triton-X100 lysis 
buffer containing protease inhibitors was added to the cell pellet, followed by 15 min 
incubation on ice. The lysate was centrifuged at 4°C and 20,800xg for 15 min and the 
supernatant was transferred to a new tube. The protein concentration of the lysates was 
determined and equal protein amounts were resuspended in 1x SDS sample buffer followed 
by SDS-PAGE and Western blotting. 
Alternatively, cells were washed twice in PBS and counted using a Neubauer chamber. The 
cells were spun (5 min, 200xg, RT) and lysed by adding SDS sample buffer normalized for 
the cell number and by boiling for 10 min at 95°C.  
 
 
2.16. BIOPHYSICAL METHODS 
 
2.16.1 Optimum solubility screen (OSS)  
The OSS enables rapid and optimal buffer selection for the sample by simultaneously 
screening small amounts of protein for solubility in 24 buffers of different pHs. To perform 
this screen, a PknG (wildtype) sample of high concentration (17.5 µg/µl, in 20 mM Tris, 500 
mM NaCl) was prepared. Four different PknG sample buffer conditions were tested (PknG in 
200 mM or 500 mM NaCl with or without 10% glycerol), making up 96 conditions under 
which PknG solubility was analyzed. 5 µl PknG were incubated for 2 h (RT) with 45 µl of 
screening buffer (100 mM) supplemented with NaCl and, if required, glycerol. Then, PknG 
was centrifuged for 20 min (RT) at 17,900xg and the supernatant was transferred to a new 
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tube. Protein concentration and possible aggregation were analyzed by measuring the 
absorption spectrum using a NanoDrop photometer (Thermo Fisher Scientific). The 
remaining supernatant was pipetted into wells of a 24 well-plate (VDX 24) and the 
hydrodynamic radius was measured by dynamic light scattering using a DynaProTMTitan 
device (Wyatt Technology Europe GmbH) with DYNAMICSTM software (Version 6.7.3). 
Buffers resulting in a monomodal and monodisperse PknG profile were considered as 
optimal.  
 
2.16.2 Static light scattering (SLS) 
SLS analysis was performed using a miniDAWN TriStar equipped with an Optilab rEX 
refractometer (Wyatt Technology Corp.) coupled to Superdex 200 10/30 (Amersham 
Biosciences) gel filtration column run on an Agilent 1100 HPLC. 100 µl of PknG full length 
(2.5 µg/µl, in 20 mM Tris pH 7.5, 500 mM NaCl) were injected onto the column equilibrated 
in 20 mM Tris pH 7.5, 500 mM NaCl. Samples were eluted at a constant flow rate of 0.5 
ml/min. The shape-independent molecular mass was determined with Wyatt Astra version 
4.90.08 software package. 
 
2.16.3 Circular dichroism spectroscopy (C/D) 
Circular dichroism spectroscopy was performed in order to verify the structural integrity of 
several PknG mutants. Protein samples were diluted with buffer (20 mM Tris pH 7.5, 500 
mM NaCl) to a final concentration of 0.06-0.08 µg/µl. Measurements were done in 0.1 or 0.2 
cm quartz glass cuvettes at 20°C. C/D data were collected on a Jasco J720 spectropolarimeter. 
Per measurement, 8 scans of spectra ranging from 190-260 nm were recorded and normalized 
for the buffer. 
 
2.16.4 Crystallization 
The crystallization work comprising crystallization assays, assessment of plates, x-ray 
measurements and structure determination, was carried out at the Paul Scherrer Institut (PSI) 
in Villigen in collaboration with S. Honnappa and M. Steinmetz.  
Freshly purified, non-frozen protein (5-15 µg/µl) was used for the crystallization assays. 
During storage and transport the sample was kept on ice. PknG was centrifuged for 10 min at 
17,900xg (4°C) and the supernatant was transferred to a new tube. PknG was pre-incubated 
for 2h at RT in case inhibitor or ATP analoga were added. 
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Crystallization was carried out according to the sitting drop vapour diffusion method. 
Crystals were set up in 24 well plates (Hampton). Various conditions were screened by 
testing buffers provided by commercial crystallization kits (Sigma, Hampton, Emerald). 300 
µl of the individual buffers was pipetted into each well, 2 µl protein sample were pipetted on 
top of the plateau before 2 µl of the mother liquor (buffer) were added to PknG to initiate the 
evaporation process. The crystallization plates were usually stored at 20°C and analyzed at 
different time points. For crystals diffracting to a low resolution, buffer and incubation 
conditions were further optimized.  The scheme below showes the variety of methods applied 
to obtain well-diffracting 3D-crystals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.16.5 Structure determination 
PknG∆N (10 mg/ml) was co-crystallized with AX20017 (135 µM final concentration) by 
mixing equal volumes of protein/inhibitor (each 2 µl) with the reservoir solution by using the 
sitting drop method at 20oC. The crystals grew within 1 day in a reservoir solution containing 
100 mM sodium citrate at pH 5.5, 1 M (NH4)2HPO4, 200 mM NaCl and 10 mM CdCl2. Data 
sets were collected at the Swiss Light Source (Villigen PSI, Switzerland) protein beam line 
X10SA on an MAR CCD detector. All x-ray diffraction data were collected at 100 K. A total 
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- Different Tris/NaCl concentrations
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of 360 and 240 rotation images of 0.5° were recorded for native and derivative crystals, 
respectively.  
The structure of the PknG∆N-AX20017 complex was solved by single isomorphous 
replacement anomalous scattering (SIRAS) using a mercury derivative obtained by overnight 
soaks of crystals in the presence of 0.5 mM thiomersal. Iterative rounds of model building 
and maximum likelihood refinement resulted in a complete 2.4 Å resolution model for the 
PknG∆N-AX20017 complex. The final model converged at an R/Rfree of 0.18/0.22 with very 
good stereochemistry. Data sets and refinement statistics are given in Table 1.  
Figures were prepared with the program PyMOL (De-Lano Scientific LLC, San Carlos, CA, 
www.pymol.org). Solvent accessible area calculations were carried out with the program 
NACCESS (http://wolf.bms.umist.ac.uk/naccess/). Determination of the structure was carried 
out by S. Honnappa and M. Steinmetz. 
 
2.16.6 Crystallographic data and refinement statistics  
 
 Native Mercury (at λ p
Wavelength, Å 1.008503 1.008503 
Space group P65 P65 
Resolution, Å 2.4 3.1 
Unit cell, a, b, and c, Å 122.6, 122.6 and 122.4, 122.4 and 2
No. of observed reflections 908,852 283,571 
No. of unique reflections 80,540 73,241 
Rsym*, % 7.3 (80.1)† 6.4 (76.0)†
I/σ (l) 20.1 (3.4)† 13.6 (2.1)†
Completeness, % 99.9 (100)† 99.7 (99.6)†
Phasing power (centric/acentri 0.56/0.84  
RCullis (centric/acentric)§ 0.92/0.86  
Figure-of-merit (centric/acentr 0.12/0.14  
No. of refined atoms   
Proteins     9,973  
Water     299  
Ligand/ion     72/3  
R-factor/free R-factor∥ 0.18/0.23  
R.m.s.d. bond lengths/bond an 0.011/1.4  
 
*Rsym = ΣhΣi|li(h) − l(h) |/ΣhΣiIi(h), where li(h) and l(h)  are the ith and mean measurement of the intensity of 
reflection h. 
†Figures in parentheses indicate the values for the outer shell of the data. 
‡Phasing power = Σ FHcalc/Σ |FPHobs − FPHcalc|, where FHcalc is the calculated heavy atom amplitude and FPHobs and 
FPHcalc are the observed and calculated heavy-atom derivative structure factor amplitudes, respectively. 
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§RCullis = Σ |FPHobs ± FPobs| − |FHcalc|/|Σ |FPHobs − FPobs|, where FPHobs is the observed heavy-atom derivative 
structure factor amplitude, FPobs is the observed native structure factor amplitude, and FHcalc is the calculated 
heavy atom amplitude. 
¶Figure-of-merit = α |∫ αP(α)exp(iα)dα/∫\αP(α)dα|, with α ranging from 0 to 2π. 
∥R = Σ |FPobs − FPcalc|/Σ FPobs, where FPobs and FPcalc are the observed and calculated structure factor amplitudes, 
respectively. 
**R.m.s.d., root-mean-square-deviation from the parameter set for ideal stereochemistry. 
Data measured and calculated by S. Honnappa and M. Steinmetz. 
 
 
2.16.7 Sequence analysis 
To calculate the frequency of occurrence of the four individual AX20017-contacting residues 
Ile165, Val179, Gly236, and Ile292 of PknG, an alignment of 491 human kinases was used 
as a reference (Manning et al, 2002). The corresponding positions of the four residues within 
the alignment was corroborated by superimposing the x-ray structure of PknG with the ones 
of PKA (PDB ID 1ATP), (PDB ID 2BHE), CaMK1 (PDB ID 1A06), PAK1 (PDB ID 1F3M), 
TgFβR1 (PDB ID 1B6C), and IRK (PDB ID 1IRK). Identical PknG residues in the alignment 
were counted and divided by 491 to obtain the frequency of occurrence. Carried out by M. 
Steinmetz and F. Winkler. 
 
 
2.17. CELLULAR ASSAYS 
 
2.17.1 Phagocytosis of mycobacteria by J774 macrophages 
Phagocytosis was analyzed by treating J774 cells for 30 min with 10 and 20 µM of AX20017, 
followed by incubating the cells for 2 hours with latex beads (3 µm diameter, Polysciences) 
at a 10:1 ratio of beads:cells in the continued presence of the inhibitor followed by fixation in 
3% paraformaldehyde as described before (Ferrari et al., 1999). Cells were observed with an 
Axiophot (Zeiss) using a 63X objective. Carried out by G. Kunz. 
 
2.17.2 Proliferation assay 
Proliferation of J774 macrophages was determined by measuring 3H-thymidine incorporation 
as a function of replication (Jayachandran et al., 2007). J774 macrophages (2.5 x 104) were 
seeded in 100 µl of DMEM medium (with 10 % FBS and 2 mM Glutamine) per well in a 96 
well plate and allowed to adhere while incubating for 1 h at 37°C, 5 % CO2. Then, 100 µl 
medium supplemented with AX20017, (final concentration 12.5 µM and 25 µM), G418 
(final concentration 2 mg/ml) or DMSO (same volume as highest inhibitor concentration) 
were added. At timepoint 0, 24 h and 48 h, 50 µl of tritiated thymidine (0.5 µCi) were added 
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to each well. To allow incorporation of 3H-thymidine into DNA, the cells were incubated for 
12 h at 37°C, 5 % CO2 and afterwards frozen at -20 °C. For harvesting, the cells were thawed 
and lysed by hypotonic shock and the DNA isolated using Packard FilterMate Harvester 196, 
with Unifilter-96, GF/C filter. CPMA numbers were measured using the TopCount (Perkin 
Elmer) microplate scintillation counter.  
 
2.17.3 Survival assay 
Survival of mycobacteria was determined by measuring 3H-Uracil incorporation as a function 
of transcription. Prior to infection, mycobacteria were washed twice and resuspended in bone 
marrow macrophage medium (DMEM supplemented with 30 % L929 medium 10% FBS, 2 
mM L-glutamine, 1 mM Na-pyruvate, 50 µM β-Mercaptoethanol). Bone marrow derived 
macrophages were infected with mycobacteria (ODI = 0.05) for 1 h at 37°C. Extracellular 
bacteria were removed by adding amikacin (200 µg/mL), followed by a 45 min incubation at 
37°C. The cells were washed and chased in bone marrow medium. At different time points, 
the medium was replaced by incorporation medium containing 0.15 % saponin to lyse the 
macrophages and 1 µCi 3H-Uracil to label RNA. After 24 h incorporation time at 37°C, 
mycobacteria were killed by NaOH/TCA treatment and the RNA was harvested onto 
UniFilter-96 GF/C glass fiber filter plates (Packard). The recovered radioactivity was 
measured by liquid scintillation counting (Microplate Scintillation Counter, Packard). 
 
2.17.4 Protein translation assay 
Protein synthesis of J774 macrophages was determined by measuring 35S-Methione and 35S-
Cysteine incorporation into proteins (Pieters et al., 1991; Tulp et al., 1993). J774 
macrophages (2.5 x 104) were seeded in 100 µl of DMEM medium (with 10 % FBS and 2 
mM Glutamine) per well in a 96 well plate and let adhere for 12 h. Then, 100 µl medium 
supplemented with 12.5 µM, 25 µM AX20017, cyclohexamide (100 µg/ml) or DMSO (same 
volume as highest inhibitor concentration) were added. After 45 min incubation at 37°C, 5 % 
CO2, the medium was removed using a pipette and replaced by 100 µl of starvation medium 
supplemented with the above mentioned concentrations of inhibitor, DMSO or 
cyclohexamide and pre-incubated for 1 h. To label the cells, 100 µl starvation medium 
containing 0.4 µCi 35S-Methione and 35S-Cysteine (Easy Tag Express Protein Labeling Mix 
[35S], Perkin Elmer) as well as inhibitor, DMSO or cyclohexamide was added to each well 
and the plates were incubated at 37°C, 5 % CO2. After a chase time of 4 h or 9 h, the cells 
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were washed 2x in 200 µl PBS++ and lysed by adding 100 µl lysis buffer containing 20 mM 
HEPES pH 7.4, 100 mM NaCl, 5 mM MgCl2, 1 % Triton X-100 and protease inhibitors 
(Complete EDTA-free protease inhibitor cocktail, Roche). The plates were incubated shaking 
on ice for 30 min, and lysis efficiency was checked by microscopy. The lysed cells (without 
nuclei) were carefully transferred from the well to an Eppendorf tube and spun for 15 min at 
17,900xg. The supernatant was mixed and 5 µl and 10 µl per sample were spotted on 
Whatman paper pieces. Then, the pieces were washed 2x in 10 % TCA and 2x in diethyl 
ether and dried for approx. 45 min at 50°C. Then, the pieces were placed in scintillation vials 
and 10 ml of scintillation fluid (Ultima Gold XR, Perkin Elmer) were added. The samples 
were mixed (vortexed) and the incorporated 35S was analyzed by counting CPMB numbers 
using the TRI-CARB Liquid Scintillation Analyzer 1900 TR (Packard). 
 
2.17.5 Cell organelle electrophoresis 
Bone marrow derived macrophages were infected for 3 hours with mycobacteria. Cells were 
washed twice (450xg, 7 min), resuspended in 1 ml buffer and homogenized using a cell 
cracker. The post-nuclear supernatant (240xg, 15 min) was trypsinized (25 µg/mg protein) 
for 5 min at 37°C and the reaction was stopped by adding soybean trypsin inhibitor 
(Calbiochem, 625 µg per mg protein). After sedimentation of the membranes (100,000xg, 60 
min), the pellet was resuspended in 0.5 ml homogenization buffer containing 6 % Ficoll-70 
(Pharmacia), and loaded in the middle of a 10-0 % Ficoll gradient. During electrophoresis 
(10.4 mA, 80 min), fractions were collected to be tested for β-hexosaminidase activity and 
protein amount (Bradford, 1976). Cytospins were performed to analyze the presence of 
bacteria in the collected fractions. After pelleting the fractions on glass slides, the cells were 
fixed with paraformaldehyde and acid-fast stained (Becton Dickinson). The slides were 
analyzed by fluorescence microscopy in order to count the number of bacteria in the fractions 
(Hasan and Pieters, 1998; Tulp et al., 1993). Carried out by B. Combaluzier. 
 
2.17.6 Video microscopy 
Video microscopy was done using a Zeiss Axiovert 100TV and processed using Openlab 
software (Gatfield and Pieters, 2000). Carried out by R. Jayachandran. 
 
2.17.7 Growth of mycobacteria 
An aliquot of a culture (OD600 = 0.5-0.6) was used to inoculate 40 ml 7H9 medium 
supplemented with 10 % OADC (no antibiotics). Per strain, four 100 ml-Erlenmeyer flasks 
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were prepared and the cultures were adjusted to a start OD600 of 0.05. The cultures were 
incubated shaking orbitally (90 rpm) in the dark at 37°C. Every 12 h, an aliquot (dependent 
on the OD600 500µl, 100µl or 50µl) was removed, diluted and the OD600 was determined. 
Bacterial growth was observed for about 7-8 days until the cultures reached the stationary 
phase.  
Alternatively, mycobacterial growth was measured in 96-well plates (BD Falcon). First, the 
cultures were left at RT to allow sedimentation of bacterial clumps. The supernatant was then 
transferred and diluted to OD600 = 0.05. Per strain, 10 wells of 200 µl were prepared. The 
plates were incubated at 37°C and the OD600 was determined every 12 h for 4-5 weeks.  
 
 
2.18. MICROSCOPY  
 
Microscopy was used to analyze the effects of Ag84 overexpression and to determine the 
localization of Ag84 within mycobacteria. In addition, PknG localization upon transfection 
of mammalian cells or upon infection of macrophages was studied by fluorescence 
microscopy. Furthermore, trafficking of PknG mutants in macrophages was analyzed. All 
studies described here were carried out using a confocal laser scanning microscope (CLSM 
510 META, Zeiss). 
 
2.18.1 Staining cells for immunofluorescence microscopy 
Upon transfection or infection, the adhered eukaryotic cells were carefully washed twice with 
PBS on slide prior to fixation in 100 % MeOH (at -20°C for 4 min). The cells were blocked 
in PBS with 5 % FBS for 30 min at RT. Incubation with primary antibodies was performed 
on slide by adding 25 µl blocking buffer (PBS with 5 % FBS) including antibodies, followed 
by six washing steps in blocking buffer and PBS (5 min each). Staining with secondary 
antibodies was done by incubating cells with Alexa-antibodies for 30 min in the dark. Cells 
were washed as previously in blocking buffer and PBS, but were kept in the dark. If required, 
DNA was stained using intercalating DRAQ5 prior to further washing in PBS (2 x 5 min). 
FluoroGuard antifade-reagent was added to each well and the slides were covered with cover 
slips and sealed with nail polish. Slides were stored at 4°C in the dark until usage for 
microscopy analysis. 
Alternatively, cells were fixed with paraformaldehyde (3 % in PBS, pH 7.2) for 30 min at RT 
and washed 1x 5 min with PBS, 1x with PBS containing 10 mM glycine for quenching of 
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PFA and again 1x 5 min with PBS. Blocking and lysis was performed in PBS with 2 % BSA 
and 1 % Triton-X100. Antibody incubations were carried out in blocking buffer (PBS 
containing 2% BSA, 1% Triton-X100). 
 
2.18.2 Measuring cell length of Ag84 expressing mycobacteria 
To measure size, transformed mycobacterial cells from colonies grown on 7H10 agar 
supplemented with OADC and 25 µg/ml kanamycin were resuspended in 7H9 liquid medium 
and diluted to a density of 10-20 cells per microscopic focal plane. Cell length (the maximum 
distance between the two cell poles) and cell width (largest diameter of examined cell) of 
around 100 bacteria were measured at different times after transformation using the scaling 
tool provided by the software.  
 
2.18.3 Localization of Ag84 within mycobacteria 
To analyze localization of Ag84, M. smegmatis overexpressing wag31MS-gfp was grown on 
7H10 agar (supplemented with OADC and 25 µg/ml kanamycin). Cells were resuspended in 
7H9 medium and ~ 100 cells were analyzed each day during cultivation. Ag84 localization 
was considered as asymmetric, when the cell poles contained different amounts of Ag84 and 
regarded as symmetric, when Ag84 was equally distributed at both poles.  
 
2.18.4 Lysosomal trafficking   
Bone marrow derived macrophages were seeded on glass slides and infected with bacteria of 
an ODI = 0.05 for 1 h, followed by a 3 h chase. Cells were fixed in methanol (4 min at -20°C) 
and incubated with primary antibodies (rat-anti-LAMP1 or polyclonal rabbit-anti-BCG) for 
40 min at room temperature, washed in PBS containing 5 % FCS and then incubated with 
Alexa Fluor 488 or Alexa Fluor 568 (Molecular Probes) coupled to goat anti-rabbit or goat 
anti-mouse antibodies (Southern Biotech). Coverslips were mounted in FluoroGuard antifade 
reagent (Bio-Rad). In three independent experiments, 3x100 events per strain were analyzed. 
Carried out by D. Perisa. 
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3.1 Introduction 
 
Mycobacterium tuberculosis continues to be one of the world's deadliest pathogens, causing a 
prospected burden of one billion newly infected individuals and 36 million casualties within 
the next 20 years (http://www.tballiance.org/). Despite the existence of effective 
chemotherapies, no new drugs have come to the market for more than 40 years. In addition, 
the rise in drug resistance among M. tuberculosis strains is becoming a severe threat to public 
health, illustrated by the recent emergence of extensively (or extremely) drug resistant 
tuberculosis (XDR-TB) that has caused a mortality of >98% (Anonymous, 2006; Masjedi et 
al., 2006).  
 
Virulence of pathogenic mycobacteria is related to their capacity to survive for prolonged 
times within macrophage phagosomes (Nguyen and Pieters, 2005; Russell, 2001). Whereas 
normally internalized and phagocytosed bacteria are rapidly degraded within phago-
lysosomes, pathogenic mycobacteria have evolved to block lysosomal delivery (Russell, 
2001). One strategy by which pathogenic mycobacteria prevent lysosomal maturation is 
through the activity of mycobacterial protein kinase G (PknG), a eukaryotic-like 
serine/threonine protein kinase that is not required for mycobacterial growth per se but 
essential for survival within host macrophages (Nguyen et al., 2005; Walburger et al., 2004). 
PknG is one of the 11 serine/threonine protein kinases found in M. tuberculosis, and the only 
soluble kinase maintained in the genome of Mycobacterium leprae, that is believed to have 
retained the minimal set of genes needed for virulence (Cole et al., 2001). The presence of 
domains typically found in proteins from eukaryotic species as well as the finding that PknG 
is dispensable for in vitro growth (Av-Gay and Everett, 2000; Nguyen et al., 2005) of M. 
tuberculosis suggests that PknG has arrived in the M. tuberculosis genome through 
horizontal gene transfer and has been maintained as a virulence factor important for its 
survival inside the eukaryotic host (Leonard et al., 1998).  
 
Importantly, mycobacteria overexpressing a kinase-dead mutant of PknG are rapidly 
transferred to lysosomes and killed, demonstrating that PknG kinase activity is crucial for 
mycobacterial survival. The fact that PknG is translocated into the host cytosol suggests that 
compounds aimed at blocking PknG activity do not require translocation across the only 
limited permeable mycobacterial cell wall (Walburger et al., 2004). Together, these findings 
make PknG an attractive and promising drug candidate. Indeed, blocking PknG kinase 
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activity by a specific small molecular weight inhibitor, the tetrahydrobenzothiophene 
AX20017, results in a rapid transfer of mycobacteria to lysosomes and killing of the 
intracellularly residing bacilli (Nguyen and Pieters, 2005; Walburger et al., 2004).  
 
Despite the relatively simple structure of AX20017, it inhibits PknG with high specificity. To 
explore the mechanism for this specificity we intended to solve the structure of the PknG-
AX20017 complex by x-ray crystallography.  
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3.2 Results 
 
3.2.1 Specificity of the PknG inhibitor AX20017 
 
The inhibitory activity of AX20017 against the 11 known mycobacterial kinases revealed 
that the compound is highly selective for PknG (Walburger et al., 2004). To test the activity 
of the drug towards eukaryotic kinases, 24 different archetypical human kinases originating 
from six major protein kinase groups (Manning et al., 2002) were selected for a performing a 
radiometric ATP consumption assay (ProQinase/Freiburg). Twelve different AX20017 
concentrations in the range from 5x10-5 and 1.5x10-10 M were tested and the IC50 values were 
determined. The results (figure 3.1) demonstrate that AX20017 did not affect the human 
kinases while the activity of PknG was effectively inhibited. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To analyze whether AX20017 interferes with kinase-dependent processes within the 
macrophage host cell, macrophages were left untreated or incubated with AX20017 and 
analyzed for their capacity to proliferate, synthesize proteins, and phagocytose; activities that 
are known to depend on host kinase activity (Hamilton, 1997; Vieira et al., 2002; Xaus, 
2001). In all experiments similar levels were obtained for the non-treated and treated sample 
implying that none of these cellular processes was affected by AX20017 (figure 3.2). 
 
 
 
Figure 3.1. Inhibition of eukaryotic kinases by AX20017. The IC50 values were determined by 
performing a radiometric ATP consumptive assay (ProQinase, Freiburg). Kinases selected from the six 
major kinase families and PknG were incubated with 12 different concentrations of the inhibitor 
AX20017 for 80 min at 30°C. The reaction was stopped and the incorporation of 33Pi was determined 
using a scintillation counter. CMGC: CDK, MAPK, GSKs, CLK family, AGC: PKA, PKG, PKC family, 
STE: Homologs of yeast Sterile 7, 11, 20 kinases, CAMK: Calcium, Calmodulin-dependent kinases, 
TKL: Tyrosine kinase-like kinases, TK: Tyrosine kinases. 
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Figure 3.3. Analysis of 
macrophage morphology 
upon treatment with  
AX20017.  J774 cells were 
incubated with 20 µM 
AX20017 and morphology, 
membrane ruffling and 
macropinocytosis were 
analyzed by video 
microscopy. Data obtained 
by R. Jayachandran. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In addition, video microscopy revealed that the 
presence of AX20017 did not affect cellular 
morphology, membrane ruffling, or 
macropinocytosis of J774 macrophages (figure 
3.3). These results demonstrate that AX20017 is 
a highly specific inhibitor of PknG. Furthermore, 
adverse effects regarding essential kinase-
dependent processes can be exluded.  
 
3.2.2 Purification of PknG 
 
The first prerequisite for solving the three-dimensional structure of a protein by x-ray 
crystallography is a well-ordered crystal that will diffract x-rays strongly. The formation of 
crystals is critically dependent on a number of different parameters, including pH, 
temperature, protein concentration, the nature of the solvent and precipitant as well as the 
presence of added ions or ligands to the protein. A pure and homogeneous (> 97%) protein 
sample is crucial for successful crystallization. For PknG, a purification protocol was 
established that yielded large amounts of protein of high purity (see chapter 2).                                              
             
Figure 3.2.  Effect of AX20017 on cellular processes in macrophages. Left panel: Proliferation of macrophages 
in the presence and absence of AX20017, data obtained by R. Jayachandran. Middle panel: Protein translation in 
macrophages left untreated or treated with AX20017. Right panel: Phagocytosis of latex beads (3 µm, 3 h) in the 
absence and presence of AX20017. Displayed is the percentage of phagocytosing cells (n=30-50) +/- SD, data 
obtained by G. Kunz. 
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The purity and homogeneity of purified PknG was analyzed by SDS-PAGE and analytical 
size-exclusion chromatography (figure 3.4). Besides, kinase activity was usually verified by 
performing a kinase assay.  
 
 
 
 
 
 
 
 
 
3.2.3 Optimization of the sample buffer conditions 
 
 
To make sure that the PknG sample buffer (composed of 20 mM Tris pH 7.5, 500 mM NaCl) 
used so far is ideal to allow growth of well-shaped crystals, an optimal solubility screen 
(OSS) was performed. This extensive screen is based on an initial incubation step of the 
sample in several buffers, followed by centrifugation and determination of the protein 
concentration in the supernatant which then is subjected to dynamic light scattering (DLS) 
analysis. The scattered light is used to measure the rate of diffusion of protein particles. The 
data are processed to derive a size distribution for the sample, where the size is given by the 
hydrodynamic radius of the protein particle which depends on mass and shape. All buffers 
resulting in a monomodal and monodisperse profile of PknG could in principal be selected 
for crystallization setups. The evaluation of the screen showed that the buffer (20 mM Tris 
pH 7.5, 500 mM NaCl) chosen for PknG was optimal (figure 3.5), addition of glycerol or 
decreasing the NaCl concentration did not further improve the quality of the sample. In 
several cases, PknG homogeneity was obtained when 10% glycerol was included as a buffer 
component (figure 3.5). In conclusion, the sample buffer used so far provides good start 
conditions for the continued crystallization experiments.   
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Figure 3.4. Quality tests of purified PknG. 
(A) To perform an aging assay, the sample 
was spun at 20,800xg (15 min, 4°C) and 
aliquots were analyzed by SDS-PAGE. (B) 
Analytical gel filtration was carried out with 
~50 µg PknG loaded on a Superdex column 
equilibrated in PknG sample buffer. 
A B
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The crystallization assays were set up manually or by robot according to the sitting drop 
method. Various buffers were screened until needle-like crystals were obtained; by refining 
and optimizing the buffer conditions 2D-crystals diffracting to 6 Å were produced, but the 
quality could not be further improved (figure 3.6).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Dynamic light scattering analysis of PknG 
in different buffers. Shown is the mean radius of the 
different PknG species as measured by DLS using a 
DynaPro Titan device. For crystallization, a monomodal 
and monodisperse distribution is optimal. Prior to 
analysis, PknG was incubated with 24 different buffers 
(pHs), each with or without 10% glycerol and in 200 or 
500 mM NaCl, making up 96 conditions in total. 
(A) 100 mM Tris pH 7.5, 500 mM NaCl 
(B) 100 mM Tris pH 7.5, 500 mM NaCl, glycerol 
(C) 100 mM Tris pH 7.5, 200 mM NaCl  
(D) 100 mM Cacodylate pH 6.5, 500 mM NaCl 
(E) 100 mM Cacodylate pH 6.5, 500 mM NaCl, glycerol 
A
B
C 
E
D
A B C
 
 
 
Figure 3.6. PknG full length 
crystallization progress. 
 
(A) 1D-crystal, 3 days 
(B) 2D-crystal, 10 Å, 5 days 
(C) 2D-crystal, 6.5 Å, 1-2   
      weeks 
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3.2.3 Defining PknG∆N 
 
Full length PknG expressed in bacteria was found to degrade when stored at 4°C. Since 
unstable proteins in general are not likely to yield well-diffracting crystals, a limited 
proteolysis approach was undertaken in order to obtain more stable PknG protein. The 
rationale of this approach relies on the fact that cleavage of peptide bonds may preferably 
occur at sites which are either flexible or exposed. Proteolysis of PknG was induced by 
protease treatments or by natural degradation. To check whether proteolysis occurred at the 
N-terminus or at the C-terminus, degraded or trypsin digested PknG was analyzed by 
Western blotting. The results indicate that PknG is cleaved at the N-terminus (figure 3.7).  
 
 
 
 
 
 
 
 
 
 
To analyze degradation of PknG, the sample was kept for several days at 4°C and aliquots 
were analyzed by SDS-PAGE and blotted to a PVDF membrane (figure 3.8). One prominent 
stable band of ~70 kDa was excised and analyzed by Edman sequencing. Based on the results, 
a truncated version of pknG, termed pknG-∆N, was cloned into pET-15b.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8. Limited proteolysis of PknG. Left panel: Full-length PknG was stored for 4 weeks at 4°C. At 
different time points (days 0, 10, and 26) aliquots were taken and analyzed for proteolysis on a Coomassie-stained 
7.5% SDS-PAGE. Right panel: Amino acid sequence of PknG. The N-terminus of the stable form of the PknG 
fragment (asterisk in A) that was identified by Edman degradation is indicated by a red box. The dipeptide 
sequence of the catalytic loop, which discriminates between RD- and non-RD kinases is indicated by a blue box. 
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Figure 3.7. Proteolysis 
of PknG. Degraded and 
digested PknG samples 
were loaded on a 10% 
SDS-PAGE and analyzed 
by Western blotting using 
antibodies directed either 
against the N-terminus 
(left panel) or the C-
terminus (right panel) of 
PknG. 
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PknG-∆N (figure 3.9) was expressed and purified from E. coli using the protocol established 
for PknG wildtype (see chapter 2, material and methods). SDS-PAGE analysis, analytical gel 
filtration as well as kinase assays (figure 3.10) were performed to analyze the quality of the 
protein. In contrast to the full length protein, the PknG-∆N deletion mutant was highly 
soluble and stable.  
 
 
 
 
 
 
 
However, PknG-∆N was not able to autophosphorylate, since the N-terminally located 
phosphorylations sites were missing. To monitor kinase activity, the kinase-dead version of 
PknG-K181M was included in the reaction mix (figure 3.10). Using the same experimental 
setup it was tested whether the inhibitor AX20017 inhibits the activity of PknG-∆N. As 
observed for wildtype PknG, the kinase activity was efficiently inhibited (figure 3.10). This 
finding is relevant for the crystallization studies since the inhibitor is likely to stabilize the 
kinase which might be crucial for the formation of well-diffracting crystals. 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. Schematic 
view of PknG full 
length and PknG∆N. 
The truncated version of 
PknG is missing the first 
73 amino acids at the N-
terminus.  
 
       
         
K181M
– +
PknG∆N
– +
PknG∆N
K181M
204
115
95
54
37
29
Mr (kDa)
 
Figure 3.10. Purified PknG∆N, activity and inhibition of PknG∆N. (A) Purified PknG∆N (2.5 µg) analyzed by 
SDS-PAGE followed by staining with Coomassie. (B) For the in vitro kinase assay, 0.5 µg PknG∆N was incubated 
in reaction buffer containing the PknG-K181M kinase-dead mutant as substrate. Reaction mixtures were analyzed 
after separation by 10% SDS-PAGE followed by autoradiography. (C) To inhibit PknG∆N, 0.5 µg kinase was 
incubated in reaction buffer containing PknG-K181M as substrate and 63 µM AX20017 for 30 min at 37°C before 
the mixture was analyzed by 10% SDS-PAGE and autoradiography. 
A B C
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PknG∆N (10 µg/µl, in 20 mM Tris pH 7.5) treated with thrombin to remove the His-tag  was 
tested for crystallization by first setting up basic crystallization screens before refining the 
conditions (figure 3.11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Crystals diffracting to 2.4-2.6 Å were found and used for further x-ray crystallography 
analysis. 
 
 
 
3.2.4 The Structure of PknG 
 
To define the structural basis of the high specificity of AX20017 for PknG, the crystal 
structure of the PknG-AX20017 was determined by x-ray crystallography.  
PknG in complex with AX20017 (figure 3.12) yielded well diffracting crystals which were 
used to solve the structure at 2.4 Å resolution by single isomorphous replacement anomalous 
scattering (SIRAS). The asymmetric unit of the crystal contains two copies of the complex 
which are related by a non-crystallographic two-fold (RMSD for 571 backbone atoms equals 
0.8 Å). PknG consists of three distinct structural domains whose combination to our best 
knowledge is not found in any other protein kinase.  
 
 
 
A B C Figure 3.11. PknG∆N crystallization progress. 
 
(A) 2D-crystal, 9-12 Å, 6-8 weeks
        grown in: 1M (NH4)2HPO4,   
        100 mM Citrate pH 5.5,   
        200 mM NaCl 
(B) 3D-crystal, 6 Å, 3-4 weeks 
        grown in: see (A), but pH 5.9  
        and 2x inhibitor added 
(C) 3D-crystal, 3 Å, o/n 
        grown in: see (B), but CdCl2 
       (100 mM) included 
 
D
(D) 3D-crystal, 2.6 Å, o/n using the following “hit” conditions: 
 
?  His-tag cleavage 
?  c (PknG) = 10 µg/µl  
?  buffer: 20 mM  Tris pH 7.5, 500 mM NaCl  
?  additive: inhibitor (molar ratio: 1: 2 (inhibitor)) 
?  precipitant: 1.0 M (NH4)2H PO4,                
?  100 mM NaCitrate pH 5.9, 200 mM NaCl 
?  metal additive: 10 mM CdCl2 
?  freshly purified protein 
?  adapted/improved freezing protocol 
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. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.5 The Tetratricopeptide repeat containing domain  
 
The C-terminal half of PknG contains a tetratricopeptide repeat (TPR) and assumes a 
characteristic extended and curved superhelical fold (D'Andrea, 2003) (figure 3.12). This 
domain interacts with the tip of the C-terminal lobe of the PknG kinase domain. It forms an 
extensive intermolecular lateral contact with the TPR domain of the twofold related molecule 
within the asymmetric unit of the crystal (figure 3.12), consistent with the known function of 
 
 
 
 
 
 
 
 
 
 
Figure 3.12. X-ray crystal structure of the PknG-AX20017 complex. Overall fold of the dimeric PknG-
AX20017 complex (ribbon representation) as seen in the asymmetric unit of the crystal. The three PknG domains 
of the left subunit are labeled and depicted in different colors (RD, rubredoxin domain with the bound metal, 
cadmium in the present structure, depicted as sphere; KD, kinase domain; TPRD, tetratricopeptide repeat-
containing domain). 
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Figure 3.13. Light 
scattering analysis of 
full length PknG. 250 
µg PknG were loaded on 
a Superdex 200 column 
equilibrated in 20 mM 
Tris pH 7.5, 500 mM 
NaCl. The molecular 
weight of PknG was 
determined using a 
miniDAWN device 
(Wyatt). 
TPR domains to mediate protein-protein interactions (D'Andrea, 2003); however, the role of 
the dimer interface for PknG function is currently not known.  
 
Static light scattering (SLS) analysis was performed in order to analyze whether PknG forms 
dimers also in solution. It was found that PknG in solution exists in a dimeric form (figure 
3.13); two protein peaks were detected which corresponded to a molecular weight of 155 
kDa and 78.4 kDa, 
respectively (figure 3.13). To 
analyze whether dimeric 
PknG is catalytically active, a 
preparative size exclusion 
chromatography (SMART® 
system) step was performed. 
Purified PknG was loaded 
onto a gel filtration column and fractions were collected. The protein concentration was 
determined and equal amounts of monomeric and dimeric PknG were used for a kinase assay 
(figure 3.14). The results showed that PknG in its dimeric form is active.  
 
 
 
 
 
 
 
D M
↓↓
670 158 44 kDa
200
116
97
66
45
31
Mr (kDa)
D  M
+ 
D  M
–SDS/DTT
Figure 3.14.  Activity of PknG 
monomers and dimers. (A) 
Separation of PknG monomers and 
dimers. 500 µg PknG (in 20 mM Tris 
pH 7.5, 500 mM NaCl) were loaded 
on a Superdex 200 gel filtration 
column. The fractions were collected 
and the protein concentrations 
determined. (B) Kinase assay. Equal 
amounts of PknG were included for 
the kinase assay. Samples were left 
untreated or boiled in SDS/DTT, 
loaded on a SDS-PAGE and then 
analyzed by autoradiography.  
D: Dimer, M: Monomer  
BA 
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3.2.6 The Kinase domain 
 
The kinase domain of PknG is sandwiched between the rubredoxin and the TPR domains 
(figure 3.12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The kinase domain displays the typical two-lobed structure, with a topology reminiscent of 
serine/threonine kinases (figure 3.15). Importantly, several active site signature sequence 
elements adopt conformations that are characteristic of an activated state of protein kinases 
(Huse and Kuriyan, 2002; Johnson et al., 1996; Nolen et al., 2004). First, the activation loop 
which controls catalytic activity in most kinases by switching between different states is fully 
ordered and stabilized in an open and extended conformation (figure 3.15). The β9-strand 
preceding the activation loop forms a short antiparallel β-sheet with the β6-strand preceding 
the catalytic loop, which provides a site for substrate binding in active states of kinases. 
Although phosphorylation is the most common mechanism for positioning the activation 
loop (see, for example, PknB (Ortiz-Lombardia et al., 2003; Young et al., 2003)); it is not 
phosphorylated in the PknG-AX20017 structure. The absence of an arginine (R) immediately 
preceding the invariant catalytic aspartate (D) of the catalytic loop (figure 3.8) classifies 
PknG as a unique mycobacterial non-RD kinase (Johnson et al., 1996; Nolen et al., 2004), 
explaining the open and extended conformation of the activation loop in the absence of 
Figure 3.15. Topology of the 
PknG kinase domain (ribbon 
representation). Characteristic 
active site secondary structure 
elements conserved in protein 
kinases are indicated in 
different colors and labeled 
accordingly. The chemical 
structure of AX20017 is 
indicated. The AX20017 
molecule is shown in blue 
sticks representation. 
_______________________________________________________________________________CHAPTER 3 
89 
phosphorylation. Second, the side chains of the functionally important and conserved 
residues such as Asp276 and Asn281 of the catalytic loop and Asp293 of the highly 
conserved Asp-Phe-Gly motif (denoted DFG) are positioned and adopt conformations similar 
to their counterparts, Asp166, Asn171, and Asp184 in the active structural state of protein 
kinase A (Knighton et al., 1991) (figure 3.16). Likewise, Lys181 of PknG is positioned as 
Lys72 in the active PKA conformation. However, the ionic interaction observed in PKA 
between Lys72 and Glu91 (Glu198 in PknG) which is located on the αC helix is not present 
in PknG due to a tilted and rotated orientation of this α-helix (Figure 3.16). The orientation 
of the αC helix in the present PknG-AX20017 crystal structure appears to be required to 
avoid a steric clash with the C-terminal part of the activation loop.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Structure of the AX20017 binding pocket 
 
 
 
 
 
 
 
 
Figure 3.16. AX20017 stabilizes the PknG kinase domain in an active-like conformation. (A-D) Superposition of 
the AX20017-bound PknG kinase domain and an active structure of protein kinase A (PDB ID 1ATP). The two 
proteins were first aligned globally over all Cα atoms. Fine tuning was achieved by minimizing the rmsd of Cα atoms 
from the interlobe kinase cleft. The following conformations of active-site residue side chains (in stick representation 
and with labels) and elements (in cartoon representation) are shown: segment encompassing the activation loop; the 
substrate-binding β9-strand is indicated (A); residue side chain conformations of the DFG motif (B); highly conserved 
residue side chains contacting the substrate and the nucleotide (C); αC helix with the catalytically important 
glutamate (D). Oxygen and nitrogen atoms of residue side chains are colored in red and blue, respectively. Carbon 
atoms are colored in grey and green for PknG and PKA, respectively. 
A 
B D 
C 
_______________________________________________________________________________CHAPTER 3 
90 
Figure 3.17. In vitro kinase assay of PknG 
(WT) and PknG-C/S (Cys106, Cys109, 
Cys128, and Cys131 mutated to serines). 
Reaction mixtures were analyzed after 12.5% 
SDS-PAGE separation by autoradiography. 
The N-terminal fragment of PknG was 
included as a substrate. PknG-C/S construct by 
P.  Müller. 
3.2.7 The Rubredoxin motif 
 
The N-terminal part contains two iron-binding Cys-X-X-Cys-Gly (X representing any amino 
acid residue) motifs characteristic of rubredoxin. This small globular domain interacts with 
both the N- and C-terminal lobes of the PknG kinase domain, packing on top of the active 
site without blocking its access (figure 3.12). Rubredoxins are used as electron donors in 
electron-transfer reactions predominantly in certain microorganisms and hence could act as 
regulatory modules (Sieker et al., 1994).  
To test whether the rubredoxin domain could 
modulate the activity of PknG, the four critical 
metal coordinating cysteines, Cys106, Cys109, 
Cys128, and Cys131, were mutated to serines by 
site-directed mutagenesis. The protein was 
expressed and purified from E. coli in order to 
check the activity in a kinase assay. Remarkably, 
the resulting mutant PknG, denoted PknG-C/S, 
was devoid of activity; no signal was detectable for 
either autophosphorylated PknG-C/S or for the 
substrate (figure 3.17). To exclude that this is due 
to a possible misfolding of the protein, circular 
dichroism spectroscopy was performed. The mean residue ellipticity was determined, 
normalized for the buffer and plotted against the wavelength. The overall profile of the 
PknG-C/S mutant was similar to the one of the wildtype (figure 3.18) suggesting that the 
modified protein is properly folded.  
 
 
 
 
 
 
 
 
 
  
Figure 3.18. Structural 
integrity of the C/S 
mutant. Wildtype PknG 
and PknG-C/S mutant 
were diluted with buffer 
(20 mM Tris pH 7.5, 500 
mM NaCl) to a 
concentration of 0.06-
0.08 µg/µl and 8 scans in 
the range of 190-260 nm 
were recorded using a 
Jasco spectropolarimeter 
(J720). 
Pink:  PknG wildtype 
Lilac: PknG-C/S 
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In addition, analytical gel filtration was performed to test the quality of the purified PknG-
C/S mutant. In the chromatogram, PknG-C/S protein appeared as a sharp peak eluted in the 
same fraction as observed for the wildtype, further confirming that the sample used for the 
kinase assay was neither degraded nor precipitated (data not shown). 
The finding, that the activity of PknG is dependent on the rubredoxin motif is a first 
indication that PknG might be regulated by the redox status of the environment via the 
rubredoxin domain.  
 
 
3.2.8 Structure of the AX20017-binding pocket 
 
The AX20017 inhibitor  (figure 3.19) is bound deep within a narrow pocket formed by the 
interlobe cleft of the kinase domain and a unique peptide segment originating from the N-
terminus of PknG (residues Pro85-Met94). Accessible surface area calculations revealed that 
90% of the molecular surface of AX20017 is buried within the kinase domain.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A set of 15 residues originating from both the kinase lobes and the unique N-terminal 
segment of PknG make extensive polar and non-polar contacts with the inhibitor (figure 
3.20).  
The almost planar tetrahydrobenzothiophene moiety of the inhibitor occupies the conserved 
hydrophobic pocket that otherwise binds the adenine base of ATP (Knighton et al., 1991). 
 
 
 
Figure 3.19. 
Surface complementarity 
between the PknG kinase 
domain and AX20017.  
(A) View of AX20017 (light 
blue) buried into the PknG 
kinase domain-binding pocket. 
Both molecules are shown as 
surface representation.  
(B, C and D). Three views of a 
section of the AX20017-PknG 
interaction (A) 90° apart. 
A B
C D
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The main chain Glu233:O and Val235:NH of PknG form hydrogen bonds to the primary 
amido substituent of the thiophene ring of the inhibitor reminiscent of the ones made to the 
adenosine moiety of ATP. An additional hydrogen bond is formed between Val235:O and 
the secondary amido group substituent of the thiophene ring. This hydrogen bonding network 
places the tetrahydrobenzothiophene moiety of the inhibitor such that van der Waals contacts 
are made with the side chains of Ala158, Ile165, Val179, Lys181, Met232, Ile292, and 
Asp293 of PknG. Apart from the conserved ATP site, the cyclopropyl ring of AX20017 
exploits an additional hydrophobic pocket of PknG which is less homologous among protein 
kinases. This moiety of the inhibitor packs against the side chains of Ile87, Ala92 of the 
unique N-terminal segment of PknG, and of Ile157, Tyr234, Gly236, and Met283 of the 
kinase domain (figures 3.20, 3.21). 
 
 
 
 
 
 
 
 
 
 
 
 
Together, these findings show that AX20017 targets both the residues shaping the conserved 
ATP site as well PknG-specific structural elements adjacent to the ATP site. The remarkable 
surface complementarities between the PknG kinase domain and inhibitor interfaces (figure 
3.19) demonstrate that AX20017 exploits the shape and chemical nature of the PknG binding 
pocket in a nearly optimal fashion. Sequence comparison of the 11 known Mycobacterium 
tuberculosis serine/threonine protein kinases (Cole et al., 1998) reveals that the identities of 
four inhibitor contacting residues from the conserved kinase domain are specific to PknG. 
Sequence analysis of 491 human protein kinases (Manning et al., 2002) unveils that the 
frequency of occurrence of these four individual inhibitor-contacting residues of the ATP site, 
Ile165, Val179, Gly236 and Ile292, is 0.037, 0.065, 0.088, and 0.077, respectively. In 
combination, these four residues are not observed in any human kinase. This finding is 
Figure 3.20. Interactions between 
PknG and inhibitor (sticks 
representation). PknG (grey carbon 
atoms)-AX20017 (light blue carbon 
atoms) binding site. Residue side 
chains which in combination are 
unique to PknG are highlighted by 
yellow carbon atoms. Hydrogen 
bonds are indicated as dashes. 
Oxygen, nitrogen, and sulfur atoms 
are colored in red, blue, and dark 
yellow, respectively. 
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illustrated in figure 3.21 which shows a sequence alignment of selected Mycobacterium 
tuberculosis and human kinase domains originating from six major protein kinase groups 
(Manning et al., 2002). Together with the two additional inhibitor contacting residues, Ile87 
and Ala92, which are unique to PknG, this sequence-to-structure analysis provides a basis for 
explaining the high specificity of AX20017 for PknG. The precise combination of residues, 
together with the conformational plasticity of specific structural elements of the PknG kinase 
domain, appear to generate a uniquely shaped binding pocket for AX20017 not occurring in 
any other protein kinase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21. Structure-based sequence alignment of three selected Mycobacterium tuberculosis (Cole et al., 
1998) and six human kinase domains originating from six major kinase groups (Manning et al., 2002). Selected 
secondary structure elements of kinase domains are indicated on the bottom of the alignment. The fifteen AX20017-
interacting residues of PknG and their identity in homologues are indicated in grey (for variable residues) and yellow 
(for residues which in combination are unique to PknG; residue numbers shown on top correspond to the PknG 
sequence). Highly conserved catalytic site residues of protein kinases are indicated by boxes. Species identifiers are: 
mt, Mycobacterium tuberculosis; hs, Homo sapiens. UniProtKB/Swiss-Prot and Protein Data Bank accession 
numbers, respectively, are as follows: PknG (Protein kinase G), P65728, 2PZI; PknB (Protein kinase B), P0A5S4, 
1O6Y; PknE (Protein kinase E), P72001, 2H34; PKA (cAMP-dependent protein kinase, AGC group), P17612, 
1ATP; Cdk2 (Cell division protein kinase 2, CMGC group), P24941, 2BHE; CaMK1 (Calcium/calmodulin-
dependent protein kinase type 1, CAMK group), Q14012, 1A06; PAK1 (Serine/threonine-protein kinase PAK 1, STE 
group), Q13153, 1F3M; TgFβR1 (TGF-β receptor type-1, TKL group), P36897, 1B6C; IRK (Insulin receptor, TK 
group), P06213, 1IRK. 
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Figure 3.22. Inhibitory 
activity of AX20017 (25 µM) 
on PknG-I87S/A92S (Mut; 
0.5 µg) and comparison to 
wild type PknG (WT).  
Reaction mixtures were 
analyzed by autoradiography 
after separation on 12.5% SDS-
PAGE  
To experimentally test the importance 
of the two unique PknG inhibitor 
contacting residues Ile87 and Ala92, 
both sites were mutated to serines 
(denoted PknG-I87S/A92S). The 
double mutation resulted in a >50% 
loss in the inhibitory capacity of 
AX20017, indicating that the unique N-
terminal segment of PknG is important 
for AX20017 binding (figure 3.22).  
 
In conclusion, we confirmed that PknG is a multidomain protein consisting of a rubredoxin-, 
kinase-, and tetratricopeptide repeat domain and found that the rubredoxin domain is 
essential for the activity of PknG. The structure revealed that the inhibitor binding pocket is 
shaped by a unique set of amino acid residues which in combination is not found in any 
human kinase. The structural information presented here explains the highly specific mode of 
action of AX20017 and provides a basis for the rational design of new PknG drugs aimed at 
blocking the proliferation of Mycobacterium tuberculosis.  
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3.3 Discussion 
 
Understanding of the virulence factors of pathogenic mycobacteria at the atomic level is 
required for the development of novel and effective therapeutics for the treatment of diseases 
caused by these microbes (Goulding CW, 2002; Koul et al., 2004). The eukaryotic-like 
serine/threonine protein kinase PknG plays a crucial role in the survival mechanism of 
pathogenic mycobacteria, as genetic deletion or chemical inhibition of PknG is sufficient to 
kill intracellularly residing bacteria (Walburger et al., 2004).  
 
Important functional information could be extracted from the molecular structure of PknG. 
The N-terminal rubredoxin-motif, forming a complex with cadmium in the model, interacts 
with the kinase domain but does not restrict the binding of inhibitor and possibly ATP. By 
site-directed mutagenesis, the four cysteins of the rubredoxin motif were replaced by alanine 
residues which resulted in a catalytically inactive mutant suggesting that the rubredoxin motif 
controls the catalytic activity by limiting the interactions within the kinase domain. 
Rubredoxin motifs represent the simplest type of an iron-sulfur centre, consisting of an iron 
atom coordinated by the thiol groups of four cysteines. These motifs are known to confer 
stability to the protein (Henriques et al., 2006) and introducing mutations in this particular 
region might lead to severe conformational changes and instability. However, this was not 
true for PknG-C/S protein which did not display any detectable phenotype when analyzed by 
analytical gel filtration and C/D spectroscopy.  
CXXC motif-containing proteins, regulated by oxidation and S-thiolation, have been shown 
to carry out protective and adaptive functions in the cell (Conway et al., 2008). The motif can 
have highly reductive or oxidative potential (Grauschopf et al., 1995; Moore et al., 1964). 
Mycobacteria encounter different oxygen conditions ranging from high oxygen levels outside 
their host to nearly oxygen depleted conditions as found in granulomas within the host. 
Therefore, it is likely that the N-terminus of PknG acts as a sensor which, upon certain redox 
stimuli, undergoes slight, but crucial conformational changes leading to interactions with the 
kinase domain which finally regulates the catalytic activity of the kinase.  
 
The tetratricopeptide repeat (TPR), typically occurring in 3-16 copies per protein, is a 
degenerate 34-amino acid motif which mediates protein-protein interactions and the 
assembly of multiprotein complexes (Das, 1998; Sikorski et al., 1990). Proteins containing 
TPR repeats are localized in various subcellular compartments which include mitochondria, 
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cytoplasm and nucleus (Goebl M, 1991). TPR proteins are ubiquitously found in prokaryotes 
and eukaryotes. These proteins carry out functions in cell-cycle control, transcription 
repression, protein kinase inhibition, mitochondrial and peroxisomal protein transport, 
neurogenesis and stress response (D'Andrea, 2003; Lamb et al., 1995). A single TPR repeat 
contains two antiparallel α-helices with a turn-position in between (Das, 1998). The smallest 
functional unit was reported to be three tandem TPR motifs (Lamb et al., 1995). PknG, 
however, possesses only one classical tetratricopeptide repeat involved in dimerization of 
PknG. Whether this motif has an additional function possibly mediating one of these 
processes mentioned above, remains to be established. 
 
Importantly, the crystal structure of PknG in complex with AX20017 provides insight into 
how high specificity for blocking a prominent kinase target can be achieved without 
compromising homologous kinases. Target selection and inhibitor selectivity is of utmost 
importance as chemical inhibition of a microbial kinase that is highly homologous to its 
eukaryotic counterparts poses potential risks since essential host signal transduction 
pathways may be affected as well (Noble et al., 2004).  
 
The structural information presented here offers a basis for the rational design of new PknG 
drugs aimed at blocking the proliferation of Mycobacterium tuberculosis. One promising 
option to further improve the affinity, selectivity, and potency of AX20017 is to 
systematically explore modifications of the cyclopropyl ring as this part of the inhibitor does 
not appear to fully exploit its binding capacity to the unique N-terminal sequence of PknG. In 
this context, the finding that a small compound such as AX20017 targets an active 
conformation of PknG may have prospective rewards as the active conformation requires a 
high degree of structural conservation and the inhibitory mode of action is likely to be less 
tolerant for the development of resistant mutations (Noble et al., 2004). 
 
One of the roadblocks in controlling tuberculosis relates to the ability of Mycobacterium 
tuberculosis to modulate the macrophage innate antimicrobial response, making its host 
permissive for mycobacterial survival and growth. Since blocking PknG reverts the 
macrophage into a degradative environment in which mycobacteria are efficiently cleared, 
the results described here open the possibility of developing a novel class of compounds that 
are desperately needed with respect to the global tuberculosis epidemic. 
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4.1 Introduction 
 
PknG has been shown to promote intracellular survival of mycobacteria (Walburger et al., 
2004). The question therefore arises which intrinsic property of PknG is responsible for the 
inhibition of phagosome-lysosome fusion. In this respect, gaining knowledge about PknG 
autophosphorylation and its relevance regarding regulation of kinase activity is important.  
Autophosphorylation can confer various attributes to a kinase; it may regulate the catalytic 
activity, influence the binding of allostoric effectors and has been shown to affect proteolysis 
and membrane association (Smith et al., 1993). Intramolecular phosphorylation occurs either 
within a specific region of the kinase domain (the activation segment) or outside the kinase 
domain at multiple other sites (Johnson et al., 1996). 
 
Mass spectrometry (MS) analysis revealed that most mycobacterial kinases studied displayed 
several autophosphorylation sites which is in contrast to most eukaryotic kinases; and these 
sites identified were located mainly within the kinase domain or adjacent to this domain 
(Greenstein et al., 2005). In PknB, PknD, PknE, PknF, PknH, autophosphorylation occurs on 
two conserved threonine residues within the activation loop (Duran et al., 2005; Scheeff and 
Bourne, 2005). Introducing point mutations at these sites resulted in drastically decreased 
kinase activity towards myelin basic protein (MBP); treatments with mycobacterial 
phosphatase (PstP) resulted in inhibition of kinase activity (Boitel et al., 2003) strongly 
suggesting autophosphorylation as the predominant activation mechanism for MBP 
phosphorylation.  
Alignments of the kinase domain demonstrated that none of these two specific residues are 
present in PknG or PknI, which are also characterized by shorter autophosphorylation loops 
(Boitel et al., 2003).  
 
Kinases in general can be classified into so-called RD and non-RD kinases based on the 
presence of a conserved arginine (R) and aspartate (D) sequence in the catalytic loop of the 
kinase domain. The RD arginine interacts with the phosphorylated activation loop and 
controls its fold, finally resulting in the activation of kinase activity (Johnson et al., 1996; 
Nolen et al., 2004). Interestingly, PknG is unique among mycobacerial kinases in that the 
critical arginine residue in the kinase domain is lacking (figure 4.1). The fact that PknG is 
classified as a non-RD kinase therefore suggests absence of autophosphorylation in the 
activation loop (Scherr et al., 2007).  
_______________________________________________________________________________CHAPTER 4 
101 
 
 
 
 
 
 
 
 
Previous experiments demonstrated that PknG undergoes autophosphorylation (Koul et al., 
2001; Walburger et al., 2004), whereas a kinase-dead mutant of PknG (displaying a lysine-
methionine point mutation at amino acid position 181 of the kinase domain) was not able to 
undergo autophosphorylation. In addition, the exact residues that become autophosphorylated 
have been mapped (P. Müller, master thesis). 
 
In this chapter, studies are presented that further characterize autophosphorylation of PknG 
and preliminary work is described suggesting that autophosphorylation of PknG is important 
for its function during an infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
→
Figure 4.1. Sequence alignment of 
catalytic domains of the eleven 
mycobacterial kinases.  PknG is the 
only kinase which does not possess the  
conserved arginine residue within the 
kinase domain. 
Figure modified from Av-Gay (2000). 
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Figure 4.2.Autophosphorylation 
activity of PknG in presence of 
divalent ions. 0.5 µg PknG were 
incubated in a kinase buffer 
containing [γ-32P]ATP for 30 min 
at 37°C, loaded on a SDS-gel and 
analyzed by autoradiography. 
4.2 Results 
 
4.2.1 Autophosphorylation of PknG 
 
PknG, overexpressed and purified from E. coli, undergoes autophosphorylation as analyzed 
by in vitro kinase assays 
(Walburger et al, 2004). Moreover, 
manganese was identified of being 
the cofactor for the catalysis. 
Magnesium, which often acts as 
cofactor, was found to inhibit the kinase reaction (figure 4.2).  
 
To analyze whether PknG is multiply phosphorylated, PknG was incubated with either ATP 
or shrimp alkaline phosphatase (SAP) and the resulting phosphorylated or dephosphorylated 
sample was analyzed by 7.5 % SDS-PAGE. The non-treated PknG sample was not running 
as one define band; instead, 3 diffuse bands were detected. In the case of phosphorylation by 
ATP, these bands were clearly shifted to the upper of these bands. In contrast, the SAP 
treatment led to a shift to the lower band suggesting that PknG is phosphorylated on multiple 
phosphorylation sites (figure 4.3).  
 
 
 
 
 
 
 
Mapping of the autophosphorylation sites showed the presence of six phosphorylated 
threonine residues (T21, T23, T26, T32, T63, T64) in a short N-terminal region of PknG (P. 
Müller, master thesis). 
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Figure 4.3. Multiple autophosphorylation of 
PknG. For phosphorylation, 2 µg PknG were 
incubated in kinase buffer containing 50 µM ATP. 
For dephosphorylation, PknG was treated with 1 U 
shrimp alkaline phosphatase. The samples were 
incubated for 30 min at 37°C. After addition of 5x 
sample buffer, PknG was boiled for 7 min at 95°C
and loaded on a big 7.5% SDS-PAGE allowing a 
high resolution. The gel was stained in Coomassie. 
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Figure 4.5. Analysis of 
autophosphorylation in vitro. A 
kinase assay was performed by 
incubating 0.5 µg PknG-WT, ∆N 
or PknG-P-mut in a kinase buffer 
containing [γ-32P]ATP for 30 
min at 37°C. The mixture was 
analyzed by 10% SDS-PAGE. 
4.2.2 Analysis of PknG kinase activity in the absence of autophosphorylation 
 
To investigate whether autophosphorylation of PknG is required for its activity, two PknG 
mutant proteins - a mutant with mutated phosphorylation sites (P-mut) and the truncated 
PknG version missing 8 kDa of the N-terminus including all six phosphorylation sites 
(PknG-∆N) were expressed and purified from E. coli (figure 4.4). To analyze 
autophosphorylation of these mutant proteins, PknG-P-mut and PknG-∆N were tested in an 
in vitro kinase assay. As a control, PknG wildtype was included in the reaction.  
 
 
 
 
 
 
 
 
 
 
 
PknG was incubated for 30 min at 37°C in a kinase 
reaction buffer containing [32γ]P-ATP. As expected, no 
autophosphorylation signal was detected for PknG-P-mut 
and PknG-∆N (figure 4.5) in contrast to PknG wildtype displaying a strong signal. Thus, 
these two proteins are devoid of autophosphorylation and can be used to address the question 
whether autophosphorylation is involved in the regulation of kinase activity. PknG-P-mut 
and PknG-∆N were incubated with an excess of PknG-N-term serving as a substrate for 
PknG (figure 4.6). The results of the kinase assay show that the amount of phosphorylated 
substrate is equal to wildtype PknG for both mutant proteins, implicating that PknG 
autophosphorylation is not needed to activate PknG kinase activity. 
 
 
 
 
 
Figure 4.4. Expression of PknG mutant proteins. Truncated PknG-
∆N and PknG-P-mut carrying six threonine-to-alanine point mutations 
were cloned into pET15b, expressed and purified from E. coli. 
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Figure 4.7. Expression 
of PknG mutant 
proteins. Cultures of M. 
bovis BCG wild type and 
PknG mutants (KO, ∆N, 
P-mut) were disrupted 
using the mixer mill. 5 
µg lysate was run on a 
10% SDS-PAGE gel. 
Western Blot analysis 
was performed using 
PknG specific polyclonal 
antibody FB18.  
 
 
 
 
 
 
 
 
 
4.2.3 Role of PknG autophosphorylation on intracellular trafficking and survival of 
pathogenic mycobacteria 
 
To analyze a possible role of PknG autophosphorylation in intracellular trafficking or 
survival of mycobacteria, Mycobacterium bovis BCG-∆PknG (Pasteur) expressing PknG-P-
mut (D. Perisa) and PknG-∆N (M. 
Bratschi) were generated. To test 
expression of the mutant proteins, 
mycobacterial lysates of the strains 
indicated in figure 4.7 were prepared 
using a mixer mill and equal 
amounts were loaded on a 10% 
SDS-PAGE and analyzed by 
Western blotting. Both mutant proteins, PknG-P-mut and PknG-∆N, were expressed to the 
same level as wildtype PknG. As expected, no band was detected for the M. bovis 
BCG∆PknG strain (figure 4.7).  
 
A growth curve was recorded to analyze whether autophosphorylation is needed for in vitro 
growth. Four cultures per strain were incubated for 6 days and the OD600 was measured 
regularly every 12 h. Overall, PknG-P-mut and PknG-∆N strains grew with the same growth 
rate as PknG wildtype and KO strains (figure 4.8). These results show that the strains do not 
display growth defects.  
 
 
 
 
Figure 4.6. Analysis of substrate 
phosphorylation in vitro. A kinase assay 
was performed by incubating 0.5 µg PknG-
WT, PknG-∆N or PknG-P-mut in a kinase 
buffer containing [γ-32P]ATP. As a substrate, 
2 µg PknG-N-terminus (AA 1-140) were 
included. The reaction mix was incubated 
(30 min at 37°C) and analyzed by 12.5% 
SDS-PAGE and autoradiography. 
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4.2.4 Analysis of intracellular survival of internalized mycobacteria 
 
Three different experimental approaches were undertaken to study the in vivo role of PknG 
autophosphorylation. Bone marrow derived macrophages were infected for 1 h with M. bovis 
mutant strains PknG-P-mut and PknG-∆N including M. bovis wildtype and ∆PknG strains as 
controls. After a chase time of 3 h, the cells were fixed and immunostained using α-LAMP1 
and α-BCG antibody. Confocal microscopy was performed to analyze the intracellular 
localization of the bacteria within macrophages. It was found that wildtype M. bovis BCG 
was largely present in phagosomes, whereas a high percentage of M. bovis BCG-∆PknG 
(~70%) resided in LAMP1-positive vacuoles. For mycobacteria expressing PknG-P-mut as 
well as PknG-∆N, lysosomal delivery was also significantly increased (to about 60 %) 
suggesting that autophosphorylation of PknG regulates mycobacterial trafficking (personal 
communication D. Perisa).  
The lysosomal localization of the mutant strains was independently confirmed by cell 
organelle electrophoresis, a method which allows the charge-based separation of lysosomes 
and phagosomes, followed by the detection of acid-fast stained mycobacteria in these 
subcellular compartments (personal communication B. Combaluzier, Hasan and Pieters, 
1998; Hasan et al., 1997, Ferrari et al., 1999). 
To investigate whether the mycobacteria are killed by bactericidal activities inside 
lysosomes, survival assays were carried out. To that end, bone marrow derived macrophages 
were infected for 1 h with M. bovis BCG wildtype, M. bovis BCG-∆PknG, M. bovis BCG-
∆PknG overexpressing PknG-∆N or PknG-P-mut, and the non-phagocytosed bacteria were 
removed. After different chase times the macrophages were lysed and medium containing 
Figure 4.8. Growth curve of M. 
bovis BCG strains. Wildtype 
and mutant strains (WT, KO, 
∆N, P-mut) were grown in 7H9-
OADC medium for 6 days at 90 
rpm and 37°C until stationary 
phase. The OD600 of the cultures 
(n=4) was measured every 12 h. 
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3H-Uracil to be incorporated into mycobaterial RNA was added to the bacteria. After 24 h 
growth in labeling medium, the amount of incorporated 3H-Uracil was measured by 
scintillation (figure 4.9).  
 
 
 
 
 
 
 
 
 
 
 
Preliminary results demonstrated that high cpm counts were obtained for wildtype bacteria, 
indicating bacterial proliferation, whereas PknG-KO bacteria displayed low counts pointing 
to killing inside lysosomes. The survival of the mutant strains overexpressing PknG-∆N and 
PknG-P-mut was also drastically reduced, reaching a 6-7 x decreased level when compared 
to the wildtype (figure 4.10). These findings suggest that autophosphorylation of PknG is 
crucial for the capacity of the mycobacteria to escape lysosomal delivery.   
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Figure 4.10. Survival assay. 
Survival of internalized M. bovis 
BCG wild type and mutant 
strains (KO, ∆N, P-mut). 
Mycobacterial survival was 
determined upon incorporation 
of tritiated uracil for 24 h, RNA 
harvesting and scintillation 
counting. Shown here is a one 
representative experiment 
performed in 10 wells. 
Amikacin-treatment Lysis of macrophages
Proliferation and
3H-Uracil incorporation
Infection
chase
Lysis of bacteria Harvesting of RNA and 
scintillation counting
0, 48 h
24 h
 Figure 4.9. Survival assay (method). Bone marrow derived macrophages were infected for 1h with M. bovis
BCG wild type and mutant strains. Extracellular bacteria were killed by amikacin and the macrophages were 
washed and lysed using 0.15 % saponin at indicated chase times. Mycobacterial survival was determined by 
bacterial incorporation of tritiated uracil for 24 h, followed by scintillation counting. 
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4.3 Discussion 
 
Previous studies revealed that PknG is phosphorylated on threonine residues located within a 
short stretch at the N-terminus of PknG. By performing kinase assays including PknG mutant 
proteins missing the potential phosphorylation sites, no signal could be detected, confirming 
the results obtained by mass spectrometry. Similarly, autophosphorylation of residues in the 
“activation” loop could be excluded experimentally.  
 
The fact that PknG with mutated or depleted phosphorylation sites was still able to 
phosphorylate an “artificial” substrate to the same extent as the wildtype protein implies that 
PknG autophosphorylation is not necessary for kinase activity per se.  
 
However, it needs to be stated that autophosphorylation of PknG seems to be relevant for its 
in vivo role, since mycobacteria expressing PknG defective of undergoing 
autophosphorylation were not able any more to prevent lysosomal delivery and killing within 
macrophages. More defined experiments are needed to specify the function of 
autophosphorylated PknG in mycobacterial trafficking. 
 
In addition to the common function to activate kinases, autophosphorylation has been 
evidenced to be a prominent mechanism to create bindings sites for potential substrates 
which also could apply to PknG. Proteins containing forkhead-associated (FHA) domains for 
example recognize specific phosphothreonine-peptide motifs and states of the kinase 
(Durocher and Jackson, 2002; Pallen et al., 2002). Many of the so far identified in vivo and in 
vitro substrates of mycobacterial serine/threonine kinases have indeed been shown to possess 
FHA domains  (Molle et al., 2004, Molle et al., 2003) At this point, however, is should be 
mentioned that the genome of M. tuberculosis comprises only six FHA containing proteins 
(Cole et al., 1998), a relatively small number in view of the whole phospho-proteome, which 
is supposed to encompass (roughly estimated) 500-1000 pSer/pThr containing proteins 
(Greenstein AE, 2005). 
    
Taken together, it was demonstrated that autophosphorylation of PknG has a function 
different from the other mycobacterial kinases studied so far. Autophosphorylation was not 
linked to the catalytic activity of PknG, but was shown to be essential for the role of PknG in 
preventing lysosomal delivery and allowing survival of the bacteria.  
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5.1 Introduction 
 
 
PknG, a eukaryotic-type serine/threonine protein kinase expressed by pathogenic 
mycobacteria is secreted into the cytosol of macrophages, where it interferes with the 
maturation of the phagosome, thereby ensuring intracellular survival of the bacilli. Moreover, 
it was demonstrated that the kinase activity of PknG was required to block the fusion of 
phagosomes with lysosomes (Walburger, 2004). How, precisely, PknG achieves blocking of 
phagosome-lysosome fusion, has not been defined. 
 
Knowledge on the localization of PknG within the host cell might help to delineate its 
function. Therefore, in this chapter, two different approaches were used to study the 
localization of PknG. Firstly, by localizing PknG in established cell lines (HeLa, HEK293 
and Mel JuSo) transfected with pknG expression vectors and secondly, PknG localization 
was analyzed within macrophages upon infection.  
 
The results of this work may contribute to elucidate in which subcellular compartment PknG 
is localized and the findings obtained might be helpful with regard to the identification of 
potential substrates or interacting partners present in the same subcellular environment. 
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5.2 Results 
 
5.2.1. Localization of PknG in eukaryotic cells 
 
In order to analyze the role of PknG in eukaryotic cells, localization studies were carried out. 
To that end, different human cell lines, namely HeLa, HEK293 and Mel JuSo cells, were 
transfected with the eukaryotic pEGFP-N1::pknG vector in which the gfp gene was replaced 
by pknG. After 24 h, the cells seeded on slides were fixed by 3% PFA and immunostained 
using protein A purified polyclonal α-PknG antibody or, alternatively, with affinity purified 
polyclonal α-PknG antibody and crude anti-serum FB18. Fluorescence microscopy revealed 
that PknG was largely localized in the nucleus in all three cell lines (figure 5.1). No 
differences were observed for the different primary antibodies used. 
 
 
 
 
 
 
 
 
 
To further confirm these findings, pknG was cloned into a different eukaryotic vector, pIRES, 
for expression of full length PknG. The experiment was performed as described above using 
Mel JuSo cells (figure 5.1). Again, PknG was detected in the nucleus of the cells.  
 
To determine the domain or sequence responsible for translocating PknG to the nucleus, 
different truncated versions of pknG were cloned and ligated into the pIRES vector (figure 
5.2). The following experiments were carried out using HeLa cells. Cells were transfected, 
fixed using 100% MeOH and stained with protein A purified α-PknG and Alexa-568 
antibodies prior to analysis by fluorescence microscopy. The analysis of the mutant proteins 
(figure 5.3) revealed that PknG-∆N1 and PknG-∆C1 localized to the nucleus, similar to the 
localization of PknG full length. Nuclear localization was also observed for PknG-∆N2 and 
PknG-kin, but here the protein formed distinct clusters. This finding might be explained by 
improper folding of these two proteins both missing the N-terminal rubredoxin motif. 
A B C D
Figure 5.1. Nuclear localization of PknG. HeLa (A) and Mel JuSo (B) cells transfected with pEGFP-N1::pknG
were incubated for 24 h at 37°C. In addition, Mel JuSo cells (C, D) transfected with pIRES::pknG. The cells were 
fixed by 3% PFA and immunostained using Protein A purified α-PknG and Alexa-568 antibodies and analyzed by 
fluorescence microscopy. Bar: (A-C) 20 µm, (D) 10 µm. 
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However, the sequence for nuclear translocation must still be present. In cells expressing 
PknG-∆C2 and PknG-∆C3, most of the signal was found in the cytoplasm; in some cases 
even excluding the nucleus. For the K/M mutant, the localization was not clear, since the 
protein was found in the area of the nucleus as well as in the cytoplasm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5.2. Overview of the PknG mutant proteins expressed in eukaryotic cells. Using the jetPEI 
transfection reagent, HeLa cells were transfected with different pIRES vectors for expression of wildtype 
PknG and mutant proteins. After 24 h, the cells seeded on slides were fixed, immunostained and prepared for 
microscopy analysis.  
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Figure 5.4. Western Blot analysis of PknG expression. 
Lysates of HeLa cells were prepared by using Triton X-
100. Per sample, 15 µg lysate were loaded on a 10% SDS-
PAGE. PknG was detected using the same antibody 
(protein A purified FB18) as for the microscopy analysis. 
Due to the cytoplasmic localization of the mutants displaying a C-terminal deletion, this 
domain including the TPR motif might be responsible for the nuclear localization. However, 
even the isolated PknG kinase domain located in the nucleus making thed result difficult to 
interpret. Vectors for expression of PknG P-mutant and C/S mutant were constructed, but not 
included at this stage of the analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In parallel, expression of PknG and mutant proteins was analyzed. HeLa cells were lysed 24 
hours after transfection and the lysates 
were analyzed by Western Blot analysis. 
The results (figure 5.4) demonstrated 
that the proteins were expressed to 
different levels. For PknG-∆N2 and 
PknG-kin, no band was detectable 
suggesting absence of expression. 
However, the microscopy data clearly 
showed that PknG-∆N2 and PknG-kin 
were expressed, but to a smaller extend. 
In addition, the localization pattern of 
WT K181M ∆N1 ∆N2
Kin ∆C1 ∆C2 ∆C3
Figure 5.3. HeLa cells expressing PknG and mutant proteins. HeLa cells were transfected with pIRES 
constructs for the expression of PknG wildtype and mutant proteins K/M, ∆N1, ∆N2, Kin, ∆C1, ∆C2 and ∆C3. The 
cells were fixed by 3% PFA, immunostained using α-PknG and Alexa-568 antibodies and analyzed by 
immunofluorescence microscopy. Bar: 20 µm. 
_______________________________________________________________________________CHAPTER 5 
114 
protein clusters differed from the diffused localization observed for PknG full length. These 
findings might support the idea of improper PknG folding. Another kinase domain construct, 
expressed and purified from E. coli was shown to be unstable in previous studies. 
 
In order to confirm the localization patterns of PknG by using a different expression vector, 
pknG and truncated fragments (figure 5.2) were additionally cloned into a vector which 
allowed the expression of 3xFLAG-tagged proteins (figure 5.5). In case the nuclear 
localization for PknG wildtype is reproduced experimentally, 3xFLAG-pknG can be 
transferred into a mycobacterial vector in order study the localization under more realistic 
conditions upon infection of host cells. 
 
 
 
 
 
 
Preliminary analysis of the localization of FLAG-PknG in Mel JuSo and HeLa cells showed 
that PknG wildtype localized in both cell types to the nucleus as observed before (figure 5.6). 
The nuclear localization was more even more distinct when using the FLAG vector and 
monoclonal α-FLAG antibody (as opposed to the α-PknG antibody).  
 
 
 
 
 
 
 
 
 
In addition, transfections were performed with different vectors to express FLAG-tagged 
PknG wildtype as well as the FLAG-tagged mutant proteins PknG-K181M, PknG-∆N1, 
PknG-∆N2, PknG-kin, PknG-∆C1, PknG-∆C2 and PknG-∆C3 (figure 5.2).  
 
Figure 5.5. FLAG-PknG 
(wildtype). The FLAG-tag is a 
small polypeptide which is 
repeated 3x (with slight 
modifications) and fused N-
terminally to PknG wt or 
mutant protein.  
HeLa Mel JuSo
Figure 5.6. Expression of FLAG-PknG 
(wt) by Mel JuSo and HeLa cells.  Mel 
JuSo and HeLa cells were transfected on-
slide with the 3xFLAG::pknG vector. After 
24 h, cells were fixed by 100% MeOH, 
stained by monoclonal α-FLAG and 
Alexa-488 antibodies and analyzed by 
immunofluorescence microscopy.  
Bar: 10 µm. 
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It was found that PknG-∆N1, PknG-∆N2, PknG-∆C1 localized, like PknG-wt, to the nucleus 
(figure 5.7). The kinase domain showed a different localization by forming distinct spots in 
the nucleus. Coronin 1, used as a control for cytoplasmic localization (Gatfield and Pieters, 
2000), was exclusively detected in the cytoplasm excluding the nucleus. For unknown 
reasons, no FLAG signal was detectable for PknG-∆C2, PknG∆-C3 and PknG-K/M. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
However, by using the protein A purified α-PknG antibody, a signal for all constructs was 
obtained. The mutant proteins with a C-terminal deletion were localized in the cytoplasm and 
nucleus whereas the kinase-dead mutant formed distinct dots in the cytoplasm (figure 5.8).   
A
B
C
E
F
D
Figure 5.7. Expression of FLAG-PknG mutant proteins in HeLa cells. The cells were fixed 24 h after 
transfection and stained with DNA dye DRAQ5 (blue) and α-FLAG antibody (green) to detect FLAG-PknG. 
The pictures are tripartite and show the staining of nucleus and PknG (small panels) and the merged picture 
(enlarged).  (A) PknG-wt, (B) PknG∆N1, (C) PknG∆N2, (D) PknG-kin, (E) PknG∆C1 and (F) Coronin 1 (as a 
control). Bar: 10 µm. 
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Figure 5.9. Expression of PknG wildtype in J774 
macrophages. The cells were seeded on slides, incubated 
for 2 h and transfected using the jetPEI reagent. After 24 
h transfection, the cells were fixed by MeOH and stained 
with DRAQ5 (blue) to label the nucleus (DNA) and α-
FLAG antibody (green) to detect 3xFLAG-PknG. 
Bar: 10 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Taken together, the results obtained before with the α-PknG antibody were reproduced by 
using the N-terminal FLAG-tag as an epitope for the antibody.  
 
In an additional study, the same 
3xFLAG::pknG constructs were used for 
the transfection of J774 macrophages. 
The localization patterns were identical 
to the ones of HeLa cells, with the 
exception that PknG-K/M was 
predominantly found in the cytoplasm 
(personal communication V. Sundara-
murthy). The fact that PknG localizes 
also in macrophages to the nucleus 
(figure 5.9) justifies the construction of a 
mycobacterial vector for the expression 
of PknG upon infection of macrophages. 
 
 
 
A
B
?
?
?
?
?
C
 
Figure 5.8. Expression of PknG mutant proteins 
in HeLa cells. The cells were fixed 24 h after 
transfection and stained with DNA dye DRAQ5 
(blue) and α-PknG antibody (red) to detect PknG. 
The pictures are tripartite and show the staining of 
nucleus and PknG (small panels) and the merged 
picture (enlarged).  (A) PknG-∆C2, (B) PknG∆C3, 
and (C) and PknG-K/M. Bar: 10 µm. 
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5.2.2. Construction of a mycobacterial FLAG-PknG vector to be used for infections 
 
To be able to investigate the role of PknG upon infection of macrophages, a mycobacterial 
vector was constructed allowing the expression of FLAG-tagged PknG. To do so, 
3xFLAG::pknG was used as a template for the construction of the subcloning vector 
pGEM::3xFLAG::pknG. Sequence analysis of the FLAG region was performed to screen for 
mutants containing the three N-terminal FLAG repeats. The plasmid DNA from a positive 
clone was prepared and the insert was ligated into the target vector pSD5.  
Both, Mycobacterium smegmatis which does not express PknG and Mycobacterium bovis 
BCG pasteur depleted of pknG were transformed with a pSD5::3xFLAG::pknG and plated on 
7H10-Kanamycin agar. The colonies obtained 2-3 days (M. smegmatis) or 3-4 weeks (M. 
bovis BCG Pasteur) later were analyzed for the presence of 3xFLAG-PknG.  
Western Blot analysis was performed using a monoclonal α-FLAG antibody. All clones 
tested were found to express 3x-FLAG-PknG (figure 5.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thus, both mycobacterial strains can be used for the infection of J774 macrophages to 
analyze the localization of secreted PknG within its host cell, the macrophage.  
 
 
 
 
 
 
116
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31
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Mr (kDa)
wt      1       2     3       4       5       6      MJ 
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wt   ko 1       2      3      4
Figure 5.10. Expression of 3x FLAG-PknG by mycobacteria. Using the mixer mill, lysates of M. bovis 
BCG Pasteur ∆PknG (left panel) and M. smegmatis (right panel) transformed with 3xFLAG::pknG were 
prepared and the protein concentration was determined. Ten µg were loadad on a 10% SDS-PAGE and 
analyzed using the α-FLAG antibody. As controls, M. bovis wildtype (wt) and ∆PknG (ko) as well as M. 
smegmatis (wt) and a lysate of PknG transfected Mel JuSo cells (MJ) were used. 
A B 
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5.3 Discussion 
 
PknG was shown to localize in the nucleus of HeLa, Mel JuSo and J774 macrophages. 
However, PknG does not possess a classical nuclear localization sequence (NLS) (Boulikas, 
1993); thus it remains unclear how PknG is translocated into the nucleus. Nevertheless, the 
nuclear localization observed by microscopy as described here should be further verified by 
performing biochemical experiments, for example by cell fractionation and subsequent 
analysis of PknG in the nuclear fraction.  
 
The analysis revealed that PknG displayed a diffuse distribution within the nucleus; however, 
certain nuclear structures were clearly excluded (see figure 5.1-D). Therefore it is worth to 
investigate in detail to which nuclear compartments PknG localizes. A motif scan (Dellaire et 
al., 2003) predicted that PknG might localize to the nuclear lamina, however the nucleoplasm 
seems more likely to be the site of localization with regard to the PknG pattern observed in 
the nucleus.  
 
Proteins with a diffused nuclear localization are detected throughout the nucleoplasm but are 
generally excluded from nucleoli (Sutherland et al., 2001). Many transcription factors display 
a nuclear diffused localization pattern; among them are C2H2 zinc finger proteins which 
represent the largest class of these nuclear diffused proteins, accounting for more than 12% 
of all DNA binding proteins (Sutherland et al., 2001). 
 
A motif scan using the PROSITE database predicted a FtsK-like domain at the C-terminus of 
PknG (amino acid position 687-750). FtsK is known to translocate DNA in order to transport 
chromosomes within the bacterial cell (Massey et al., 2006; Ptacin, 2006). The degree of 
structural similarity between the FtsK and PknG remains to be established. However, the 
PknG-∆C1 mutant lacking this region still localized to the nucleus, therefore, DNA binding 
mediated by this motif seems unlikely. Potential PknG-DNA interactions can be tested for 
example by performing band-shift experiments.  
 
In conclusion, it was found that PknG localizes to the nucleus in mammalian cells, 
independent from the cell line, vector or antibody used in the different studies. Experiments 
involving infected macrophages will be required to analyze the localization of mycobacterial 
PknG released within host cells.  
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Definitive conclusions regarding the exact subnuclear localization or the domain responsible 
for nuclear import cannot be drawn at this stage of analysis; however, preliminary data show 
that the C-terminal domain might contain a sequence which determines the subcellular 
localization. In addition, the finding that PknG is located in the nucleus might stimulate the 
substrate search within the nucleus. 
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6.1 Abstract 
 
In most rod-shaped bacteria, maintenance of the cell shape is accomplished by MreB-like 
proteins forming an actin-like cytoskeletal scaffold for cell wall synthesis; however, 
components that determine the more flexible rod-like shape in actinobacteria are unknown. 
Mycobacterium smegmatis expresses an essential protein, termed Ag84, which is 
homologous to eubacterial DivIVA proteins that function in cell division. 
To elucidate the function of Ag84, the protein was overexpressed in M. smegmatis. Upon 
overexpression, the cells became elongated and wider; Ag84 was distributed asymmetrically 
to one pole, causing an aberrant cell shape presumably through uncontrolled cell wall 
expansion. In addition, Ag84 was found to form oligomers in vitro, consistent with more 
complex structures observed in vivo. The results obtained for Ag84 point to a role in cell 
divison and cell shape control. 
 
 
6.2 Introduction  
 
One reason for the success of mycobacteria as pathogens is their ability to remain dormant 
within the host for decades, without being recognized by the human immune system. During 
latency, mycobacteria persist while undergoing minimal replication (Manabe and Bishai, 
2000). In the case of reactivated disease, M. tuberculosis actively replicates in vivo. The 
factors responsible for alternating between these two states have not yet been determined. 
However, one critical component of this process might be the regulation of cell division and 
cell wall synthesis in response to certain signals sensed in the hostile environment of the host 
(Kang et al., 2005). Two component-systems and serine/threonine protein kinases such as 
PknA and PknB are likely to transmit signals by reversible phosphor-transfer reactions to 
effector proteins involved in the control of cell division and cell shape.  
  
In rod-shaped bacteria, cell division usually results in the formation of hemispherical cell 
poles, which then remain inert (De Pedro et al., 1997). Elongation of the bacterial cell 
requires extension of the lateral cell wall through incorporation of new peptidoglycan into the 
wall, a process in which MreB, a homologue of actin, is involved (Carballido-Lopez, 2006). 
Rod-like bacteria express MreB and MreB-like (Mbl) proteins which, when assembled, form 
cytoskeletal structures defining the site of cell wall synthesis (Daniel and Errington, 2003; 
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Egelman, 2003; Jones et al., 2001). In addition, by binding proteins such as MreC, MreD or 
RodA, the Mre-based cytoskeleton recruits enzymes, for example penicillin-binding proteins 
(PBPs), which are part of the cell wall synthesis machinery (Cabeen and Jacobs-Wagner, 
2005; Divakaruni et al., 2005; Kruse et al., 2005; Leaver and Errington, 2005). MreB 
depletion in E. coli was reported to result in the formation of coccoid cells, supporting the 
role of MreB in the control of cell shape (Kruse et al., 2005). The function of MreB is control 
of cell width, whereas Mbl proteins are responsible for control of the cell length; thus, both 
proteins help maintaining the rod-like cell shape (Stewart, 2005). 
 
Interestingly, Actinobacteria, gram-positive bacteria having a high G+C content, display a 
different and mreB-independent mode of cell elongation. Here, the presence of MreB does 
not correlate with a rod-like shape. Mycobacterial genomes lack mreB homologs, but have 
primarily a rod-like shape. However, it should be noted that mycobacteria are as well 
pleiomorphic under certain conditions. It has been demonstrated that M. tuberculosis cells are 
shortened in older cultures (Nyka, 1974), can become filamentous within macrophages 
(Chauhan et al., 2006), ovoid under carbon starvation (Ojha et al., 2000) and have different 
cell shapes also in the stationary phase of growth (Dahl, 2005). Thus far, no cell shape 
determinants have been identified in mycobacteria. 
 
Not only the control of the cell shape, but also cell division seems to be different in 
mycobacteria. Septum formation, a critical step of cell division, is initiated by the assembly 
of FtsZ proteins into a ring structure at the midcell of rod-shaped bacteria. Two mechanisms 
have been described which determine the site of septum formation: First, nucleoid occlusion 
which excludes septum formation along the central part of the rod and second, proteins of the 
MinCD system (Edwards and Errington, 1997; Mulder and Woldringh, 1989), which in B. 
subtilis localize to the poles and inhibit FtsZ formation in this region, thereby targeting the 
midcell as a site of cell division (Marston and Errington, 1999; Marston et al., 1998). In B. 
subtilis, the protein responsible for retaining MinC and MinD at the poles, is DivIVA 
(Edwards and Errington, 1997).  
However, in mycobacteria, such a MinCD system does not exist and factors defining the site 
of septum formation have not yet been found. 
 
By sequence analysis, Ag84 has been identified to be the mycobacterial orthologue of the B. 
subtilis cell division protein DivIVA. This protein, encoded by the wag31 gene, is a highly 
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conserved mycobacterial antigen recognized by sera from people infected with M. 
tuberculosis and M. leprae (Hermans et al., 1995). In gram-positive species, functional 
studies of DivIVA demonstrated that the protein is involved in regulation of septum 
formation and nucleoid segregation (B. subtilis). In addition, a role in morphology has been 
proposed as shown in Streptomyces coelicolor (Flardh, 2003). B. subtilis wag31 is not 
essential, but inactivation or overexpression of DivIVA resulted in a strong morphological 
phenotype such as production of mini-cells or generation of filamentous cells (Cha and 
Stewart, 1997). Depletion of wag31 led to non-viable cells in several gram-positive bacterial 
species, e.g. Brevibacterium lactofermentum, Enterococcus faecalis as well as S. coelicolor, 
(Flardh, 2003; Ramirez-Arcos et al., 2005; Ramos et al., 2003). Overexpression of DivIVA 
in other actinobacteria such as S. coelicolor, led to enlarged ovoid cells and ghost cells 
indicating lysis. Interestingly, in Staphylococcus aureus, neither cell morphology nor growth 
or chromosome segregation was affected in a divIVA null mutant (Pinho and Errington, 2004).  
 
Ag84 is composed of 260 AA corresponding to a molecular weight of 28.3 kDa. The C-
terminal part of Ag84 is predicted to comprise a coil-coiled domain of 54 amino acids 
(source: Swissprot). 
 
Given the fact that certain proteins involved in cell shape control (MreB or Mbl proteins) or 
cell division (MinC, MinD) are missing in mycobacteria, the question arises how these 
processes are regulated and coordinated in this species which is characterized by a complex 
life-style. Studying the effect of Ag84 overexpression and investigating the structural 
organization of Ag84 (molecules) might therefore help to define a role for Ag84 in 
mycobacteria. Moreover, the outcome of the experiments might contribute to a better 
understanding of mycobacterial cell biology. 
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6.3 Results 
 
6.3.1 Effects of Ag84 overexpression on cell morphology 
 
To investigate the role of Ag84 in mycobacteria, transduction experiments were carried out 
to delete the wag3 locus. However, it was found that wag31 is essential for mycobacterial 
survival. Viable cells were only obtained when a vector containing wag31 under control of 
an acetamid-inducible promoter was provided in trans (Nguyen et al, 2007).  
 
Therefore, to shed light on the function of Ag84, the protein was overexpressed in M. 
smegmatis, a non-pathogenic representant of fast-growing mycobacteria. To that end, M. 
smegmatis electrocompetent cells were transformed with pMV361::ag84MS (pNDL4) and 
pMV361::ag84TB (pNDL8) for expression of Ag84 from M. smegmatis (MS) and M. 
tuberculosis (TB); as a control, the bacteria were transformed with vector pMV361. On day 2 
after transformation, colonies became visible and live cells resuspended in medium were 
analyzed by phase-contrast microscopy. It was found that Ag84 overexpressing cells 
displayed a strong phenotype reflected in altered cell morphology and increased cell size. 
The bacteria showed a wide diversity of different cell shapes ranging from bulbous and bulky 
cell morphology to bowling-pin, or oversized rod-like shaped cells (figure 6.1), the two latter 
ones being the most commonly found aberrant cell shapes. No phenotypical differences 
could be detected when comparing the mutant strains expressing Ag84MS or Ag84TB, 
respectively. 
 
 
 
 
 
 
 
 
 
 
 
An additional phenotype found among these cells was branch formation. Individual stages of 
bud initiation, bud emergence and branch formation were detected; these observations were 
confirmed by electron microscopy (Nguyen et al., 2007).  
Figure 6.1. Morphology of M. smegmatis cells overexpressing Ag84. The bacteria were transformed with either 
pNDL4 (pMV361::ag84MS) or pNDL8 (pMV361::ag84TB), grown on 7H10-10% OADC agar (25 µg/ml Kan), 
resuspended and observed in an early growth stage by phase-contrast microscopy. The first panel shows M. 
smegmatis transformed with pMV361 vector as a control. Scale bar: 2 µm. 
_______________________________________________________________________________CHAPTER 6 
125 
Electron microscopy studies also revealed that cell division was affected in Ag84 
overexpressing cells. Septum formation, normally taking place in the midcell, occurred 
adjacent to one pole, in nearly all cases close to the narrow pole. In some cases, this 
asymmetric cell division gave rise to the formation of minicells (Nguyen et al., 2007).                                      
 
 
6.3.2 Effects of Ag84 overexpression on cell size 
 
To analyze the result of Ag84 overexpression regarding cell size, M. smegmatis was 
transformed with pMV361::ag84MS and analyzed on day 2 after transformation. In this initial 
growth phase, the cell size, comprising cell length and width, was drastically altered (figure 
6.2). Microscopical analysis revealed that 95-100 % of the cells displayed a strong increase 
in cell length and width when compared to wildtype bacteria typically being 2-2.5 µm long 
and 0.4-0.6 µm wide. In several cases, cells of 20 µm and more were observed, which is 
about 10x the normal size of mycobacteria.  
 
 
To analyze whether this phenotype is still detectable at later time points of growth, the 
morphology of mycobacteria with special focus on the cell size was observed for a period of 
8 days. M. smegmatis was transformed with pNDL1 (pMV361::ag84MS::gfp), pNDL4 
(pMV361::ag84MS) and pNDL8 (pMV361::ag84TB) and vector pMV361 as a control. Starting 
on day 2 after transformation, the cells were resuspended in medium and analyzed by phase-
contrast and fluorescence microscopy. To quantify the changes in cell size, width and length 
of ~ 100 cells were measured for one week. The analysis revealed, that the average size 
decreased from around 1.5 x 6 µm to 0.6 x 2.5 µm similar to wildtype dimensions (see figure 
6.3).  
 
Figure 6.2. Effect of 
Ag84 overexpression in 
mycobacteria.  
Cells transformed with 
pMV361::ag84MS (left 
panel) or with pMV361 
vector control, (right 
panel), incubated for 2 
days and analyzed by 
phase-contrast. Bar in the 
lower right corner: 2 µm. 
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Figure 6.4. Kinetics of Ag84 overexpression associated with 
induced changes in cell morphology. M. smegmatis lysates were 
prepared daily from cells grown on agar plate and analyzed by 
western blots using Ag84 specific F126-2 antibody.
 
Ag84-GFP
Ag84
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To investigate whether the increased cell size and the aberrant cell morphology observed in 
the initial growth phase are reflected in the protein expression levels, western blot analysis 
was carried out. Lysates of M. smegmatis expressing Ag84MS-GFP were prepared at the times 
indicated (figure 6.4) and analyzed using Ag84 specific antibody. Two bands per sample 
were detected; the lower band 
corresponding to Ag84 expressed 
from its native promoter and the 
upper band representing Ag84MS-
GFP overexpressed from the hsp60 
promoter. Comparison of the 
expression levels revealed that 
Ag84MS-GFP overexpression is 2-3 
x higher than expression of native 
Ag84 in the early growth phase (see 
figure 6.4). However, the amount of Ag84MS-GFP decreased over time to about 50% on day 
8.  In accordance with the loss of phenotype on day 6, levels of Ag84-GFP were considerably 
reduced at these time points. 
 
 
 
 
 
 
Figure 6.3. Quantification of the cell size over time. Mean values of cell length and width of M. smegmatis 
MC2155 cell measured at interval time points (days) after transformation with pMV361 (blue), pNDL1 (yellow), 
pNDL4 (red) and pNDL8 (green). Cell size was measured as described in the text. Error bars represent standard 
deviation of the mean (n~100 cells per strain). 
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6.3.3 Intracellular localization of Ag84 
   
Since Ag84MS contained a C-terminal GFP-tag, the localization of Ag84 within bacteria 
could be adressed. Initial experiments with M. smegmatis cells transformed with a vector 
containing wag31::gfp for integration at the chromosomal locus showed that Ag84 is equally 
distributed at both cell poles (data not shown). However, in oversized bowling pin-shaped 
cells, Ag84MS-GFP was asymmetrically distributed, localizing mainly to the enlarged pole, 
which suggests that Ag84 influenced polar cell wall extension resulting in increased cell 
length and width (figure 6.5).  
In addition, studies including the membrane marker FM4-64 revealed that septum formation 
did not occur adjacent to high accumulations of Ag84, but at the opposite site at the narrow 
pole containing less Ag84 (data not shown). 
 
 
 
 
 
 
 
 
 
 
A quantitative analysis over a 8 days period showed that along with the decrease in cell size 
and the progressively normalized cell shape, the intensity of Ag84MS-GFP per cell declined 
and became more equally distributed between the cell poles (figures 6.5, 6.6). It was 
demonstrated that 2% of the cells displayed an asymmetric Ag84 distribution in the early 
growth phase, whereas at later time points, around 95% of the cells exhibited a symmetric 
distribution similar to the wildtype (figure 6.6). Furthermore, in some cells, Ag84 was found 
to localize to structures within the cylindrical part of the cell; these structure are believed to 
represent an early stage of bud initiation (data not shown).  
 
 
 
 
Figure 6.5. Intracellular 
localization of Ag84. M. 
smegmatis cells overexpressing 
Ag84-GFP were analyzed by 
phase-contrast microscopy for 8 
days. Depicted here are cells 
analyzed on day 2 (A) and day 
10 (B) after transformation.  
Bar: 2 µm 
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6.3.4 Oligomerization of Ag84 
 
In order to investigate whether Ag84, observed at the cell poles, is an integral protein of the 
cell wall, the subcellular localization of Ag84 was analyzed. Cell fractionation with M. 
smegmatis lysates, followed by Western blot analysis using monoclonal antibodies was 
performed. Ag84 was only found in the supernatant indicating that Ag84 is a cytosolic 
protein (figure 6.7). The fact that Ag84 is not present in the membrane fraction suggests that 
the polar localization observed by microscopy is not explained by strong hydrophobic 
interactions with the cell wall.  
 
 
 
 
 
 
 
 
 
Another possibility would be that polar localization is a consequence of the three-
dimensional shape of Ag84 multimers that fit into the curvature of the pole. To test this, a 
series of experiments was carried out. Initial in silico analysis (MultiCoil program; 67) 
 
 
Figure 6.6. Time-dependent 
symmetric versus asymmetric 
localization of Ag84 in M. 
smegmatis overexpressing 
Ag84-GFP. Bacteria from 
colonies grown on plates at 
37°C were resuspended in 
liquid medium and diluted to a 
density of 10 to 20 cells per 
focal plane. Around 100 cells 
were analyzed at interval time 
points after transformation. 
 
Figure 6.7. Subcellular localization of Ag84 in 
M. smegmatis lysates. Bacterial cultures were 
grown at 37o C in 7H9-OADC medium and cellular 
fractionation was carried out as described in 
Material and Methods. Ag84 was detected in 
subcellular fractions by Western Blot using F126-2 
antibody. GroEL and lipoprotein specific 
antibodies were used as controls for cytosolic and 
membrane proteins, respectively (t: total cell 
extract, s: supernatant, p: pellet). 
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predicted two coil-coiled domains which are commonly known for catalyzing polymerization 
(data not shown). 
To analyze whether Ag84 oligomerizes in vivo, M. bovis BCG lysates were prepared and 
treated with increasing concentrations of the cross-linking agent formaldehyde. Western blot 
analysis revealed the presence of Ag84 oligomers, which, according to their molecular 
weight, could be assigned as dimers, tetramers and hexamers (figure 6.8). A 19 kDa 
lipoprotein unable to polymerize was used as a control. The presence of oligomers was also 
analyzed with purified Ag84 by incubating the sample with different concentrations of 
formaldehyde, and bands corresponding to dimers, tetramers and hexamers were identified. 
However, the existence of higher-order multimers could not be excluded due to the limited 
resolution of the SDS-PAGE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Finally, Ag84 oligomerization was analyzed by size-exclusion chromatography. To that end, 
M. bovis BCG was lysed and the lysate was applied to a gel filtration column. The eluted, 
protein-containing fractions were collected and tested for presence of Ag84 by Western 
blotting (figure 6.9). Ag84 was detected in a single fraction with an approximate molecular 
weight of 670 kDa confirming the presence of oligomers.  
 
 
 
  
Figure 6.8. Analysis of Ag84 oligomerization by 
crosslinking. M. bovis BCG in cell extracts (A) and 
purified in M bovis BCG Ag84 protein (C) were 
incubated with different concentrations (0.1 to 2%) of 
formaldehyde followed by SDS-PAGE and 
immunoblotting to detect mono- and oligomers with 
Ag84-specific F126-2 antibody. A lipoprotein-specific 
antibody was used as a control (B). Data shown in (C) 
obtained by A. Walburger. 
A
B C
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Figure 6.9. Size-exclusion chromatography to analyze the molecular weight of Ag84 oligomers. 
Cell lysates of M. bovis BCG were applied to a gel filtration column equilibrated in PBS and fractions 
were collected. Values representing the molecular weights of standards eluting at different fractions are 
indicated above the chromatogram. (*) Ag84. 
*
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6.4 Discussion 
 
The fact that the wag31 gene is essential for survival, as well as the effects of Ag84 
overexpression suggest that Ag84 plays a crucial role in cell growth and division. In wildtype 
bacteria having an average rod-like cell shape of 2 µm x 0.6 µm, Ag84 is distributed equally 
at the cell poles. This equal distribution inhibits septum formation near the poles during 
elongation and ensures balanced cell wall extension. Upon overexpression, Ag84 
accumulates at one pole which is accompanied by various morphological effects like bulbous 
and bowling pin-like cell shapes. Such an increase in volume and cell mass can only be 
accomplished by a highly active cell wall synthesis machinery pointing to a possible role of 
Ag84 in cell growth. In addition, mutant mycobacteria exhibit defects in septum formation 
accompanied by the generation of mini cells. Septum formation only occurred in regions 
adjacent to the smaller cell pole implying that Ag84 might carry out a function in regulation 
(inhibition) of septum formation. The model proposed summarizes and illustrates the effects 
of Ag84 (figure 6.10). 
 
 
 
 
 
 
 
 
 
 
 
 
Oligomerization of DivIVA has been studied in-depth in B. subtilis. Using analytical 
ultracentrifugation and blue native gel electrophoresis, oligomers of 10-12 molecules have 
been detected (Muchova et al., 2002). Individual mutants carrying single point mutations 
within the predicted catalytical core displayed partly altered multimerization and had a 
morphological phenotype reflected in an increased cell length indicating that oligomerization 
of DivIVA seems to be important for its biological function (Muchova et al., 2002). Coiled-
coil structures, composed of two or more alpha-helices wound around one another, are 
Figure 6.10. Model explaining how Ag84 overexpressing 
in M. smegmatis results in pleiomorphism. Overexpressed 
Ag84 (green) progressively accumulates at one pole (A, B). 
This results in cell wall expansion (red) and localized 
increase in cell diameter at one pole with septation observed 
at the opposite pole (C). This creates bowling-pin shaped 
giant cells (D2) and small cells (D3). Alternatively, a 
recovery in balanced distribution of DivIVA creates rod-
shape giant cells (D1).  Untargeted accumulation of Ag84 
along the lateral cell wall stimulates cell wall expansion 
leading to the formation of branches (D4). 
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known to stabilize higher-order structures, often at membrane interfaces (Rose et al., 2005). 
By cryonegative stain transmission electron microscopy, B. subtilis DivIVA was shown to 
exist as doggy-bone shaped oligomers, which further polymerize end-to-end to form pairs 
(Stahlberg et al., 2004). These assemble to strings and continued lateral oligomerization 
results in wires which then form a two-dimensional network. The lattice-forming properties 
might have a biological function similar to FtsZ, the tubulin homologue which polymerizes 
in a GTP-dependent manner to form filaments and sheets. DivIVA, as a homologue of 
tropomyosin which is known to bind actin, might oligomerize in order to anchor different 
proteins allowing the control of complex processes (Stahlberg et al., 2004).  
 
Interestingly, Ag84 was identified of being the substrate of protein kinase A (PknA) in vitro 
and in vivo. The kinase specifically phosphorylates Ag84 on a single threonine residue 
(threonine 73) within the intercoiled region. Moreover, it has been demonstrated that the 
phosphorylation state of Ag84 is important for its functionality. Therefore it is likely that 
Ag84 activity is regulated by phosphorylation through PknA which, in principle, could 
trigger Ag84 oligomerization and activity. PknA, an essential serine/protein kinase, has been 
shown to be involved in chromosome segregation and maintenance of cell morphology 
supporting a role of Ag84 in a pathway controlling cell shape and division. 
 
In conclusion, it has been demonstrated that M. smegmatis Ag84 is an essential protein 
responsible for maintaining the cell shape presumably by ensuring balanced cell wall 
extension in mycobacteria, which is likely to occur upon oligomerization of Ag84. By 
forming more complex/organized structures, Ag84 may provide a rigid scaffold stabilizing 
the cell shape and thereby possibly creating a binding surface for interacting proteins. The 
observation that Ag84 prevents septum formation in adjacent regions suggests that Ag84 in 
mycobacteria has an additional role in cell division. Thus, M. smegmatis Ag84 is a 
multifunctional protein which may compensate for the lack of cell shape (Mre, Mbl) and cell 
division (MinC, MinD) proteins in this genus of rod-shaped bacteria.  
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7. Summary and conclusions 
 
 
The genome of M. tuberculosis comprises eleven serine/threonine protein kinases which 
carry out various functions, e.g. in cell division, metabolism and pathogenicity. Nine of these 
eleven kinases are membrane-bound and have a C-terminal extracellular domain and an 
intracellular Hanks-type kinase domain located at the N-terminus. Protein kinase G (PknG) 
differs from these kinases, because it is predicted to be a cytosolic protein since it lacks a 
transmembrane domain. The kinase domain is preceded by a long N-terminal stretch 
containing two CXXC motifs. Moreover, PknG possesses a tetratricopeptide repeat within its 
C-terminal domain. PknG, expressed by pathogenic mycobacteria upon infection, has been 
shown to be secreted into the macrophage cytosol where it modulates and prevents 
phagosome-lysosome fusion, finally resulting in survival of the bacilli. 
 
A potent inhibitor, termed AX20017, was identified which specifically inhibited the catalytic 
activity of PknG in vitro. Infection of J774 macrophages with mycobacteria treated with 
AX20017 led to an increase rate of lysosomol delivery events. The same effect was observed 
when macrophages were infected with mycobacteria expressing a kinase-dead-version of 
PknG which strongly supports the idea that PknG activity is required for mycobacterial 
survival. A broad-ranged kinase assay screen including 25 kinases representatively chosen 
from the six major kinase families showed that the inhibitor was highly selective by 
inhibiting only PknG with high efficiency. Normal cellular processes within host cells were 
not affected. 
 
To elucidate the structural basis of inhibition of PknG and to learn more about the function of 
the kinase, the structure of PknG in complex with its inhibitor was solved. Since PknG full 
length was shown to be unstable, limited analysis was performed and a truncated version of 
PknG missing 8 kDa of the N-terminus was constructed. A purification protocol was 
established that allowed the purification of pure and stable protein. Crystallization assays 
were performed to screen for optimal conditions. The structure of dimeric PknG in complex 
with its specific inhibitor AX20017 was solved at a resolution of 2.4 Å using SIRAS. Three 
domains of PknG were defined: 
 a) The N-terminal region encompassing the two CXXC motifs, which were shown to 
complex iron, thus forming a rubredoxin domain 
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 b) The kinase domain displaying a closed configuration, with the inhibitor occupying the 
nucleotide-binding pocket 
 c) and the C-terminal domain with the tetratricopeptide repeat mediating dimerization of the 
two PknG molecules.  
 
The structure explained the high specificity of inhibition by AX20017. In total, 15 polar and 
non-polar interactions between the inhibitor and the kinase- or N-terminal domain were 
determined. Sequence alignments with all 518 human kinases derived from six major kinase 
families revealed that 6 of these interactions were not detected in any other kinase 
underlining the high specificity of inhibition. By expressing proteins with mutated inhibitor 
binding sites, these sites of interaction were further confirmed. 
 
Moreover, the molecular model of the kinase allowed insights into the regulation of PknG. 
Site-directed mutagenesis on the four cysteines forming the rubredoxin motif completely 
abolished PknG activity. This, in combination with the observed interactions between the 
rubredoxin domain and the lobes of the kinase domain, suggested that PknG activity might 
be regulated by the N-terminal globular domain. 
 
PknG undergoes autophosphorylation, similar to most mycobacterial kinases studied thus far. 
However, in-depth analysis of PknG autophosphorylation revealed significant differences. 
Whereas most mycobacterial kinases display a conserved autophosphorylation pattern on the 
activation loop, phosphorylated residues in PknG were exclusively identified at the N-
terminus. For PknG, classified as the unique mycobacterial non-RD kinase due to a missing 
arginine residue in the catalytic loop, absence of autophosphorylation in the activation loop 
was suggested. By performing kinase assays using constructs lacking the potential N-
terminal phosphorylation sites, this assumption was confirmed. Moreover, by analyzing these 
mutants on an endogenous substrate, it was demonstrated that autophosphorylation is not a 
prerequisite for activating the catalytic activity of PknG.  
Infection experiments with mycobacteria expressing mutated unphosphorylated PknG protein 
indicated that autophosphorylation is crucial for the role of PknG in preventing lysosomal 
delivery. Preliminary results of survival assays showed that mycobacteria which express 
PknG devoid of autophosphorylation sites were rapidly transferred to lysosomes and 
degraded. 
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To further understand the activity of PknG within host macrophages, PknG was localized in 
eukaryotic cells. Upon transfection, PknG was detected in the nucleus of HeLa, Mel JuSo 
and HEK cells. Transfection assays with different truncated PknG constructs point to the C-
terminal TPR containing domain of PknG for being responsible for nuclear translocation.  
 
In addition, Ag84, a downstream target of PknA, was studied. To address its function, Ag84 
was overproduced in mycobacteria. Overexpression resulted in drastic changes in cell 
morphology, particularly in cell size and shape. Localization studies revealed that wildtype 
Ag84 localized equally to the cell poles, whereas overexpressed Ag84 was asymmetrically 
distributed at the poles leading to unbalanced cell wall extension. Furthermore, 
overexpressed Ag84 was found to affect cell division by preventing septum formation 
adjacent to the cell pole with higher Ag84 concentrations. Biochemical analysis revealed that 
Ag84 is a cytosolic protein. As an alternative explanation for the polar localization, 
oligomerization of Ag84 was analyzed. Chemical crosslinking and size-exclusion 
chromatography analysis showed that Ag84 is able to form oligomers of >6 molecules which 
might act as a complex scaffold fitting to the curvature of the cell poles. This complex 
structure then might allow recruiting other proteins involved in processes such as cell wall 
synthesis. 
Ag84 is the first effector protein, for which a role in mycobacterial cell shape control has 
been described. In addition, Ag84 was found to be involved in septum formation and 
therefore has a similar role as B. subtilis DivIVA, which in Bacillus however interacts with 
the MinCD system that is absent in mycobacteria. 
 
To conclude, the results presented in this thesis contribute to a better understanding of 
mycobacterial virulence. The knowledge of the structure of PknG might be particular useful 
with regard to the design of more potent drugs and the biochemistry data obtained for PknG 
allowed important insights into function and regulation of this eukaryotic-like 
serine/threonine protein kinase. Taken together, the results add more information to the 
complex network of mycobacteria-host interactions. 
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I. Abbreviations 
 
 
aa   Amino acid 
Ab   Antibody 
Ag84   Antigen 84 
Amp   Ampicillin 
AP   Alkaline phosphatase 
APS   Ammonium persulfate 
ATP   Adenosine triphosphate 
BCA   Bicinchoninic acid 
BCG   Bacille Calmette Guérin 
BMM   Bone marrow-derived macrophages 
BSA   Bovine serum albumin 
CAPS   N-cyclohexyl-3-aminopropanesulfonic acid 
CLAAP  Chymostatin, leupeptin, aprotinin, antipain, pepstatin 
conc.   Concentration 
CPM    Counts per minute 
DMEM  Dulbeccos’s modified Eagle’s medium 
DMSO  Dimethylsulfoxide 
DLS   Dynamic light scattering 
dNTP   Deoxynucleoside triphosphate 
DTT   Dithiothreitol 
ECL   Enhanced chemiluminescence 
EDTA   Ethylendiamine tetraacetate 
EtBr   Ethidium bromide 
EtOH   Ethanol 
FBS   Fetal bovine serum 
FCS   Fetal calf serum 
FF   Fast flow 
FHA   Forkhead-associated (domain) 
FPLC   Fast performance liquid chromatography 
G418   Geneticin 
GFP   Green fluorescent protein 
HEK   Human embryonic kidney 
HiLoad  High load (column) 
HRP   Horseradish peroxidase 
IC   Inhibitory concentration 
Ig   Immunglobulin 
Kan   Kanamycin 
KD   Kinase domain 
KO   Knock-out 
LAM   Lipoarabinomannan 
LAMP-1  Lysosome-associated membrane protein 1 
LB   Lysogeny Broth (Luria-Bertani Broth) 
LM   Lipomannan 
MDR   Multi drug-resistant (strains) 
MeOH   Methanol 
MHC   Major Histocompatibility Complex 
MM   Master mix 
Mr   Molecular weight 
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MS   Mass spectrometry 
NLS   Nuclear Localization Signal 
NMR   Nuclear magnetic resonance 
OADC   Oleic acid, albumin, dextrose and catalase supplement 
OD   Optical density 
O/N   Over night 
PAGE   Polyacrylamide gel electrophoresis 
PBS    Phosphate buffered saline 
PCR   Polymerase chain reaction 
PFA   Paraformaldehyde 
PEG   Poly ethylene glycol 
PFA   Paraformaldehyde 
pH   Potential hydrogenii 
PknX   Protein kinase x 
PMSF   Phenylmethylsulfonylfluoride 
rpm   Round per minute 
RT   Room temperature 
SAP   Shrimp alkaline phosphatase 
SB   Sample buffer 
SD   Sensor domain 
SDS   Sodium dodecylsulfate 
SIRAS   Single isomorphous replacement anomalous scattering 
SLS   Static light scattering  
TB   Tuberculosis 
TBE   Tris-borate-EDTA 
TCA   Trichloracetic acid 
TE   Tris-EDTA 
TEMED  N, N, N’, N’-tetraethylmethlylendiamide 
TEN   Tris-EDTA-NaCl 
TLC   Thin-layer chromatography 
TPR   Tetratricopeptide repeat  
Tris   Tris(hydroxyethyl)aminomethane 
TX-100  Triton X-100 
U   Unit 
UV   Ultraviolett  
WT   Wild type 
XDR   Extremely drug-resistant (strains) 
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